patient_filename,text,processed_outputs
TCGA-BB-A5HZ.DF88E41E-7CBD-468E-9D42-A2D7AEA8183B,"SURG PATH REPORT. FINAL DIAGNOSIS. Primary Pathologist: Other Pathologist: 1. UPPER LIP SKIN MARGIN #1 (EXCISION) : NEGATIVE FOR TUMOR. 2. LOWER LIP SKIN MARGIN #2 (EXCISION) : NEGATIVE FOR TUMOR. 3. MARGIN #3 (EXCISION) : NEGATIVE FOR TUMOR. 4. MARGIN #4 (EXCISION) : NEGATIVE FOR TUMOR. 5. MARGIN #5 (EXCISION) : NEGATIVE FOR TUMOR. 6. MARGIN #6 (EXCISION) : NEGATIVE FOR TUMOR. 7. MARGIN #7 (EXCISION) : NEGATIVE FOR TUMOR. 8. RIGHT CHEEK MARGIN #8 (EXCISION) : NEGATIVE FOR TUMOR. FOCAL. FOREIGN BODY GIANT CELL REACTION. 9. UPPER LIP MUCOSA MARGIN (EXCISION) : NEGATIVE FOR TUMOR. 10. LOWER LIP MUCOSA MARGIN (EXCISION) : NEGATIVE FOR TUMOR. 11. MAXILLARY BUCCAL GINGIVAL SULCUS (EXCISION) : NEGATIVE FOR. TUMOR. 12. RETROMOLAR TRIGONE MARGIN (EXCISION) : NEGATIVE FOR TUMOR. 13. FLOOR OF MOUTH MARGIN (EXCISION) : NEGATIVE FOR TUMOR. 14. MANDIBLE AND CHEEK (COMPOSITE RESECTION) : SPECIMEN TYPE: Resection (specify type) : mandible and cheek. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension: 7. 5cm. HISTOLOGIC TYPE: Carcinomas of upper aerodigestive tract: squamous cell carcinoma,. conventional. HISTOLOGIC GRADE: G2: Moderately differentiated. EXTENT OF INVASION (7th Edition AJCC) : PRIMARY TUMOR (pT) : oT4a: Oral cavity: tumor invades skin of face. REGIONAL LYMPH NODES (pN) : pN1: Metastasis in a single ipsilateral lymph node, 3cm or. less in great dimension. See note. Specify: Number examined: 39. Number involved: 1. Extracapsular Extension of Nodal Tumor: Present. MARGINS. Margins uninvolved by tumor (see parts 1-13) . Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHERWISE NOTED ON THE DETAIL PAGE, ALL LAB RESULTS PERFORMED AT: page 1 or 2. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION: Indeterminate. PERINEURAL INVASION: Indeterminate. Note: The involved node is present in the main resection specimen. The tumor focus is 0.2 cm in greatest dimension. 15. LYMPH NODES, RIGHT NECK (DISSECTION) : THIRTY SEVEN (37) LYMPH. NODES AND BENIGN SALIVARY TISSUE, NEGATIVE FOR TUMOR. Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHERWISE NOTED ON THE DETAIL PAGE, ALL LAB RESULTS PERFORMED AT: Page 4 or 2.","Squamous cell carcinoma, conventional, moderately differentiated, with focal foreign body giant cell reaction. Tumor invades skin of face. Metastasis in a single ipsilateral lymph node with extracapsular extension of nodal tumor. Margins uninvolved by tumor. Venous/lymphatic invasion and perineural invasion are indeterminate. No tumor involvement in multiple margins, including upper lip skin, lower lip skin, right cheek, upper lip mucosa, lower lip mucosa, maxillary buccal gingival sulcus, retromolar trigone, and floor of mouth. Thirty-seven lymph nodes and benign salivary tissue from the right neck dissection are negative for tumor."
TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE,"Peferring Physician: Provider Group : Date of Service: Date Received: Room: A copy of this report will be faxed to: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. - B.) BREAST, AXILLARY LYMPH NODE, RIGHT, MASTECTOMY AND. SENTINEL LYMPH NODE BIOPSY (400): - Invasive lobular carcinoma, grade 1. - Multifocal, 40 mm, 14 mm and 5 mm in greatest dimension. - Lobular carcinoma in situ (LCIS). - Surgical margins negative. - One of two lymph nodes, POSITIVE metastatic carcinoma (1/2). - Largest focus in lymph node: 2.5 mm. - No extracapsular extension identified. C. BREAST, LEFT, MASTECTOMY: - Sclerosing adenosis, usual ductal hyperplasia, columnar cell change and. apocrine metaplasia. - No atypical hyperplasia or carcinoma identified. PATHOLOGIC TUMOR STAGING SYNOPSIS (RIGHT BREAST): Type and grade (invasive): Invasive lobular carcinoma, grade 1. Type and grade (in situ): Lobular carcinoma in situ (LCIS). Primary tumor: pT2. Regional lymph nodes: pN1a (1 of 2 lymph nodes POSITIVE). Distant metastasis: N/A. Pathologic stage: IIB. Lymphovascular invasion: Not identified. Margin status: R0, negative, all margins 20 mm or greater. Breast Invasive Tumor Stag. 7. Information. (AJCC Cancer Staging Handbook,. Ed, and. protocol,. This staging also incorporates: Previous biopsy: Breast profile: Printed: This report continues (FINAL). MR No. -. icct No. -. Pathology Report - Page 1/5. Specimen type: Total breast. Specimen procedure: Total mastectomy. Lymph node sampling: Sentinel lymph nodes. Specimen integrity: Single intact specimen. Specimen laterality: Right. Specimen size (other than mastectomy): N/A. INVASIVE TUMOR FEATURES: Invasive tumor size: 40 mm, 14 mm, 5 mm. Invasive tumor site: 10:30. Invasive tumor focality: Multiple foci. Histologic type: Invasive lobular carcinoma. Total Nottingham Grade: Grade 1, cumulative score 5 of 9. Tubule formation: Less than 10%, 3 of 3. Nuclear Pleomorphism: Low-grade, 1 of 3. Mitotic count for Nottingham: Low, 1 of 3. Mitotic count: 2 per 10 high power field. Other Grading System: N/A. Lymphatic invasion: Not identified. MARGIN STATUS FOR INVASIVE COMPONENT: R0, negative. Distance of tumor from margins: Closest margin: All margins 20 mm or greater. Other margins: N/A. DUCTAL CARCINOMA IN-SITU (DCIS): Not identified. LOBULAR CARCINOMA IN-SITU (LCIS): Present. Skin: Present, not involved. Nipple: Present, not involved. Skeletal Muscle: Not identified. LYMPH NODES: 1 of 2 lymph nodes positive, 2.5 mm focus, no. extracapsular extension identified. INVASIVE PATHOLOGIC TUMOR STAGING (pTNM). Primary tumor (pT): pT2. Regional lymph nodes (pN): pN1a (1 of 2 lymph nodes positive). Distant metastasis (pM): N/A. Pathologic stage: IIB. RECEPTOR STATUS AND HER2/NEU: Estrogen receptors: POSITIVE (99-100% positive cells. strong. intensity). Progesterone receptors: Negative (0% positive cells). Her2/neu: Negative (0, scale 0-3+). Ki-67 proliferative index: Intermediate (11% positive cells). Printed: This report continues. (FINAL). Acct No. -. S. Pathology Report - Page 2/5. FINAL SURGICAL PATHOLOGY REPORT. Comment: The touch preparation of the sentinel lymph. node biopsy was review and no evidence of. metastatic carcinoma is identified. Additional pathologic findings: Usual ductal hyperplasia, columnar cell change. and apocrine metaplasia. Source of Specimen: A. Sentinel lymph node;right sentinel node axillary. B. Breast;right breast. C. Breast;left breast. Clinical History/Operative Dx: Right/left breast cancer. Intraoperative Diagnosis: A. Right sentinel node axillary. No tumor cells identified. (Dr. 1. The intraoperative. interpretation(s) was/were performed and rendered at. Gross Description: A. The specimen is labeled right sentinel node axillary. and is received without fixative. It consists of. two lymph nodes measuring 1 x 0.7 x 0.7 cm and 1.5 x 0.8 x 0.4 cm. Both nodes are serially sectioned. and touch imprints are obtained. The larger node is submitted for permanent section in cassettes A1-A2. The smaller node is submitted for permanent section in cassette A3. Printed: This report continues. MR No. -. Acct No. -. $. Pathology Report - Page 3/5. FINAL SURGICAL PATHOLOGY REPORT. B. The specimen is labeled right breast tissue and is received without fixative. It consists of a mastectomy. specimen which weighs 381 grams. A black suture at one end of the skin ellipse marks medial. With this. orientation, the specimen measures 16 cm from medial to lateral, 11 cm from superior to inferior, and 4. cm from anterior to posterior. There is an overlying ellipse of tan skin measuring 11.8 x 7 cm. The areola. measures 3.3 cm and the nipple appears slightly inverted. The anterior-superior margin is inked blue, the. anterior-inferior margin is inked green, and the posterior margin. which consists variably of smooth facial. appearing tissue and lobulated fatty tissue, is inked black. The breast is serially sectioned along the. superior-inferior axis resulting in fifteen slabs. Slab #1 is most medial. In the central portion of the excision, in slabs 6-9, there is a stellate hard, gritty neoplasm (tumor #1) which. overall measures 4 cm from medial to lateral, 1.2 cm from superior to inferior, and 1 cm from anterior to. posterior. This neoplasm is 1.5 cm from the closest skin. It is 2 cm from the closest anterior-superior margin. and is greater than 4 cm from all other margins. Representative sections of the medial portion of the tissue. are obtained for research purposes and the biopsy site clip is identified within the neoplasm in slab 7. Slab 10 (intervening tissue between tumor #1 and tumors #2 and #3) consists of palpably unremarkable. fibrofatty tissue. In slab 11, 1 cm lateral to the tumor #1, there is chalky yellow discoloration and slight retraction of the. fibrofatty tissue suggestive of two small deposits of neoplastic tissue. The larger of these (tumor #2) is 8 cm. lateral to the nipple. It measures 1.4 x 1 x 0.6 cm and is greater than 2 cm from the anterior-superior,. anterior-inferior, and posterior margins. It is 2.3 cm from the closest lateral margin and widely free of the. medial margin. The smaller tumor deposit (tumor #3) measures 0,5 cm and is 0.8 cm superior of the larger deposit in slab. 11. It is 2 cm from the closest anterior-superior margin and greater than 2 cm from all other margins. No. other palpable lesions are identified. No lymph nodes are identified within the lateral portion of the. excision. Representative sections are submitted. Section summary: B1) nipple and tissue just deep to nipple,. B2) medial edge of tumor #1 from slab 6,. B3) anterior-superior margin (tumor #1), slab 6,. B4) central sections of tumor #1 from slab 7 (biopsy site clip here),. B5) anterior-inferior margin (tumor #1) from slab 7,. B6) tumor #1 from slab 8 including closest anterior-superior margin,. B7) lateral section of tumor #1 from slab 8,. B8) representative section from slab 10 intervening tissue between tumor #1 and tumors #2 and #3,. 89) complete cross-section, slab 11, tumor #2 and #3,. B10) section of tumor #2 in slab 12,. B11) representative upper inner quadrant (slabs 2, 3, 4),. B12) representative lower inner quadrant (slabs 3, 4, 5),. B13) representative lower outer quadrant (slabs 9 and 10). C. The specimen is labeled left breast tissue and is received in formalin. It consists of a mastectomy. specimen weighing 341 grams. A black suture at one end of the skin ellipse marks medial. With this. Printed: This report continues. MR No. . Acct No. Pathology Report - Page 4/5. 4) Page 4. FINAL SURGICAL PATHOLOGY REPORT. orientation, the specimen measures 15.5 cm from medial to lateral, 11 cm from superior to inferior, and. 5.5 cm from superficial to deep. There is an overlying broad ellipse of tan skin which measures 12 x 7 cm. In the lateral skin, there is a 0.4 cm violaceous skin lesion. Centrally, there is a well-delineated 4 cm. areola and a flat to slightly retracted appearing 1 cm nipple. The anterior-superior margin is inked blue,. the anterior-inferior margin is inked green, and the posterior margin, which consists of lobulated fatty. tissue, with central fascial appearing tissue, is inked black. The specimen is serially sectioned at close. intervals to reveal lobulated fatty tissue and scattered tan-white fibrous parenchyma which is most. prominent centrally. The fibrous parenchyma is focally finely nodular to palpation but there are no. discrete areas suggestive of invasive neoplasm. There are scattered small fluid-filled cysts within the. fibrous parenchyma. No lymph nodes are identified within the lateral portion of the excision. Representative sections are submitted. Section summary: C1) nipple and tissue just deep to nipple,. C2) lateral skin lesion,. C3) representative upper inner quadrant,. C4) representative lower inner quadrant,. C5) representative upper outer quadrant,. C6) representative lower outer quadrant,. C7-C8) sections of central breast including central deep margin. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Immunohistochemistry was performed with adequate control and shows positive staining for. metastatic tumor cells in one lymph node. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Dr. notified of results on. at. Printed: END OF REPORT (FINAL). Acct No. -. Patient Name - I. Pathology Report - Page 5/5.","Invasive lobular carcinoma, grade 1, with a multifocal growth pattern. Tumor composed of cells with a characteristic appearance. Lobular carcinoma in situ present. No lymphovascular invasion identified. One of two lymph nodes positive for metastatic carcinoma, with no extracapsular extension. Surgical margins negative. Non-neoplastic breast tissue shows usual ductal hyperplasia, columnar cell change, and apocrine metaplasia. No atypical hyperplasia or carcinoma identified in the left breast. Sclerosing adenosis, usual ductal hyperplasia, columnar cell change, and apocrine metaplasia present. Skin and nipple present, not involved by tumor. No skeletal muscle identified."
TCGA-Q1-A73O.2D4BBE0A-11E4-46C1-8416-FA0E724B53FC,"RUN DATE: RUN TIME: SPEC # : Obtained: CLINICAL HISTORY : CERVICAL MASS, ANEMIA. SPECIMEN/PROCEDURE. 1. CERVIX. 2. CERVIX - TUMOR. IMPRESSION. 1). CERVIX, BIOPSY: Invasive squamous cell carcinoma, large cell non-keratinizing type, poorly. difforentiatod. 2). CERVIX, BIOPSY: Invasive squamous cell carcinoma, large cell non-keratinizing type, poorly. difforentiatod. Entered: SPECIAL STAINS/PROCEDURES : One initial frozen section (1F) . Distated by: GROSS DESCRIPTION: 1). Received fresh for frozen section examination, labeled with the patient's name,. medical record number and ""cervical mass, "" is a 1.2 X 0.8 x 0.5 cm portion of red tan. tissue. The specimen is entirely submitted for frozen section evaluation. The frozen. section residue is submitted in cassette 1F. FROZEN SECTION DIAGNOSIS: Squamous coll carcinoma. Reported to. on. 2). Received fresh labeled with the patient's name, medical record number and ""cervix,. tumor, permanent, "" is a 1.5 x 0.5 x 0.5 cm portion of friable white tan tissue. The. specimen trisected and entirely submitted in cassettes 2A-2B. Entered: 3. COPIES TO: CPT Codes : FS INITIAL/88331, H&E-88313, CERVICAL BIOPSY/88305/2. ICD9 Codes : 180.9. Resident Physician: I have personally reviewed the material. (specimen/slide) and approve this final report. Eleatronically Signed by:","Invasive squamous cell carcinoma, large cell non-keratinizing type, poorly differentiated, with no necrosis identified. Tumor composed of cells with marked pleomorphism and hyperchromasia. No lymphovascular invasion or perineural invasion identified. Tumor confined to the cervix with no invasion into adjacent structures. No tumor involvement at the margins. Non-neoplastic cervix shows no significant pathological changes. No lymph nodes identified."
TCGA-CS-6666.9bc50bcf-b22b-4516-b8a9-aec943756116,"ADDENDED. FINAL DIAGNOSIS: 1. Right parietal tumor: ANAPLASTIC ASTROCYTOMA, WHO GRADE iii. 2. Capsule wall: SMALL PORTION OF ASTROCYTIC NEOPLASM, SEE DIAGNOSES. FOR SPECIMENS #1 AND #2. 3. Right parietal tumor: ANAPLASTIC ASTROCYTOMA, WHO GRADE iii. SEE. MICROSCOPIC DESCRIPTION. This diagnostic report has been personally interpreted by the signatory. of record. Aperio. Ki67. Percent : 16%. Cells counted : 40,914 cells. This test was performed by. in conjunction with the. assisted image analysis. Addendum. NEU-N IMMUNOHISTOCHEMICAL STAIN: NEGATIVE IN TUMOR CELLS. POSITIVE. STAINING OF RESIDENT, NON-NEOPLASTIC NEURONS IN AREAS OF TUMOR. INFILTRATION OF GREY MATTER. Microscopic Description: This tumor is an infiltrative glial neoplasm composed of pleomorphic. astrocytes. The malignant features of this tumor are best seen in. specimen #3. Tumor cells show strong positive immunohistochemical. staining for GFAP. Tumor cells that are gemistocytic in appearance are. present focally. Numerous mitotic figures are identified. The Ki67. proliferation index of the tumor is 16%. No ganglion cell component of. the tumor is identified on chromogranin or neurofilament. immunohistochemical stain. The majority of tumor cell nuclei show. positive immunohistochemical staining for p53. While scattered tumor. cells show immunohistochemical staining for EMA, this neoplasm does not. show histologic features of an ependymoma and is best classified as. Anaplastic Astrocytoma. The possibility that this neoplasm arose from. a lower grade tumor cannot be excluded. Case was reviewed in. conference with. Case discussed with. An addendum with the results of. Neu-N immunohistochemical stain will be issued. Frozen Section Diagnosis: 1. Right parietal tumor: Astrocytic neoplasm, grading defer. 2. Capsule wall: Tumor present. Frozen section diagnoses by. Clinical History and Diagnosis: Right parietal tumor. Source of Specimen: 1: Right parietal tumor. 2: Capsule wall. 3: Right parietal tumor. Gross Description: 1. Right parietal tumor: Received fresh for frozen labeled with the. patient's name and #1 right parietal tumor is a 2 X 1 X 0.5 cm. aggregate of tan-white soft tissue. Touch preps are prepared. Approximately 60% of the specimen is submitted for frozen section. The. remainder of the specimen is entirely submitted in one additional. cassette. 2. Capsule wall: Received fresh for frozen labeled with the patient's. name and #2 capsule wall is a 0.3 X 0.2 X 0.2 cm fragment of tan. tissue. Touch preps are prepared. The specimen is entirely submitted in. one cassette for frozen section. 3. Right parietal tumor: Received in formalin in a specimen container. labeled with the patient's name and a buccal #3 right parietal tumor"". single fragment of red white soft tissue measuring 1.8 X 1.3 X 0.5 cm. The specimen is entirely submitted in one cassette. Histology Laboratory. Part 3: Right parietal tumor. CHROMOGRANIN A. EPITHELIAL MEMBRAINE Ag (EMA). GLIAL FIBRIALLARY ACIDIC PROTEIN (GFAP). KI 67 (Aperio). NEU N. NEUROFILAMENT PROTEIN. P 53. SYNAPTOPHYSIN. Immunohistochemistry Notes. 1. Quantification of immunohistochemistry assay for ER and PR studies. is by the method of. et.al. 2. Hercept Test (DakoCytomation) Formalin fixed, paraffin embedded. Interpretation follows the manufacturer' S recommendation. Documented by. EGFR pharmDx Clone 2-18C9 Formalin fixed, paraffin embedded. Interpretation follows the manufacturer' recommendation. Doucmented by. 3. Analyte Specific Reagent (ASCR) Disclaimer. The use of one or more. reagents in the above tests is regulated as an analyte specific reagent. (ASR). These tests were developed and their performance characteristics. determined by the. They have not been cleared by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not. necessary.","Anaplastic astrocytoma, WHO grade III, characterized by an infiltrative glial neoplasm composed of pleomorphic astrocytes with strong positive staining for GFAP and numerous mitotic figures. Tumor cells show pleomorphism and are gemistocytic in appearance focally. No ganglion cell component is identified. The majority of tumor cell nuclei show positive staining for p53. Scattered tumor cells show staining for EMA, but the neoplasm does not show histologic features of an ependymoma. The possibility that this neoplasm arose from a lower grade tumor cannot be excluded. Tumor cells infiltrate the grey matter. No necrosis is identified. The tumor is confined to the right parietal region with involvement of the capsule wall. No lymph nodes are examined. Non-neoplastic brain tissue is not described in detail, but resident non-neoplastic neurons in areas of tumor infiltration are noted."
TCGA-DJ-A3UZ.16D17ADE-B455-481E-A233-76E96DDCB635,"Clinical Diagnosis & History: Bilateral thyroid nodules,. history left lobe PTC positive. Specimens Submitted: 1: Tissue near left upper pole (fs). 2: Left paratracheal tissue (fs). 3: Total thyroidectomy. DIAGNOSIS: 1. Tissue near left upper pole, blopsy (fs): -Benign thyroid tissue. 2. Left paratracheal tissue, excision (fs): -One benign lymph node (0/1). 3. Total thyroidectomy: Part # 3. Tumor Type: Five foci of papillary carcinoma: one classical type and four microcarcinomas. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Right lobe. The largest tumor focu is located in the right lobe. Tumor Size: Tumor foci range from 0.4 cm to 1.1 cm in greatest dimensionon. Tumor Encapsulation: Partially surrounded. for the largest tumor focus. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:perithyroidal adipose tissue and parathyroid gland. Surgical Margins: Free of tumor. Tumor Multicentricity: Gross and microscopic. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Identified. Two parathyroid glands, one in each lobe (the right one is intrathyroidal). Tumor involves the parathyroid gland. on teh left side. Lymph Nodes: Two benign lymph nodes (0/2). Note: The congo red stain and the immunohistochemical stains for chromogranin, synaptophysoin, CEA-M, and calcitonin were. performed on one of the thyroid nodules and they are negative. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT THA. REVIEWED AND APPROVED THIS REPORT. Report clectronically Signed Out. Special Studies: Special Stain. Comment. CHR. SYN. CEA M. CALC. CONGO. IMM RECUT. NEG CONT. Gross Description: 1) The specimen is received fresh for frozen section, labeled ""tissue near left upper pole,"" and consists of a tan pink soft tissue. measuring 0.6 x 0.4 x 0.3 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC-frozen section control. 2) The specimen is received fresh for frozen section, labeled ""left paratracheal tissue,"" and consists of a tan soft tissue measuring. 0.5 x 0.4 x 0.3 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC-frozen section control. 3) The specimen is received fresh, labeled ""total thyroidectomy, stitch marks left lobe"", and consists of a thyroid weighing 22 g. The. rightlobe measures 4.5 x3x2 cm, the left lobe measures 4.5 x 3 x 2 cm and the isthmus measures 3 x 1 x cm. The external. surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals two separate nodules measuring 0.8 cm and 0.3 cm in diameter. The nodules are located in the right lower pole,. they display white/tan cut surfaces, and / are not encapsulated. Sections through the remaining tissue reveal another nodule in. middle portion of left lobe measuring 0.5 cm in diameter and is not encapsulated. The remaining thyroid parenchyma is red brown. and beefy. Representative sections of the specimen submitted fo. ind a photograph has been taken. The entire thyroid is. submitted. A small portion of right lobe nodule is submitted for. Summary of sections: RN1 - right lobe nodule, entirely submitted. RN2-right lobe nodule ( small). RL - right lobe. LN--left lobe nodule, entirely submitted. LL left lobe. IS isthmus. Summary of Sections: Part 1: Tissue near left upper pole (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Left paratracheal tissue (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 3: Total thyroidectomy. Block. Sect. Site. PCs. 4. IS. 5. 9. LL. 10. 2. LN. 3. 3. RL. 4. 2. RN1. 5. 2. RN2. 3. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. Frozen Section Diagnosis: Tissue near left upper pole (fs): Benign thyroid tissue 1. Permanent Diagnosis: same. 2. Frozen Section Diagnosis: Left paratracheal tissue (fs): One benign lymph node (0/1). Permanent Diagnosis: same.","Papillary carcinoma with five foci, one classical type and four microcarcinomas, well differentiated, with partial encapsulation of the largest tumor focus. Tumor invades perithyroidal adipose tissue and parathyroid gland. No blood vessel invasion or tumor necrosis identified. Surgical margins are free of tumor. Non-neoplastic thyroid exhibits nodular hyperplasia and chronic lymphocytic thyroiditis. Two parathyroid glands are identified, one in each lobe, with the right one being intrathyroidal, and the tumor involves the parathyroid gland on the left side. Two benign lymph nodes are present, with no evidence of tumor."
TCGA-AA-3494.ee6b348b-b4c2-41d3-923d-741c30766ed9,"Diagnosis / Diagnoses: 22-cm-long resection of the colon under inclusion of a moderately differentiated,. centrally ulcerated adenocarcinoma, of a maximum of 3.5 cm in diameter and of the. colorectal type, with a recent onset of infiltration of the pericolic fatty tissue (pT3; G2),. as well as a further poorly differentiated, centrally ulcerated colorectal adenocarcinoma,. of a maximum of 1 cm in diameter and with infiltration of the tunica submucosa (pT1;. G3). Low-grade, also focal high-grade dysplasia (synonym: high-grade intra-epithelial. neoplasia) in the remainder. Tumor-free resection margins of the colon. A follow-up report will be made on the lymph node status. Follow-up report: A total of 39 histologically carcinoma-free lymph nodes of a maximum of 0.8 cm in. diameter were determined after acetone fixation. Final tumor stage: pT3 (2) pNX (0/39) pMX; G2-3.","Adenocarcinoma of the colorectal type, moderately differentiated, with central ulceration and infiltration of the pericolic fatty tissue. A further poorly differentiated adenocarcinoma with central ulceration and infiltration of the tunica submucosa. Low-grade dysplasia, also focal high-grade dysplasia, in the remainder. Tumor-free resection margins of the colon. No lymph node involvement identified, with a total of 39 histologically carcinoma-free lymph nodes. Tumors exhibit varying degrees of differentiation, with the moderately differentiated tumor showing a more organized architecture, while the poorly differentiated tumor displays a more disorganized pattern. No necrosis or significant inflammatory response is noted in the tumors."
TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE,"DATE OBTAINED: DATE RECEIVED: DIAGNOSIS. 1. RIGHT BREAST, PARTIAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA mixed. SIZE (INVASIVE): Approximately 70 mm; see comment. LATERALITY: Right. TUMOR FOCALITY: Unifocal. LESIONAL SITE: 9:00 (according to operative report). HISTOLOGIC TYPE: Invasive lobular carcinoma, classical type, focal pleomorphic type. NUCLEAR GRADE: I of III (classical type) and II-III of III (pleomorphic type). HISTOLOGIC GRADE: N/A. (invasive lobular carcinoma). IN-SITU COMPONENT: Not present. LYMPH NODE SAMPLING: Positive (11/12), (largest 45mm; with extranodal Involvement); see specimen #2. AJCC CATEGORIES: Stage IIIC. (assuming cM0"" status). pTNM: pT3. pN3a. cTNM: cT2. cN1. cMO. INTEGRITY/ORIENTATION: Intact specimen with designated margins. MARGINS (Invasive lobular): Negative. <0.1mm superior margin (1P, highlighted by CK7 Immunostain); 0.2mm medial margin. (1EE) and 1mm posterior margin (1N); other margins >3mm. LYMPHOVASCULAR INVASION: Focal suspicious for LVI. MICROCALCIFICATIONS: Not identified. NIPPLE/SKIN: (if applicable). Negative skin. SKELETAL MUSCLE: Not present. OTHER: Focal atypical lobular hyperplasia, sclerosing adenosis, usual ductal hyperplasia,. apocrine metaplasia and prior blopsy site changes. 2. RIGHT AXILLARY NODE CONTENTS, DISSECTION: ELEVEN OUT OF TWELVE LYMPH NODES TOTALLY. REPLACED BY METASTATIC LOBULAR CARCINOMA (11/12), LARGEST TUMOR 4.5 CM, EXTRANODAL. EXTENSION PRESENT; ADDITIONAL INVASIVE LOBULAR CARCINOMA WITHIN THE FAT (ABOUT 2CM). 3. OMENTUM, RESECTION: ADIPOSE TISSUE; NEGATIVE FOR TUMOR. COMMENT. Tumor grossly is 5.3 cm. In the axillary contents (#2), sizeable tumor mass within the fat is also present in multiple blocks, which. most likely represents a direct extension from the lumpectomy, and thus the tumor size is estimated to be 7cm. 88307x2, 88305, 88329, 88342. Clinical Diagnosis and History: Right breast cancer, gastric cancer. cT2,cN1,cM0 clinical stage Il. Tissue(s) Submitted: 1: RIGHT BREAST MASS SHORT SUTURE SUPERIOR LONG SUTURE LATERAL. 2: RIGHT AXILLARY NODE CONTENTS. 3: OMENTUM. Gross Description: Specimen #1 is received fresh for intraoperative consultation, labeled with the patient's name and right breast mass, and consists. of an 11.3 cm (medial to lateral) X 8.5 cm (superior to inferior) x 4.5 cm (anterior to posterior) product of partial mastectomy which. is surfaced by a 6.9 x 2.2 x 0.2 cm ellipse of unremarkable white tan skin. No nipple is identified. A short suture designating. superior and a long suture designating lateral are present. Two needle localization wires are entering the specimen in the superior. and inferior aspects. The specimen is radiographed and differentially inked as follows: superior-blue, inferior-green, lateral-yellow,. medial-red, posterior/deep-black and serially sectioned from lateral to medial into 10 slices. No biopsy clip is identified. An ill-. defined, rubbery to firm, white-tan area measuring 5.3 x 5.0 x 3.5 cm is identified in slices 4 to 10. This area of fibrous tissue. shows. some. extensions to the posterior, inferior, superior, and medial margins. This fibrous area is also 2.0 cm from the overlying. skin. other. lesions are grossly identified. The breast parenchyma consists of tan-yellow, lobulated adipose tissue (60%) and. fibrous tissue (40%). Time in formalin: Some tumor and normal tissue is frozen for TCGA studies. Representative sections of all slices (with the exception of slices 2 and 3) are submitted as follows: 1A-1B: slice #1, lateral margin, perpendicular (representative). 1C-1D: slice #4, irregular fibrous area. 1E: slice #4, fibrous area to posterior margin. 1F: slice #4, fibrous area to superior margin. 1G-1H: slice #5, fibrous area contiguous section. 11: slice #5, posterior margin. 1J: slice #5, inferior and posterior margins. 1K: overlying skin. 1L-1M: slice #6, contiguous section of fibrous area to inferior margin. 1N-10: posterior margin. 1P: superior margin. 1Q-1T: slice #7, contiguous section from superior to inferior (orange ink denotes contiguous section). 1U: overlying skin. 1V: slice #8, fibrous area. 1W: superior margin. 1X: inferior margin. 1Y: posterior margin. 1Z: slice #9, inferior margin. 1AA: slice #9, irregular fibrous area. 1BB: superior margin. 1CC: posterior margin. 1DD-1GG: slice #10, medial margin, perpendicular (representative). Specimen #2 is received in formalin labeled right axillary dissection, and consists of 11.0 x 10.0 x 2.5 cm yellow adipose tissue. The specimen was serially sectioned to reveal 16 lymph nodes ranging in size from 1.5 to 4.5 cm. The lymph nodes are entirely. submitted and labeled as follows: 2A: Two lymph nodes intact. 2B: Two lymph nodes intact. 2C: Four lymph nodes intact. 2D: One lymph node, bisected. 2E: One lymph node, bisected. 2F: One lymph node, bisected. 2G: One lymph node, bisected. 2H: One lymph node, representative section. 21: One lymph node, representative section. 2J: One lymph node, representative section. 2K-2L: One lymph node, representative section. Specimen #3 is received fresh labeled omentum, and consists of a 20 x 20 x 5.0 yellow lobulated adipose tissue. The specimen is. serially sectioned and no lesion is grossly identified. Representative sections are submitted labeled 3A-3B. Intraoperative Consult Diagnosis. 1A/GDX: NEEDLE LOC WIRE ENTERS SUPERIORLY AND ONE OTHER ENTERS INFERIORLY. VAGUE AREA, NO. DISCRETE MASS; MARGINS HARD TO DETERMINE; QUESTION POSTERIOR, INFERIOR, AND MEDIAL MARGIN.","Invasive lobular carcinoma, classical type, with focal pleomorphic type, showing a mixed growth pattern. Tumor cells have a discohesive appearance with a linear, single-file arrangement, and a focal pleomorphic component with larger, more atypical cells. Nuclear grade is I of III for the classical type and II-III of III for the pleomorphic type. No in-situ component is present. Focal suspicious lymphovascular invasion is identified. The tumor has a negative margin, with the closest margin being less than 0.1mm at the superior margin, and 0.2mm at the medial margin. Other margins are more than 3mm. The axillary lymph nodes show extensive replacement by metastatic lobular carcinoma, with extranodal extension. Additional invasive lobular carcinoma is present within the fat. The omentum is negative for tumor. Non-neoplastic findings include focal atypical lobular hyperplasia, sclerosing adenosis, usual ductal hyperplasia, apocrine metaplasia, and prior biopsy site changes."
TCGA-EB-A3Y6.BD058487-A37C-4BB1-AC9E-FE492F83F0E6,"Laterality:Tumor Features: Pigmented, Tumor Extent: More than 4 mm. with or without ulceration, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of skin lesion. Tumor site: Skin, hip. Tumor size: 1x0x1.5cm. Tumor features: Ulcerated, Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Breslow thickness is 4.5 mm. Comments: None.","Malignant melanoma, ulcerated and pigmented, with absence of venous invasion. Margins are uninvolved. No lymphatic invasion or lymph nodes are specified. Tumor exhibits features of melanoma with pigment present. No evidence of neo-adjuvant treatment is specified. Additional pathologic findings include presence of melanoma cells without specification of satellite nodules."
TCGA-12-1598.c319de13-7a4d-452e-baea-5a5f64e9ade5,"AP Surgical Pathology: Additional Info. CLINICAL HISTORY: Brain tumor. MRI: MR images were obtained for localization purposes and. compared to diagnostic MRI dated. Again seen is large irregular. enhancing lesion within the right temporal parietal lobe with central non. enhancement. GROSS EXAMINATION: A. ""Brain tissue (AF1) "", received fresh for frozen section. A 3.6 X 3 x 2 cm. portion of yellow-brown soft tissue is received. A representative section is. frozen as AF1, the frozen remnant submitted in A1. Serial sectioning. demonstrates a yellow-tan cut surface. Additional representative sections are. submitted in A2-6. B. ""Brain tissue"", received fresh and placed in formalin. Received are two. fragments of red-tan soft tissue, 2.3 X 1.2 X 0.5 cm in aggregate. Serial. sectioning demonstrates a red-tan cut surface. Representative submitted in. block B1, the remaining tissue is retained in formalin. INTRA OPERATIVE CONSULTATION: A. ""Brain tissue"" :AF1- glioblastoma. MICROSCOPIC EXAMINATION: Microscopic examination shows brain infiltrated by a malignant astrocytic. neoplasm that is densely cellular and pleomorphic with, mitotic activity,. microvascular proliferation, and necrosis. Tumor is present within the. subarachnoid space. DIAGNOSIS: A. ""BRAIN TISSUE"" (BIOPSY) : GLIOBLASTOMA (WHO GRADE IV) . TUMOR IS PRESENT WITHIN THE SUBARACHNOID SPACE. B. ""BRAIN TISSUE"" (BIOPSY). GLIOBLASTOMA (WHO GRADE IV) . I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 1: Please see Image Cytometry Report. for results of supplementary. tests. FISH INTERPRETATION SUMMARY: : CHROMOSOME 7 CENTROMERE - POLYSOMY (82% OF TUMOR CELLS EXHIBIT POLYSOMY). EGFR - AMPLIFICATION (97% OF TUMOR CELLS EXHIBIT AMPLIFICATION). CHROMOSOME 10 CENTROMERE - CENTROMERE LOSS (70% OF TUMOR CELLS EXHIBIT LOSS). 1 of 2. PTEN - ALLELIC LOSS (73% OF TUMOR CELLS EXHIBIT LOSS). 4 OF 4 ABNORMAL MARKERS. COMMENT: A MULTIVARIATE SURVIVAL ANALYSIS OF. PATIENTS WITH GLIOBLASTOMAS. REVEALS THAT THE HAZARD OF SHORT SURVIVAL AMONG PATIENTS WITH 0-2 ABNORMAL. MARKERS (OUT OF 4) WAS SIGNIFICANTLY LOWER THAN THAT FOUND WITH PATIENTS WITH. 4 ABNORMAL MARKERS EVEN AFTER ADJUSTMENT FOR AGE EFFECT. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . ADDENDUM 2: IMMUNOHISTOCHEMICAL LABELING INDEX OF TUMOR CELLS. TISSUE TYPE: BRAIN TISSUE CONTAINING GLIOBLASTOMA (WHO GRADE IV;. BLOCK A5) . MGMT - NEGATIVE (20% OF TUMOR CELLS). EGFR wt - POSITIVE (3+ IN 80% OF TUMOR CELLS). EGFR VIII - POSITIVE (3+ IN 20% OF TUMOR CELLS). PTEN - NEGATIVE (2-3+ IN 60% OF TUMOR CELLS). pS6 - POSITIVE (2+ IN 60% OF TUMOR CELLS). pAKT - NEGATIVE (2+ IN 10% OF TUMOR CELLS). Please see Image Cytometry Report. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) .","Malignant astrocytic neoplasm densely cellular and pleomorphic with mitotic activity, microvascular proliferation, and necrosis, consistent with glioblastoma, WHO grade IV. Tumor is present within the subarachnoid space. Brain infiltrated by the neoplasm, exhibiting pleomorphic cells with nuclear atypia and prominent nucleoli. Microvascular proliferation and necrosis are prominent features. Tumor cells are present within the subarachnoid space, indicating invasion. No lymphovascular invasion or distant metastasis is identified in the provided tissue. Non-neoplastic brain tissue shows reactive changes. No other significant pathological features are observed."
TCGA-AA-A00N.8A14A987-711E-49C0-AA34-2F035B02CD8A,"Diagnosis: Ileocolonic resectate under inclusion of a poorly differentiated mucinous adenocarcinoma. of the colorectal type, located in the cecum/ascending colon and of max. 7.5 cm in. diameter, with circumscribed penetration of the serosa. Tumor-free regional lymph. nodes. Tumor-free small and large intestinal resection margins. Tumor-free mesenteric. resection margin. Tumor-free omental fat tissue. Tumor stage: pT4 pNO (0/20) pMX; G3; L1, V0, locally R0. A further lymph node is still being decalcified; a follow-up report will be submitted at a. later date. Follow-up report: We now have the histological data on the decalcified lymph node. In this case, there is. also no indication of metastasis from the previously diagnosed carcinoma. Final tumor. stage therefore pT4 pN0 (0/21) pMX; G3; L1, V0, locally R0.","Poorly differentiated mucinous adenocarcinoma of the colorectal type, located in the cecum/ascending colon, with circumscribed penetration of the serosa. Tumor composed of mucin-producing cells with high-grade nuclear atypia. No necrosis identified. Lymphovascular invasion not identified. Tumor confined to the intestinal wall with involvement of the serosa. No tumor involvement of the small and large intestinal resection margins, mesenteric resection margin, or omental fat tissue. Regional lymph nodes are free of tumor, with no metastasis identified in the examined lymph nodes."
TCGA-EJ-5517.67b66178-bd1b-44a8-9a30-762b0fc7c1ba,"PATIENT HISTORY: The patient is a. with a previous history of biopsy on 1. this biopsy reveals: right. apex= Gleason grade 3+3 = 6; right base = Gleason grade 3+3 = 6; left apex = Gleason grade 3+3 = 6. PRE-OP DIAGNOSIS: Prostate cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical retropubic prostatectomy. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN TWO LYMPH NODES EXAMINED (0/2). PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF NEOPLASIA IN TWO LYMPH NODES EXAMINED (0/2). PART 3: PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL PROSTATECTOMY -. A. MULTIFOCAL INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 3 + 3 = 6 WITH. MINOR TERTIARY GLEASON GRADE 4 COMPONENT COMPRISING 4% OF THE ENTIRE TUMOR VOLUME. EXAMINED. B. THE CARCINOMA INVOLVES BOTH THE RIGHT AND LEFT LOBES AND HAS A GREATEST NODULAR DIAMETER. OF 1.4 cm. C. THE CARCINOMA INVOLVES 15% OF THE EXAMINED PROSTATE VOLUME. D. THE CARCINOMA IS ORGAN CONFINED AND SHOWS NO EVIDENCE OF EXTRACAPSULAR EXTENSION. E. BILATERAL SEMINAL VESICLES ARE FREE OF CARCINOMA. F. ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF CARCINOMA. G. PERINEURAL INVASION IS IDENTIFIED. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. i. MULTIFOCAL HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS IDENTIFIED. J. PATHOLOGIC TNM STAGE: pT2c NO Mx. K. TNM HISTOLOGIC GRADE = G2. L. BENIGN PROSTATIC HYPERTROPHY AND CHRONIC INFLAMMATION ARE NOTED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. CLINICAL DATA: PSA value: 9.6. INVASIVE CA IDENTIFIED?. TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 3. GLEASON SUM SCORE: 6. GLEASON 4/5 PERCENTAGE: 4%. WEIGHT OF PROSTATE: 56.28gm. TUMOR SIZE: Maximum dimension: 1.4 cm. LOBE LATERALITY: Right and Left Lobes. PERCENT OF SPECIMEN INVOLVED BY TUMOR: 5 25%. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: PERINEURAL INVASION: ANGIOLYMPHATIC INVASION: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 4. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT2c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G2, Moderately differentiated. Comment: There ia a minor Gleason grade 4 component, comprising 4% of the total tumor. volume examined,.","Multifocal invasive moderately differentiated adenocarcinoma, Gleason score 3 + 3 = 6 with minor tertiary Gleason grade 4 component. The carcinoma involves both the right and left lobes and is organ confined with no evidence of extracapsular extension. Bilateral seminal vesicles are free of carcinoma. All examined surgical resection margins are free of carcinoma. Perineural invasion is identified, but no angiolymphatic invasion is identified. Multifocal high-grade prostatic intraepithelial neoplasia is identified. Benign prostatic hypertrophy and chronic inflammation are noted. The tumor is composed of cells with moderate differentiation and has a Gleason score of 6, with a minor Gleason grade 4 component. No necrosis is identified. The carcinoma has no evidence of extension beyond the prostate and has no involvement of the surgical margins."
TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B,"Surgical Pathelegy. CLINICAL HISTORY: year old white female with right subareolar breast mass times 3 month. Right breast carcinoma. GROSS EXAMINATION: A. ""Right breast mass-wide local excision"" in formalin. The specimen consists. of a portion of breast tissue with a skin ellipse and nipple. The skin. ellipse measures 9 x 3.5 cm. The underlying breast tissue measures 10 x 4 x. 4. cm. The outer surface was inked in blue. Directly beneath the skin ellipse. is a 2.5 x 2 x 1.5 cm mass composed of tan firm friable tissue with focal. areas of hemorrhage. The mass is sharply circumscribed. The mass is 0.8 cm. from the deep surgical margin. Block Summary: A1: Section of nipple. A2-A11: Section of mass including deep surgical margin. MICROSCOPIC EXAMINATION: Large portions of the tumor are made up of well-formed papillary tumor with. fibrovascular cores lined by malignant, stratified, complicated, epithelium. In addition, cribriform and tubular foci infiltrate desmoplastic fibrous. tissue. This case was reviewed by Dr. DIAGNOSIS: A. ""RIGHT BREAST MASS- WIDE LOCAL EXCISION"": INVASIVE PAPILLARY ADENOCARCINOMA OF BREAST (2.5 CM IN GREATEST DIAMETER) . MARGINS OF RESECTION ARE FREE OF TUMOR. I.D. i.d. Dat. - Result forma. 1 of 1.","Invasive papillary adenocarcinoma of the breast with well-formed papillary tumor and fibrovascular cores lined by malignant, stratified, complicated epithelium, and cribriform and tubular foci infiltrating desmoplastic fibrous tissue. The tumor is sharply circumscribed. No tumor is identified at the inked surgical margin, with margins of resection free of tumor."
TCGA-VS-A9UL.79869158-C990-45B6-B77B-A6CEC4886E5C,"PRIMARY SITE: Cervix. ""Uterine cervix biopsy"": Squamous cell carcinoma, histologic grade 3, invasive, with necrotic areas.","Squamous cell carcinoma, histologic grade 3, invasive, with necrotic areas."
TCGA-A3-3387.f5199278-aa10-477e-a9a8-000ed52065ac,"Sex Male. SPECIMENINFO. DIAGNOSIS. DIAGNOSIS: Kidney, left, nephrectomy: Tumor Characteristics: 1. Histologic type: Clear cell (conventional) renal cell adenocarcinoma. 2. Tumor site: Upper pole. 3. Tumor size: 4.0 x4.0x25cm. 4. Macroscopic extent of tumor: Tumor limited to kidney. 5. Nuclear grade: Fuhrman grade: 2/4. 6. Lymphovascular space invasion: Present. 7. Transcapsular invasion: No. 8. Renal vein invasion: No. 9. Venacaval invasion: Not resected. 10. Adrenal gland: Not resected. Surgical Margin Status: 1. Soft tissue margins: Negative. 2. Ureteral margin: Negative. 3. Vascular Margins: Negative. Lymph Node Status: 1. Total number of lymph nodes examined: 0. Other Significant Findings: 2. pTNM stage: T1a NX MX. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: Left kidney. SPECIMENDATA. GROSS DESCRIPTION: The specimen is received in one container labeled. I and left kidney and consists of a previously bisected kidney with attached perinephric fat. measuring 25.0 x 15.0 x 7.5 cm and weighs 930 grams. There is no adrenal gland attached to the specimen. The ureter stump is identified measuring. 6.0 cm in length and 0.4 cm in diameter. The surface is gray to brown-tan with slight adhesions. On opening the mucosal surface lining the ureter is. gray-tan. There are no lesions seen grossly. The renal artery stump is identified measuring 2.5 cm in length and 0.5 cm in diameter and contains. clotted. blood,. but. is. otherwise unremarkable. The renal vein stump measures 0.7 cm in length and 0.5 cm in diameter and is grossly unremarkable. The deep margin of the kidney has been inked. The cut surface of the kidney is brown-tan and reveals a circumscribed golden yellow partially. hemorrhagic. mass within the upper pole measuring 4.0 x 4.0 x 2.5 cm that on sectioning comes to within 0.1 cm of the inked deep margin, but does not. appear. to. penetrate through the capsule into the surrounding perinephric fat. The surrounding renal cortex is brown-tan measuring 0.5 cm and shows a. well. demarcated cortex and renal pyramids. The renal pelvis and calices are gray-tan and uninvolved by the mass and appear grossly unremarkable. There are no other lesions seen grossly. On sectioning through the surrounding perinephric fat reveals there are no lymph nodes grossly identified. Representative sections were taken for genomic studies and placed in orange cassettes labeled A-D. Also received with the specimen are two. cassettes, one green and one yellow, labeled. Representative sections are submitted in cassettes. as follows: sections. from mass in relationship to inked deep 3, auditional sections from mass and surrounding kidney-4 and 5; sections from surrounding. uninvolved kidney-6; ureter margin-7; renal artery and vein-B.","Clear cell renal cell adenocarcinoma with a circumscribed golden yellow partially hemorrhagic mass. Fuhrman nuclear grade 2/4. Tumor composed of cells with clear cytoplasm and distinct cell borders. Lymphovascular space invasion present. Tumor limited to kidney, no transcapsular invasion, no renal vein invasion. Surgical margins negative, including soft tissue, ureteral, and vascular margins. No lymph nodes examined. Surrounding renal cortex shows a well-demarcated cortex and renal pyramids, with no involvement by the mass. Renal pelvis and calices uninvolved and appear grossly unremarkable. Adrenal gland not resected."
TCGA-24-2026.7fc3cf2f-b132-4dce-b16a-2b4a1162da14,"Hosp. NO. : surgeon: 88E. OVARIES, RIGHT AND LEFT, BILATERAL OOPHORECTOMY. - POORLY DIFFERENTIATED SEROUS ADENOCARCINOMA. UTERUS, SEROSA AND MYOMETRIUM, HYSTERECTOMY. - SEROSAL AND JYMPHATIC INVOLVEMENT BY METASTATIC. CARCINOMA. - LEIOMYOMATA. UTERUS, ENDOMETRIUM, HYSTERECTOMY - MICROSCOPIC FOCUS OF WELL. DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA ARISING. IN AN ENDOMETRIAL POLYP (SEE. 008. SOFT TISSUE, OMENTUM, EXCISION - METASTATIC ADENOCARCINOMA. CONSISTENT WITH OVARIAN PRIMARY. FALLOPIAN TUBES, RIGHT AND LEFT, BILATERAL SALPINGECTOMY. - NO IISTOPATHOLOGIC ABNORMALITY. SPECIMEN(S) SUBMITTED. Part 1: RIGHT SALPINGO OOPHORECTONY. Part 2: LEFT SALPINGO OOPHORECTOMY. Part 3: UTERUS. Part 4: OMENTUM. HISTORY. The patient is a. with bilateral adhexal masses. Clinical diagnoBis: Not stated. Operative procedura: Total. abdominal hysterectomy, bilateral salpingo-oophorectomy and. omentectomy. GROSS. The specimens are received in four containers of formalin, euch. labelled with the patient's name, The first contalner 13 laballed. ""right salpingo-oophorectomy"" and contains a salpingo-oophoreetonty. specimen which is markedly enlarged measuring 6,5 x 5.5 x 3.0 CM. surg. Patn. No. : OROSS (continued). in maxinnum dimensions. The attached fallopian tube measures 5. CM. in length and 0.5 Call in average diameter. It includes the. fimbriated end and it has been previously transected at ivs mid. portion. The serosal surface is pink-tan - and smooth and grossly. unremarkable. The attached ovary is markedly enlarged and. partially cystic measuring 5.5 x 4.5 x 4 cin in maximum dimensions. Cross sections show a solid and cystic tumor with numerous. papillary excrescences as well as solid areas, which comprise more. than 50% of the specimen grossly. The tumor extends onto the. serosal surface grously and appears to invade the No. residual ovarian tissue can be Adentified with certainty. There. is.n.o of tubal involvement by tumor. Labelled A1 to. A7 - ovary; A8 - fallopian tube, Jar 1. The second !obntainer is /labelled ""left salpingo-oophorectomy"" and. contains a alpingo-oophcrectomy specimen which is markedly. enlarged 7 x 5.5 x 5 an in maximum dimensions. The attached. tallopian tube which includes the fimbriated end measures 8 en in. length and 0.7 in average diameter. Adherent tumor is identified. on the serosal surface. Cross sections to the lumen show the. attached ovary is markedly distorted by a tan-white papillary and. cystic tumor which is noted to extend difrusely over the serusal. surface. Cut surfaces of the tumor show that it is piuk-white and. primarily solid with areas or papillation and nodularity The. solid portions of the tumor comprise less than 50% of its mass. grossly. Labelled B1 to 87 - left ovary; B 8 - lett fallopian. tube. Jar 1. The third container is labelled ""uterus"" and contains a markedly. distorted fragment of tan-white nodular muscular tissue measuring. 7.5 x 7 x 5 cm in maximum dimension. The cervix cunnot De. identified A markedly distorted and shrunken endometriar cavity. measuring 1.5. x 1- ci-s-tentatively identified. Very littlo. serosal surface is remaining. The serosal surface is partially. covered by tan-white papillary tissuo grossly consistent with the. tumor seen in the ovariam specimens. In addition, the specimen ia. markedly distorted by subserosal and intramural leiomyoads which. range from 0.5 to 2. 2 Clit in greatest diameter, Each has a firm,. white, whorled appearance without necrosis or hemorrhage. Labelled. C1 and C2 - endomyometrium; C3 to c6 - myomas; C7 and C8 - tumor,. extending to uterus. Jar 2. The fourth container is labelled ""omentum"" and contains of single. - 2 -. GROSS (continued). irregularly- - shaped tragment of tan-white-yellow hemorrhagic. lobulated adipose tissue measuring 24 x 12 x 5 cm in maximum. dimensions, The omentum is extensively grossly involved by. metastatic tumor. Laballed D1 to D4, Jar 2. COMMENT. Histologic sections or both ovaries are notable for a poorly. differentiated serous adenocarcinoma. The tumor shows papillary. as well as focal (<5%) clear cell change. Tumor 18 Glso. I.d.en-t-led-within the omentum and on the serosal surface of the. uterus Uterine lymphatic invasion is also seen. Histologic. sections of the endometrium show a microscopic focus of well. ditferentiatod endomerrioid adenocarcinoma which appears to arise. in an endometrial polyp and in an area inmediately adjacent to the. polyp. This tumor does not show evidence of myometrial invasion. and is asrphologically different from the ovarian tumor and,. therefore, does not represent a metastatic implant from the. latter, Due to the highly distorted nature of the utelus, no. cervix could be definitively identified, and only a shall portion. of the endometrial cavity (yhich included the polyp) was. identified. SYNOPTIC REPORTING FORM FOR MALIONANT OVARIAN NEOPLASMS. 1a. A neoplasm is PRESERT. 2. The HISTOLOGIC DIAGNOSIS is: Serous adenocarcinoia. The LOCATION (s) OF THE PRIMARY TUMOR (s) is/are: Right and left ovary (synchronous primary tumors). 4, The FIGO GRADE of the tumor is: III (Tumor composed of greater than 50% solid. nests). 5, The NUCLEAR (BRODERS' ) GRADE or the tumor is: G3. (Poorly-differentiated) -. Tumor IS identified on the ovarian surface(s) . 7. Tumor DOES invade the mesovarium. 8. Tumor DOES NOT invade the adjacent falloplan tube,. 9. Tumor DOES invade the pelvic soft tissue. Tumor involvement of the pelvie peritoneum da PRESEWT. 11. Metastatio involvement of the EXTRAPELVIC peritoneum is. PRESENT. 12. Metastatic involvement of the omentum is PRESENT. 13. The maximum dimension of tumor implants outside the true. 3. COMMENT (continued). pelvis is not valuable (entire omental biopsy involved). 14. Metastatic involvement or the uterine serosa is PRESENT. Metastatic involvement of the endometrium is ABSENT. Regional lymph node metasta8es CANNO'T BE EVALUATED. 17. The total number of regional lymph nodes examined is 0. 18. The total number of metastatically-involve regional lymph. nodes is. 19, DETAILED STACING INFORHATION: Based on the above information, the PRIMARY TUMOR is. classifiod as: TNM SCHEME. FIGO SCHEME. DEFINITION. T3c. IIIC. Macroscopic peritoneal. metastasis beyond true pelvis. measuring greater than 2 cul in. greatest dimension. THE REGIONAL I.MPH NODES are classified as: NX (Nodal status cannot be assessed). THE STATUS OF DISTANT TUMOR SITES is classified as: MX (Status cannot be assessed). 20. The FINAL AJCC/FIGO STAGE IS: AJCC SCHEME. FIGO SCHEME. (T3c/ NX/ MX). IIIC. {End of Report). 980.","Poorly differentiated serous adenocarcinoma of the ovaries with papillary and focal clear cell changes. Tumor involves the omentum and the serosal surface of the uterus with lymphatic invasion. Histologic sections of the endometrium show a microscopic focus of well-differentiated endometrioid adenocarcinoma arising in an endometrial polyp, which is morphologically different from the ovarian tumor and does not represent a metastatic implant. The uterus is distorted by subserosal and intramural leiomyomas. The fallopian tubes show no histopathologic abnormality. The omentum is extensively involved by metastatic tumor. Tumor invades the pelvic soft tissue and the peritoneum with metastatic involvement of the omentum and the uterine serosa. No tumor involvement of the adjacent fallopian tube is identified."
TCGA-XF-A9SZ.BBDDB909-1AE0-4F10-948A-DAA989CF87D2,"DIAGNOSIS: RADICAL CYSTECTOMY WITH BILATERAL LYMPH NODE DISSECTION, ILEAL CONDUIT DIVERSION. AND G-TUBE PLACEMENT: RIGHT DISTAL URETER (A) : INTRAOPERATIVE FROZEN SECTION DIAGNOSIS: - NEGATIVE. FINAL DIAGNOSIS: BENIGN URETER. NO UROTHELIAL DYSPLASIA OR CARCINOMA IDENTIFIED. LEFT DISTAL URETER (B) : INTRAOPERATIVE FROZEN SECTION DIAGNOSIS: - NEGATIVE. FINAL DIAGNOSIS: BENIGN URETER. NO UROTHELIAL DYSPLASIA OR CARCINOMA IDENTIFIED. BLADDER / PROSTATE (C) : INTRAOPERATIVE GROSS DIAGNOSIS: TUMOR IDENTIFIED. FINAL DIAGNOSIS: BLADDER: POORLY DIFFERENTIATED UROTHELIAL CARCINOMA, GRADE 4/4, INFILTRATING. THROUGH THE MUSCULARIS PROPRIA TO THE PERIVESICAL FAT BUT DOES NOT. INVOLVE THE RESECTION MARGIN. LYMPHOVASCULAR INVASION IDENTIFIED. RIGHT URETER AND BLADDER JUNCTION INVOLVED BY UROTHELIAL CARCINOMA. BUT WITH NEGATIVE MARGIN. - FOCAL UROTHELIAL CARCINOMA IN SITU (FLAT LESION). - ALL SURGICAL MARGINS, FREE OF MALIGNANCY. CHRONIC CYSTITIS. PERIVESICAL LYMPH NODES: NO METASTATIC CARCINOMA IDENTIFIED IN SEVEN LYMPH NODES EXAMINED (0/7). PROSTATE: - MULTIFOCAL HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN II-III). - NO INVASIVE CARCINOMA IDENTIFIED. ACUTE AND CHRONIC PROSTATITIS. PROSTATIC ATROPHY. CHRONIC PERIARITRITIS. RIGHT PARACAVAL LYMPH NODES (D) : METASTATIC CARCINOMA IDENTIFIED IN ONE OUT OF SEVEN LYMPH NODES. EXAMINED (1/7). RIGHT COMMON ILIAC LYMPH NODES (E) : - METASTATIC CARCINOMA IDENTIFIED IN FOUR OUT OF 13 LYMPH NODES. EXAMINED (4/13), THE LARGEST ONE IS UP TO 1.8 CM WITHOUT EXTRANODAL. INVOLVEMENT. INFERIOR MESENTERIC ARTERY NODE (F) : NO METASTATIC CARCINOMA IDENTIFIED IN THREE LYMPH NODES EXAMINED (0/3). PRESACRAL LYMPH NODES (G) : NO METASTATIC CARCINOMA IDENTIFIED IN TWO LYMPH NODES EXAMINED (0/2). RIGHT EXTERNAL ILIAC LYMPH NODES (H) : i. ""S/a regeun teasip : S/A teastp 'H. FV. (NOILICI XWZNGEL HOVLS WN.L. (LOT/9) GENIWYXS SECION HdWAT LOT ao ano. XIS ao TVLOL NI VWONIOHVO OILVISULEW. SCOON HdWAT. HO ON -. NOINSE. : (S) [NIOAVW] LAST. VWONIDAVO HO VISVIDSO ON -. NOINES. :  [NIDHVW] TWWIXOHA LHDIN. (zi/o) SECON HdWAT ZI NI ON -. : (0) SECON HdWATI. (5/0) SECION HdWATI SAIA NI OLLVISULEW ON -. : (d) SACION HdWAT LHDIN. (BI/O) CENIWAXS SECION HdWAT ET NI OLLVISULEN ON. : (0) SACON HdWAT DIELSVDOdAH / HOLVENISO JAST. (2/0) CENIWAXE SECION HdWATI OM.L NI ON. : (N) SECION HdWAT JVITI LAET. (L/O) acoon HAWAT ano NI ON. : (W) JENOOTIO do LAST. (8/t) CENIWYXS. SECION HdWATI LHOIE ao ENO NI. : (7) SECON HdWAT DVITI NOWWOO LUST. (L/0) CENIWYXS SECION HdWA'T NHAHS NI VWONIOUVO ON. : (x) SACION HaWAT GILHOV tava JANT. (tz/o) CENIWVXS SECION HdWATI TZ NI DILVISULEN ON. :  SECON HdWAT / LHDIE. (z/o) SECON HdWAT OM.L NI VWONIONVO ON -. : (I) ao. (E/O) SECON HdWAT NI ON -. 9 102 ebed. D: ""R. para caval lymph nodes"". E: ""R. common iliac L. nodes'. F: ""IMA node. G: ""Presacral L. nodes"". H: ""R. external iliac L. nodes"". I: ""R. node of cloquet"". J: ""R. obturator/hypogastric L. nodes"". K: ""L. para aortic L. nodes"". L: ""L. common iliac L. nodes"". M: ""L. node of cloquet"". N: ""L. external iliac L. node'. O: ""L. obturator/hypogastric L. nodes"". P: ""r. presciatic L. node"". Q: ""L. presciatic L. nodes"". R: ""R. proximal ureter (margin) n. S: ""L. proximal ureter (margin) n. CLINICAL INFORMATION: Pre-Op Dx: Bladder cancer. Post-Op Dx: Same. GROSS EXAMINATION: A: The specimen is received fresh from the O.R. and labeled ""R. distal ureter. F/S"". It consists of a portion of ureter measuring 0.2 cm in length by 0.3 cm in. diameter. The specimen is entirely submitted for frozen section in cassette AFS. B: The specimen is received fresh from the O.R. and labeled ""Left distal ureter. F/S"". It consists of a portion of ureter with attached fat measuring 0.3 cm in. length by 0.4 cm in diameter. The specimen is entirely submitted for frozen. section in cassette BFS. C: The specimen is received fresh from the O.R. and labeled ""Bladder/prostate"". It consists of a cystoprostatectomy specimen measuring 19 x 14.5 x 5 cm. Attached. is a peritoneal segment measuring 18.5 x 14.5 x 0.1 cm. The peritoneum is smooth. and glistening. The prostate measures 5 x 4.5 x 3 cm with attached right seminal. vesicle which measures 2.5 x 1.2 x 0.5 cm and the left seminal vesicle measures 2.1. x 1.2 x 0.5 cm. Also contiguous is a right distal ureter which measures 6 cm in. length and 0.6 cm in circumference, and the left ureter measures 6.5 cm. in. length. and 0.5 cm in circumference. The bladder measures 8 x 7 x 4 cm. Opening the. bladder along the anterior wall reveals a 7.5 x 4.5 x 3.5 cm gray-white tumor mass. which occupies the anterior wall and the right lateral wall, that comes within 1 cm. from the right ureterovesical junction. The tumor grossly involves the bladder. wall and comes to within 0.2 cm from the inked serosal margin. The uninvolved. bladder wall measures 0.4 cm in thickness. The urethra measures 3 cm in. length. and. 0.9 cm in circumference with ormal-appearing mucosa. The outer surface of the. prostate is inked black with superimposed red on the right side. Sectioning of the. prostate reveals multiple pink-tan soft nodules up to 0.4 cm in greatest diameter. Sectioning of the perivesical fat reveals a 2 x 1 cm firm area on the perivesical. fat. At the request of the surgeon, an intraoperative gross consultation was. performed in order to aid in the care of this patient. Representative sections. are submitted in 39 cassettes. D: The specimen is received in formalin and labeled ""R. para caval lymph nodes"". It consists of a 6 x 4 x 1 cm fatty tissue fragment. Sectioning reveals one lymph. node which measures 1.5 cm in greatest diameter. Totally embedded in three. cassettes. E: The specimen is received in formalin and labeled ""R. common iliac L. nodes"". It consists of a 3 x 3 x 2 cm matted lymph nodes with surrounding fat. Totally. Eocation-. embedded in five cassettes. F: The specimen is received in formalin and labeled ""IMA node"". It consists of a. 4 x 3 x 2 cm gray-tan soft tissue fragment. Bisected and totally embedded in one. cassette. G: The specimen is received formalin and labeled ""Presacral L. nodes"". It. consists of a 6 x 4 x 0.5 cm fibromembranous fragment with fat. Totally embedded. in four cassettes. H: The specimen is received in formalin and labeled ""R. external iliac L. nodes"". It consists of a 3 x 2 x 2 cm fibromembranous tissue fragment and fat. Totally. embedded in four cassettes. I: The specimen is received in formalin and labeled ""R. node of cloquet"". It. consists of a 0.3 x 0.3 x 0.2 cm lymph node. The lymph node is bisected and. totally embedded in one cassette. J: The specimen is received in formalin and labeled ""R. obturator/hypogastric L. nodes"". It consists of a 6 x 5 x 2 cm fibromembranous tissue fragment and fat. Totally embedded in six cassettes. K: The specimen is received in formalin and labeled ""L. para aortic L. nodes"". It. consists of a 2 x 1 x 0.5 cm fatty tissue fragment. Totally embedded in one. cassette. L: The specimen is received in formalin and labeled ""L. common iliac L. nodes"". It consists of three lymph nodes ranging from 0.4 up to 0.5 cm in greatest. diameter. The lymph nodes are totally submitted in three cassettes. M: The specimen is received in formalin and labeled ""L. node of cloquet"". It. consists of a 1 x 1 x 0.5 cm fat. The specimen is totally submitted in one. cassette. N: The specimen is received in formalin and labeled ""L. external iliac L. node"". It consists of a 2 x 1 x 1 cm fatty tissue fragment. Totally embedded in one. cassette. O: The specimen is received in formalin and labeled ""L. obturator/hypogastric L. nodes"". It consists of a 4 x 3 x 0.5 cm fatty tissue fragment. Sectioning. reveals multiple lymph nodes. Totally embedded in four cassettes. P: The specimen is received in formalin and labeled ""r. presciatic L. node"". It. consists of a 1 x 0.5 x 0.3 cm aggregate of fat. Totally embedded in two cassettes. Q: The specimen is received in formalin and labeled ""L. presciatic L. nodes"". It. consists of a 1 x 1 x 0.5 cm aggregate of fat. Totally embedded in two cassettes. R: The specimen is received in formalin and labeled ""R. proximal ureter (margin) "". It consists of a 1 cm in length and 0.2 cm in diameter portion of ureter with. stapled end. The stapled end is inked black. The specimen is trisected and. totally submitted in one cassette. S: The specimen is received in formalin and labeled ""L. proximal ureter (margin). It consists of a 1.2 cm in length and 0.2 cm in diameter portion of ureter. The. specimen is serially sectioned and totally submitted in one cassette. SECTIONS: AFS: frozen section, right distal ureter. BFS: frozen section, left distal ureter. bocation. C1,2: tumor with closest inked serosal margin. C3,4: contiguous section of tumor. C5-10. representative sections of tumor. C11: random section of posterior bladder wall. C12: random section of trigone. C13: section from left lateral wall. C14: bladder dome. C15: right ureterovesical junction. C16: left ureterovesical junction. C17: right apex. C18: left apex. C19: right upper distal prostate. C20: right lower distal prostate. C21: left upper distal prostate. C22: left lower distal prostate. C23: right upper mid prostate. C24: right lower mid prostate. C25: left upper mid prostate. C26: left lower mid prostate. C27: right upper proximal prostate. C28: right lower proximal prostate. C29: left upper proximal prostate. C30: left lower proximal prostate. C31: left upper base prostate. C32: right lower base prostate. C33: left upper base prostate. C34: left lower base prostate. C35: right seminal vesical and vas deferens. C36: left seminal vesical and vas deferens. C37-39: firm area in right perivesical fat. D1: right paracaval lymph nodes; one lymph node. D2,3: remaining tissue. E1-5: right common iliac lymph nodes-. F: inferior mesenteric artery node - all embedded. G1-4: left presacral nodes - all embedded. H1-4: right external iliac lymph nodes - all embedded. I: right node of Cloquet - all embedded. J1-6: right obturator/hypogastrio lymph nodes - all embedded. K: left para-aortic lymph nodes - all embedded. L1-3: left common iliac lymph nodes - all embedded. M: left node of Cloquet - all embedded. N: left external iliac lymph node - all embedded. 01-4: left obturator/hypogastric lymph nodes - all embedded. P1,2: right presciatic lymph node - all embedded. Q1,2: left presciatic lymph nodes - all embedded. R: right proximal ureter (margin) - all embedded. S: left proximal ureter (margin) - all embedded. INTRAOPERATIVE FROZEN CONSULTATION: AFS: Right distal ureter: - benign. BFS: Left distal ureter: - benign. Locauon,. INTRAOPERATIVE GROSS CONSULTATION. Bladder (C) : tumor identified. MICROSCOPIC EXAMINATION: A-S: See final microscopic-diagnosis.l.","Poorly differentiated urothelial carcinoma, grade 4/4, infiltrating through the muscularis propria to the perivesical fat, but does not involve the resection margin. Lymphovascular invasion identified. Right ureter and bladder junction involved by urothelial carcinoma, but with negative margin. Focal urothelial carcinoma in situ, flat lesion. All surgical margins free of malignancy. Chronic cystitis. Perivesical lymph nodes show no metastatic carcinoma. Prostate shows multifocal high-grade prostatic intraepithelial neoplasia, but no invasive carcinoma. Acute and chronic prostatitis, prostatic atrophy, and chronic periarteritis. Right paracaval lymph nodes show metastatic carcinoma in one out of seven lymph nodes examined. Right common iliac lymph nodes show metastatic carcinoma in four out of thirteen lymph nodes examined, without extranodal involvement. Inferior mesenteric artery node, presacral lymph nodes, and other lymph nodes show no metastatic carcinoma."
TCGA-AA-3562.98738f18-85bd-4aa9-887d-443a1bc00694,"Diagnosis: Resected colon with a broad, ulcerated, moderately differentiated adenocarcinoma of. colorectal type, with infiltration of the pericolic adipose tissue, lymphangiosis. carcinomatosa with tumor and seven local lymph node metastases. Tumor-free colon. resection margins. Tumor-free mesenteric resection margin. The remaining mucous. membrane of the colon displaying a circumscribed, ulcerous defect with remains of a. tubular adenoma with moderate epithelial dysplasia, as well as a further small tubular. adenoma, likewise with moderate dysplasia (synonymously: mild intraepithelial neoplasia). Stage of tumor: pT3, pN2 (7/28), MX; G2, L1, V0, local R0.","Adenocarcinoma of colorectal type, moderately differentiated, with infiltration of the pericolic adipose tissue and lymphangiosis carcinomatosa. Tumor cells display moderate epithelial dysplasia. Seven local lymph node metastases identified. The remaining mucous membrane of the colon shows a circumscribed, ulcerous defect with remains of a tubular adenoma and moderate dysplasia, as well as a further small tubular adenoma with moderate dysplasia. Tumor-free colon resection margins and tumor-free mesenteric resection margin. No vascular invasion identified."
TCGA-YT-A95G.60D44471-E8AB-47FF-BC45-0ECF59E87F81,"8584) 1. PRIMARY SITE: Thymus. I- ""Thymus"": Thymoma, type 2 of WHO (see also immunohistochemical exam). II- ""Pre-vascular fat"": Free of neoplastic compromise. Immunohistochemistry Exam: Morphological features associated with the immunohistochemistry profile support the. diagnosis of type B2 thymoma (WHO).","Thymoma, type 2 of WHO, with morphological features supporting the diagnosis. Tumor cells exhibit characteristic architectural and cellular characteristics. No neoplastic compromise identified in pre-vascular fat."
TCGA-EM-A3O7.F408FB89-12A6-4698-8E4B-C64F353C334D,"LABORATORY MEDICINE PROGRAM. Facility: Specimen(s) Received. 1. Parathyroid: RIGHT UPPER PARATHYROID QS. 2. Parathyroid: Left lower parathyroid/QS. 3. Thyroid: Total thyroid tie upper pole right lobe. Diagnosis. 1. No pathological diagnosis: Parathyroid (right upper) biopsy. 2. No pathological diagnosis: Parathyroid (left lower) biopsy. 3. Multifocal papillary carcinoma, dominant 4.7 cm, right Thyroid. No pathological diagnosis: Parathyroids, right and left. - total thyroidectomy specimen. Synoptic Data. Procedure: Total thyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 4.8 cm. 5.1 cm. 3.5 cm. Left lobe: 3.8 cm. 2.4 cm. 1.6 cm. Isthmus +/- pyramidal lobe: 2.0 cm. 3.1 cm. 2.2 cm. Specimen Weight: 69.32 g. Tumor Focality: Multifocal, bilateral. Multifocal, midline (isthmus). DOMINANT TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 5.0cm. Additional dimension: 4.7 cm. Additional dimension: 3.4 cm. Histologic Type: Papillary carcinoma, classical (usual). Classical (papillary) architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: Totally encapsulated. Tumor Capsular Invasion: Not identified. Present, extent minimal. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. SECOND TUMOR. Tumor Laterality: Isthmus. Tumor Size: Greatest dimension: 0.35cm. Histologic Type: Papillary carcinoma, follicular variant. Papillary carcinoma, microcarcinoma (occult, small or microscopic) variant. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT3: Tumor more than 4 cm, limited to thyroid or with minimal extrathyroidal extension. (eg, extension to sternothyroid muscle or perithyroid soft tissues). Regional Lymph Nodes (pN): pNX: Regional lymph nodes cannot be assigned. Number of regional lymph nodes examined: 0. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Other: multiple microcarcinomas, left. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Gross Description. 1. The specimen labeled with the patient's name and as ""right upper parathyroid QS"" consists of a tiny piece of tissue that. measures 0.5 x 0.5 x 0.3 cm and weighs 0.017 g. It is frozen for intraoperative consultation. 1A. frozen section block resubmitted. 2. The specimen labeled with the patient's name and as ""left lower parathyroid qs"" consists of a tiny piece of tissue that. measures 0.2 x 0.2 x 0.1 cm. It is frozen for intraoperative consultation. 2A. frozen section block resubmitted. 3. The specimen labeled with the patient's name and as ""total thyroid tie upper pole right lobe"" consists of a thyroid gland. that is oriented with a suture and weighs 69.32 g. The right lobe measures 4.8 cm SI x 5.1 cm ML x 3.5 cm AP, the left. lobe measures 3.8 cm SI X, 2.4 cm ML X 1.6 cm AP and the isthmus measures 2.0 cm SI x 3.1 cm ML x 2.2 cm AP. The. external surfaces have fibrous adhesions. No parathyroid glands and/or lymph nodes are identified grossly. The external. surface is painted with liquid bluing. The right lobe contains a well delineated, solid to cystic nodule that measures 4.7 cm. SI x 5.0 cm ML x 3.4 cm AP. The remainder of the thyroid tissue is grossly unremarkable. Sections of the nodule and. normal tissue are stored frozen. The remainder of the specimen is submitted as follows: 3A-O right lobe, superior to inferior. 3P-W isthmus. 3X-AG left lobe, superior to inferior. Quick Section Diagnosis. 1. Right upper parathyroid: Parathyroid tissue identified. Surgeon called 9.25 am. 2. Left lower parathyroid: Parathyroid tissue identified. Surgeon called 9.45 am. , MD.","Multifocal papillary carcinoma with classical papillary architecture and classical cytomorphology. Tumor is totally encapsulated with no capsular invasion, lymph-vascular invasion, or perineural invasion identified. Extrathyroidal extension not identified. Margins are uninvolved by carcinoma. Additional tumor in the isthmus shows follicular architecture and classical cytomorphology, also without capsular invasion, lymph-vascular invasion, or perineural invasion. Multiple microcarcinomas are present in the left thyroid. Parathyroids, right and left, show no pathological diagnosis."
TCGA-FG-A711.5E5F767F-755E-4361-AA92-42D09DE41386,"Observation Date and Time. Component. SPECIMEN DESCRIPTION. (NOTE). Med. Rec #: : Clinical History. Brain lesion. ADDENDA: : Addendum added: Addendum added: Addendum added: Final Pathologic Diagnosis. A. Left frontal lobe, excision: - Glial neoplasm, low grade. See comment. Comment: The histological profile and Ki-67 labelling index are consistent. with a low grade (WHO grade II) glial neoplasm. Though in many areas the. cells assume an oligodendroglial profile, in other areas more pleomorphic. elements with astrocytic appearance are present. More sections as well a3. assays for 1p/19q deletions are pending and an addendum will be issued. subsequently. The immunohistochemical and/or in situ hybridization tests reported here,. except for those addressing HER-2Neu overexpression, have been developed. and their performance characteristics determined by the. laboratories in the. at the. and are not required to. have nor do they have FDA approval. Addendum Report. Addendum. Detection of 1p36 and 19q by 1p36 1q25 and . 19q13/19p13. Dual-Color Probe Sets. Telephone: Outside Case#: Source of case. Block used. A2. Tissue fixation. formalin-fixed - tissue. Tissue source. Brain. Ratio of. 0.67. Cell count of 1p/1q: 118. Ratio of. 0.48. Cell count of 19q/19p: 120. Interpretation of Results: A) 1p loss;. B) 19q loss. Interpretation of findings: A) (positive) The majority of tumors cells displayed 2 control. chromosome 1q25 signals and 1 chromosome 1p36 signals (locus of. interest) The ratio of 1p36/1q25 is <0.8. The results are consistent. with the loss of 1p36 locus of interest. B) (positive) The majority. of tumors cells displayed 2 control chromosome 19p13 signals and 1. chromosome 19q13 signals (locus of interest) The ratio of. 19q13/19p13 is <0.8. The results are consistent with the loss of 1p36. locus of interest. Number of Observers: 2. Test Interpreted By: Comments. The resultant FISH section/slide is scanned by a trained licensed. medical technologist and analyzed using a FDA-approved, validated. emi-automated scanning imaging workstation. and accompanying imaging. analysis software. The resultant FISH section/slide is then. presented to the interpreting Pathologist, who will reviews the FISH. results from. and compares them to the results manually observed. under. Fluorescence Microscope. Therefore the ratio is enumerated. by computer-aided counting. as well as manual counting. Interpretation of Test. The ratio for probe set 1 is derived by dividing the total number of. 1p36 signals by the total number of 1q25 signals in at least 20. interphase nuclei with. nonoverlapping nuclei in the neoplastic glial cells. Cells with no. signals or with signals of only one color are disregarded. The ratio for. probe set 2 is derived by dividing the total number of. 19q13 signals by. the total number of 19p13 signals in at least 2 sets of 20 interphase. nuclei with nonoverlapping nuclei in the neoplastic glial cells at two. different areas of the sample. Cells with no signals or with signals of. only one color are disregarded. References ranges for our laboratory for. allelic loss versus no allelic loss were established by evaluating both. probe sets in a series of 40 normal cases from 10 different organs. For. both probe set 1 and 2 a ratio of less than 0.80 taken from at least 2 sets. of 20 interphase nuclei at 2 different areas with nonoverlapping nuclei is. consistent with allelic loss. Limitations. ANALYTE SPECIFIC REAGENT: The use of one or more reagents in the above. tests is regulated as an analyte specific reagent (ASR) These tests were. developed and their performance characteristics determined by the. They have not. been cleared by the US Food and Drug Administration. The FDA has. determined that such clearance or approval is not necessary. Addendum. A: Left frontal lobe, excision. - Oligodendroglioma (WHO grade II) . In-situ assays detect loss of both 1p and 19q loci. Addendum. Unchanged. The KI-67 stain was performed by manual immunohistochemistry method. INTRAOPERATIVE CONSULTATION DIAGNOSIS: AF1. Left frontal tumor: (FROZEN SECTION PERFORMED). Infiltrating glial neoplasm. Examining pathologist: MICROSCOPIC: Sections show an infiltrating mild to moderately cellular neoplasm composed. of glial elements having round to ovoid nuclei and scant cytoplasm. In. areas, nuclear pleomorphism with more elongated form is identified. Focally, clusters of minigemistocytes are present. Mitotic figures are. occasional. Immunostain for GFAP is positive in occasional cells and a. Ki-67 stain shows a proliferation index in the range of 1-2%. SPECIMEN (S) RECEIVED: Neuropathology Brain, Reg. GROSS DESCRIPTION: The specimen is received in one properly labeled container of which is. originally received in frozen section, with the patient' LE name and. A. The specimen is designated ""left frontal tumor"" and consists of. a 7.9 x 6.0 X 3.1 cm portion of tan-gray brain tissue. Upon serially. sectioning a 5.8 x 5.7 x 3.4 cm tan-white homogeneous mass is identified. A representative section is 3u ted for frozen section and is resubmitted. as received in cassette AF1. Summary of Cassettes: AF1, frozen section tissue; A1-6, - random. sections of mass. Lab Use Only: Lab Use Only: Gross description by:","Glial neoplasm, low grade, with a histological profile consistent with a low grade glial neoplasm, composed of cells with oligodendroglial and astrocytic appearance, and exhibiting nuclear pleomorphism. The tumor is infiltrating and mildly to moderately cellular, with round to ovoid nuclei and scant cytoplasm, and focal clusters of minigemistocytes are present. Mitotic figures are occasional. The tumor cells show positive immunostain for GFAP in occasional cells and a Ki-67 stain shows a proliferation index. No necrosis is identified. The tumor is confined to the brain tissue with no invasion into adjacent structures identified. The resection margin is not involved by tumor. Non-neoplastic brain tissue shows no significant abnormalities."
TCGA-AK-3458.f60e8526-3d2e-4526-a393-431291059bd3,"Clinical History/Diagnosis: Right Renal Mass. Source of Specimen(s): Right kidney, perirenal fat and adrenal gland. Gross Description: Received in one part. Source of Tissue: 1. Labeled #1, ""right kidney, perirenal fat and adrenal"". Gross Description: Received fresh labeled,. right kidney, perirenal fat and adrenal"". It consists of a kidney with. surrounding perinephric fat weighing a total of 1109 grams. The attached. ureter measures 13 cm in length and 0.5 cm in diameter. The ureter is. opened to reveal a smooth tan-pink mucosa with no papillary structures. noted. The specimen is bisected revealing a 13.5 X 8 x 6 cm kidney that. weighs 370 grams. A firm well-demarcated, variegated mid pole mass is. identified measuring 6.5 X 6.5 x 4 cm and comes within less than 0.1 cm of. the capsule. Grossly the mass does not appear to infiltrate the. surrounding perinephric fat. The remaining parenchyma is light-brown, soft. with no other discrect lesions present. The adrenal gland cannot be. identified grossly. Representative sections are submitted in 1A-1L. Tissue sent for Cytogenetics. Designation of Sections: 1A- ureteral and vascular margins, 1B- additional. sections of ureter, IC-1D- tumor with closest capsule, 1E-1F- sections of. perinephric fat closest to tumor, 1G-1H- tumor with adjacent normal. kidney, 1I-1L- perinephric fat to look for adrenal gland. Final Diagnosis: 1. Right kidney, perineural fat and adrenal gland, radial nephrectomy: - Renal cell carcinoma, clear cell type, 6.5 cm in greatest dimension. grossly, Fuhrman nuclear grade III of IV. - Carcinoma is confined to the kidney. - Lymphovascular invasion is not identified. - Vascular and ureteral resection margins are free of tumor. - No adrenal gland is identified. pTNM: T1b Nx Mx.","Renal cell carcinoma, clear cell type, with a well-demarcated, variegated mass. Tumor composed of cells with clear cytoplasm and distinct cell borders. Fuhrman nuclear grade III of IV. No necrosis identified. Carcinoma is confined to the kidney. Lymphovascular invasion is not identified. Vascular and ureteral resection margins are free of tumor. No adrenal gland is identified. Remaining parenchyma is light-brown, soft with no other discrete lesions present. Perinephric fat does not show infiltration by tumor."
TCGA-QG-A5YV.DCBDBBD7-E408-4E5F-AF2B-95F4D01C7D5C,"ADDENDUM. Addendum Comment. The purpose of this addendum is to report results following deeper levels. and an immunohistochemistry stain for Pancytokeratin on a lymph node in. section G35 due to a small fibrotic focus seen on the routinely stained. slide. No metastatic carcinoma is seen in the additional deeper levels of the lymph. node in section G35. An immunohistochemistry stain for Pancytokeratin is. negative; the control is appropriate. The diagnoses remain unchanged. This immunohistochemistry test(s) was developed and its performance. characteristics determined by the. Immunohistochemistry Laboratory and/or affiliated institution. It has not. been cleared or approved by the U.S. Food and Drug Administration. The FDA. has determined that such clearance or approval is not necessary. This test. is used for clinical purposes. It should not be regarded as investigational. or for research. This laboratory is certified under the Clinical Laboratory. Improvement Amendments of 1988 (CLIA) as qualified to perform high. complexity clinical laboratory testing. End of Addendum Report or Additional Results. PATHOLOGIC DIAGNOSIS. A. SOFT TISSUE, LEFT ABDOMINAL WALL, EXCISIONAL BIOPSY: - NO ADENOCARCINOMA FOUND. - EXTENSIVE FIBROSIS WITH CHRONIC INFLAMMATION INVOLVING. LOBULES OF ADIPOSE TISSUE COMPATIBLE WITH SCAR. B. URINARY BLADDER, LEFT MUCOSAL MARGIN, EXCISION: - NO ADENOCARCINOMA FOUND. - UROTHELIAL MUCOSA WITH EDEMA, FOCAL HEMORRHAGE. AND CHRONIC INFLAMMATION. C. URINARY BLADDER, POSTERIOR MUCOSA, EXCISION: - NO ADENOCARCINOMA FOUND. - UROTHELIAL-TYPE MUCOSA WITH EDEMA, CHRONIC INFLAMMATION. AND HEMORRHAGE. D. URINARY BLADDER, RIGHT MARGIN AND MUCOSA, EXCISION: - NO ADENOCARCINOMA FOUND. - UROTHELIAL-TYPE MUCOSA WITH EDEMA, CHRONIC INFLAMMATION. AND FOCAL HEMORRHAGE. E. URINARY BLADDER, POSTERIOR MUSCLE MARGIN, EXCISION: - NO ADENOCARCINOMA SEEN. - SMOOTH MUSCLE FIBERS WITHIN AN EDEMATOUS, INFLAMED. STROMA, COMPATIBLE WITH BLADDER WALL. F. SOFT TISSUE, UMBILICAL REGION, HERNIORRHAPHY: - NO ADENOCARCINOMA SEEN. - COMPATIBLE WITH HERNIA SAC. G. SIGMOID COLON AND URINARY BLADDER, PARTIAL CYSTECTOMY AND. SIGMOIDECTOMY EN BLOC RESECTION OF DOME OF UNINARY BLADDER. AND POSTERIOR ABDOMINAL WALL: - ADENOCARCIOMA, MODERATELY DIFFERENTIATED, ARISING IN A. TUBULOVILLOUS ADENOMA. - SPECIMEN LENGTH: 31.0 CM. - TUMOR SITE: SIGMOID COLON. - TUMOR SIZE: GREATEST DIMENSION: 9.5 CM. - ADDITIONAL DIMENSIONS: 7.0 X 6.0 CM. - MACROSCOPIC TUMOR PERFORATION: CANNOT BE DETERMINED. - MICROSCOPIC TUMOR PERFORATION: PRESENT. - HISTOLOGIC GRADE: LOW-GRADE. - MICROSCOPIC TUMOR EXTENSION: TUMOR PENETRATES TO. THE SURFACE OF THE VISCERAL PERITONEUM (SEROSA). AND DIRECTLY INVADES ADJACENT STRUCTURES (URINARY. BLADDER). - MARGINS: DISTAL AND PROXIMAL MARGINS NEGATIVE. - TREATMENT EFFECT: NO PRIOR TREATMENT. - LYMPHOVASCULAR INVASION: NOT IDENTIFIED. - PERINEURAL INVASION: NOT IDENTIFIED. - TUMOR DEPOSITS (DISCONTINUOUS EXTRAMURAL EXTENSION): NOT IDENTIFIED. - METASTATIC ADENOCARCINOMA FOUND IN ONE OF THIRTY-ONE. LYMPH NODES (1/31). - ADDITIONAL FINDINGS: - EXTENSIVE SEROSITIS, INCLUDING RESECTION MARGINS. - INTRAMURAL ABSCESS. - HEMORRHAGIC CYSTITIS. - TUBULOVILLOUS ADENOMATOUS CHANGE. - ANCILLARY STUDIES: NEGATIVE FOR MICROSATELLITE INSTABILITY. (SEE PREVIOUS SURGICAL REPORT. H. SIGMOID COLON, NEW PROXIMAL MARGIN, EXCISION: - NEGATIVE FOR ADENOCARCINOMA. I. SIGMOID COLON, NEW DISTAL MARGIN, EXCISION: - NEGATIVE FOR ADENOCARCINOMA. - ACUTE SEROSITIS. J. LYMPH NODE, SITE NOT SPECIFIED, REGIONAL DISSECTION: - TWO LYMPH NODES IDENTIFIED, BOTH NEGATIVE FOR METASTATIC. ADENOCARCINOMA (0/2). PATHOLOGIC STAGING (pTNM): - PRIMARY TUMOR (pT): pT4b, TUMOR DIRECTLY INVADES OR IS ADHERENT TO. OTHER ORGANS. OR STRUCTURES. - REGIONAL LYMPH NODES (pN): pN1a, METASTASIS IN ONE REGIONAL LYMPH. NODE (SEE COMMENT). NUMBER EXAMINED: THIRTY-THREE (33). NUMBER INVOLVED: ONE (1). - DISTANT METASTASIS: NOT APPLICABLE. Comment. Part G: A lymph node in section G35 contains a small suspicious fibrotic. focus underlying the subcapsular sinus. Additional deeper levels are. pending as well as a Pancytokeratin immunohistochemistry stain. These. results will be issued in an addendum report. Intraoperative Consultation. Intraoperative Frozen Section Diagnosis. FSA1-2 Soft tissue, left abdominal wall, excisional biopsy: - Scarring and inflammation. - No metastatic carcinoma seen. - The diagnosis was verbally reported to. FSB: Urinary bladder, left mucosal margin, excision: - No malignancy seen. FSC: Urinary bladder, posterior mucosa, excision: - No malignancy seen. FSD: Urinary bladder, right mucosa margin, excision: - No malignancy seen. FSE: Urinary bladder, posterior muscle margin, excision: - No malignancy seen. verbally notified of the diagnosis at. Pathology Resident. Pertinent Clinical Information. Possible abdominal wall involvement by sigmoid colon carcinoma. Gross Description. Specimen Material: A- Left abdominal wall, B- Left bladder mucosa margin,. C- Posterior bladder mucosa, D- Right bladder margin bladder mucosa, E-. Posterior bladder muscle margin, F- Hernia sac, G- Sigmoid colon and. partial bladder, H- New proximal margin (sigmoid), I- New distal margin. (sigmoid), J- Additional lymph node. The case is received in ten parts, each labeled with the patient's name. medical record number and given accession number. and it is accompanied by a requisition form labeled with the same. name and accession number. Part A: Received fresh for intraoperative consultation labeled ""RULE OUT. TUMOR LEFT ABDOMINAL WALL"" is a 2.5 X 2.0 x 0.7 cm tan-pink, irregular, soft. piece of tissue which is bisected to reveal a tan-white, homogeneous area. grossly compatible with either fibrous tissue or tumoral implant. Touch. preparations are performed and the entire specimen is submitted for frozen. section in cassettes FSA1 and FSA2. Part B: Received fresh for intraoperative consultation labeled ""BLADDER. LEFT MARGIN, BLADDER MUCOSA"" is a 2.0 X 0.7 X 0.5 cm tan-pink to red,. irregular piece of soft tissue which is entirely submitted for frozen. section in cassette FSB. Part C: Received fresh for intraoperative consultation labeled ""BLADDER. POSTERIOR, BLADDER MUCOSA"" is a 2.0 X 0.7 X 0.5 cm tan-pink to red,. irregular soft piece of tissue which is entirely submitted for frozen. section in cassette FSC. Part D: Received fresh for intraoperative consultation labeled ""BLADDER. RIGHT MARGIN, BLADDER MUCOSA"" is a 2.2 x 0.5 x 0.3 cm tan-pink to red,. irregular soft piece of tissue which is entirely submitted for frozen. section in cassette FSD. Part E: Received fresh for intraoperative consultation labeled ""BLADDER. MUSCLE MARGIN, FROZEN SECTION"" and consists of a 2.0 x 1.1 x 0.3 cm tan-pink. to red, irregular piece of soft tissue which is entirely submitted for. frozen section in cassette FSE. Pathology Resident. Part F: Received in formalin labeled ""HERNIA SAC"" is a 6.0 X 6.0 x 3.5 cm. tan-yellow, lobulated portion of adipose tissue with an attached fibrous. membrane focally adherent to fat. The specimen is serially sectioned to. reveal tan-yellow, lobulated and glistening adipose tissue with no grossly. identifiable lesions. One representative section is submitted in cassette. F. Part G: Received in formalin labeled ""SIGMOID COLON AND PARTIAL BLADDER"" is. a 31.0 cm in length and a diameter ranging from 5.0 to 6.5 cm segment of. colon marked with a stitch indicating the proximal end, as oriented by the. surgeon, with an attached 11.0 x 10.5 X 8.0 cm firm, round mass, displaying. a 5.0 x 4.5 cm ovoid, hemorrhagic, irregular area most likely compatible. with bladder mucosal resection margin (previously sent for frozen) located. towards the distal colonic end. The specimen has an attached 28.0 X 19.0 X. 1.5 cm portion of mesenteric fat. The colonic serosa is tan-gray and granular adjacent to the bladder. attachment site. Additionally there are multiple inconspicuous, thin,. irregular foci of possible fibrin deposition disseminated all over the. specimen. The mass has minimally attached adipose tissue with focal. tan-gray granular areas of possible fibrin deposition. There is a 9.5 X 6.0 cm tan-pink, focally friable, exophytic tumor involving. the colonic mucosa circumferentially with focal areas of superficial. necrosis and hemorrhage, located at 3.5 cm from the distal resection margin. and at 15.0 cm from the proximal resection margin. A perpendicular section. through the mass reveals continuity with the circumferential colonic mass. extending through a thick muscular wall, having up to 1.9 cm in thickness. This wall likely represents urinary bladder wall. The bulk mass of tumor. present outside the colon measures 9.5 X 7.0 x 6.0 cm. The mass is grossly. extending through the entire colonic wall thickness minimally penetrating. grossly into the pericolonic adipose tissue, at 0.5 cm from the serosal. lining. The tumor infiltrates the muscular wall, at 1.5 cm from the bladder. mucosal margin and at 0.4 cm from the outer bladder wall surface (purple. ink) towards the proximal colon end. Blue previous bladder resection site. Purple external mass. Black mesenteric serosa at the closest point of invasion. Section Code: G1: distal resection margin, en face. G2-3: proximal resection margin, en face. G4-6: suspicious area of extension at superior aspect of mass adjacent to. colon proximally. G7: deepest area of invasion into the mesenteric fat. G8: tumor invading the pericolonic adipose tissue. G9: tumor with adjacent uninvolved mucosa at the distal end with underlying. soft tissue abscess. G10: possible lymph node. G11-G16: representative sections of the previous bladder resection margin. (perpendicular sections grossly uninvolved). G17-G20: representative sections of tumor at the colonic location. G21-G22: colonic mucosa adjacent to tumor toward the proximal end. G23-G25: tumor in relation to the bladder wall. G26-G27: multiple whole possible lymph nodes. G28-G29: one serially sectioned possible lymph node. G30: one bisected lymph node. G31: multiple whole possible lymph nodes. G32: multiple whole possible lymph nodes. G33: one bisected lymph node. G34: multiple whole possible lymph nodes. G35: one bisected lymph node. G36: multiple whole possible lymph nodes. G37: one trisected lymph node. G38: one possible bisected lymph node. G39: multiple whole possible lymph nodes. G40-41: transition of tumor to bladder mucosa (orange ink towards the. bladder). G42-51: bladder mucosa (posterior portion towards the distal aspect of the. colon). G52-62: anterior aspect of the bladder mucosa (concluding submission of the. bladder mucosa in its entirety). G63-G68: bladder wall in relation with tumor and possible skeletal muscle. G69: tumor (orange indicates colonic luminal aspect). G70-G73: tumor. G74: one bisected lymph node. G75: one bisected lymph node. G76: three possible whole lymph nodes. Part H: Received in formalin labeled ""NEW PROXIMAL MARGIN (SIGMOID)"" is a. 5.0 x 0.8 X 0.7 cm portion of stapled fibroadipose tissue partially surfaced. by mucosa, compatible with colonic origin. The staple line is removed and. the remainder of the specimen is entirely submitted in a single cassette. Part I: Received in formalin labeled ""NEW DISTAL MARGIN (SIGMOID)"" is a 3.1. x 0.7 X 0.7 cm stapled fragment of colonic mucosa. The staple line is. removed and the remainder of the specimen is submitted in cassette I. Part J: Received in formalin labeled ""ADDITIONAL LYMPH NODE"" is a 1.2 x 0.8. X 0.6 cm round, ovoid portion of tissue which is bisected to reveal a 0.7 cm. tan-gray lymph node. The specimen is entirely submitted in cassette J. Pathology Resident. Pathology Resident. Microscopic Description. A-F: Performed. G: Sections show a moderately differentiated adenocarcinoma composed of. highly irregular, tightly packed glandular structures with pleomorphic. nuclei involved by extensive areas of necrosis, desmoplastic reaction and. chronic inflammation. The tumor is surrounded by adenomatous colonic mucosa. with tubulovillous architecture. The tumor seems to invade the sigmoid. colon wall and penetrates into the muscular bladder wall extending close to. the bladder mucosal urothelium, but without directly involving it. The. bladder mucosa shows extensive hemorrhagic cystitis with subepithelial. hemorrhage and congestion and extensive inflammatory infiltrate and edema. within the mucosal lamina propria. There is extensive acute serositis. involving the peritoneum with submesothelial polymorphonuclear cells. This. acute inflammatory process involves the resection margins, as well. An area. of intramural colonic abscess is identified near the distal aspect. underlying the tumor. H-J: Performed. This case was reviewed by the staff pathologist listed below. Pathology Resident.","Moderately differentiated adenocarcinoma arising in a tubulovillous adenoma, composed of highly irregular, tightly packed glandular structures with pleomorphic nuclei, involved by extensive areas of necrosis, desmoplastic reaction, and chronic inflammation. The tumor invades the sigmoid colon wall and penetrates into the muscular bladder wall, extending close to the bladder mucosal urothelium, but without directly involving it. The bladder mucosa shows extensive hemorrhagic cystitis with subepithelial hemorrhage and congestion, and extensive inflammatory infiltrate and edema within the mucosal lamina propria. There is extensive acute serositis involving the peritoneum with submesothelial polymorphonuclear cells, which involves the resection margins. An area of intramural colonic abscess is identified near the distal aspect underlying the tumor. Metastatic adenocarcinoma is found in one of thirty-one lymph nodes. The tumor directly invades adjacent structures, including the urinary bladder. Distal and proximal margins are negative for adenocarcinoma. No lymphovascular or perineural invasion is identified."
TCGA-UC-A7PF.EF390F2F-A13F-4661-86C6-2679E4FAEE72,"Patient ID: SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Ovary, left. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Soft tissue mass biopsy. SPECIMEN (S) : Uterus. SPECIMEN (S) : Surgical margins. SPECIMEN (S) : Surgical margins. SPECIMEN (S) : Appendix, incidental. CLINICAL DATA: Cervical cancer. GROSS DESCRIPTION: A) Received in formalin designated ""right external iliac node"" are. multiple. fragments of fatty tissue measuring 2 X 2 X 1 cm in aggregate. Three. potential. lymph nodes are identified and submitted in cassette A1. B) Received in formalin designated ""right obturator node"" are multiple. fragments of fatty tissue measuring 3 x 2 x 1 cm in aggregate. Several. potential lymph nodes are identified and submitted in cassette B1. C) Received in formalin designated ""right common para-aortic nodes"" are. multiple fragments of soft tissue measuring 1 X 1 x 1 cm. No lymph nodes. are. identified and the specimen is entirely submitted in cassette C1. D) Received in formalin designated ""left ovary"" is an ovary without. attached. tube measuring 3.5 x 3 X 2.5 cm. Multiple cysts (up to 0.8 cm) and. adhesions. are identified on the surface. The specimen is bivalved and cut surfaces. reveal. a cyst measuring 1 cm. Representative sections are submitted in cassettes. D1. and D2. E) Received in formalin designated ""left external iliac nodes"" are. multiple. fragments of fatty tissue measuring 4 x 2 X 1 cm in aggregate. Several. potential lymph nodes are identified and submitted in cassettes E1-E3. F). Received in formalin designated ""left obturator nodes"" are multiple. fragments of fatty tissue and blood clot. No lymph nodes are identified. and the. specimen is entirely submitted in cassettes F1 and F2. G) Received in formalin designated ""left common iliac nodes"" are multiple. fragments of fatty tissue measuring 2 X 1 x 0.8 cm in aggregate. One. lymph node. is identified and submitted in cassette G1. H). Received in formalin designated ""right parametria"" is a fragment of. fibroadipose tissue measuring 2 x 2 x 0.5 cm in aggregate. The specimen. is. submitted in toto in cassette H1. I) Received in formalin designated ""uterus, tube, ovary and parametrium"". is a. uterus with attached ovary and fallopian tube measuring 11 x 6 x 5 cm and. weighs. 190 grams. The uterus is covered with pink, smooth, glistening serosa. with no. focal lesions identified. The ectocervix has a pink, smooth mucosa; the. cervical canal is patent. The cervix measures 3.5 x 3.5 cm. The. parametrium. area is inked as follows: anterior blue, posterior green. No lymph. nodes. are identified in the parametrium. Bivalving the specimen reveals a 5 x. 1.5 cm. endometrial cavity The endometrium measures up to 0.2 cm in thickness and. the. myometrium measures up to 2.5 cm. in thickness. The specimen is sectioned;. sequential cut surfaces reveal multiple small leiomyomas in the myometrium. measuring up to 1.5 cm in diameter. A firm, predominantly submucosal tumor. mass,. which measures up to 1.5 cm in depth, 2.5 cm in length and which. circumferentially involves all the quadrants of cervix, is identified. within the. parenchyma of the cervix. The cut surfaces appears homogeneously white. Grossly,. The lesion does not extend to the surgical resection margin; the nearest. margin. is 0. cm from the lesion. Representative sections are submitted as. follows: Il. vaginal cuff, anterior; I2 vaginal cuff, posterior; I3 parametrium,. anterior; I4 parametrium, posterior; I5-I6 cervix, anterior left. quadrant;. I7-I8 anterior right quadrant. Cassettes I9-I10 cervix posterior. right. quadrant. Cassettes I11-I12 cervix posterior left quadrant. I13 lower. segment of uterus; I14 uterus, fundus portion and representative. sections of. leiomyoma. J) Received in formalin designated ""left post vaginal margin"" is a. fragment of mucosa measuring 4 x 1 x 0.5 cm. A suture is identified on. one side of the specimen. The specimen is sectioned and the margin near. the suture is submitted in cassette J1. K). Received in formalin designated ""right post vaginal margin"" is a. fragment of mucosa measuring 5 x 0.8 x 0.5 cm. The specimen is sectioned. and submitted in toto in cassette K1. L) Received in formalin designated ""appendix"" is an appendix with. attached fatty tissue measuring 7.5 x 2.5 X 1.5 cm. The appendix measures. 6.5 x 5 X 5. cm. The appendix is covered with pink, smooth serosa. No focal lesions. are identified. Representative sections of the tip, mid portion, and. resection margin are submitted in cassette L1. FINAL DIAGNOSIS: A) Right external iliac node, resection: Three lymph nodes, negative for. tumor. B) Right obturator node, resection: Six lymph nodes, negative for tumor. C). Right common para-aortic nodes, resection: Two lymph nodes, negative. for. tumor. D) Left ovary, resection: Serous cystadenoma (1.0 cm in diameter) . E) Left external iliac lymph node, resection: 4 out of 13 lymph nodes. positive. for metastatic tumor. F) Left obturator nodes, resection: Four lymph nodes, negative for. tumor. G) Left common iliac nodes, resection: One negative lymph node. H) Right parametrium, resection: Fibroadipose tissue; no evidence of. malignancy. I) Uterus, tubes, ovaries, and parametrium, resection: Moderately-differentiated squamous cell carcinoma of the cervix. with the following features: 1. Proportionate depth of invasion: Maximum depth of invasion is 88% of. the. 1.7 cm thick wall (1.5/1.7 cm) i tumor is circumferential. 2. Parametrium: One positive lymph node in anterior parametrium; no. tumor. invasive of soft tissue of the parametrium. 3. All surgical margins are free of tumor; nearest margin 0.2 cm from. the. tumor; vaginal cuff resection margin free of tumor. 4. Microscopic angiolymphatic invasion is present. Left post-vaginal margin, resection: Negative for tumor. K). Right post-vaginal margin, resection: Negative for tumor. L). Appendix, resection: Appendix without diagnostic abnormality. Rendering Diagnostician: In compliance with. regulations, the pathologists signature on this. indicates that the case has been personally reviewed, and the diagnosis. made or. confirmed by, the Attending Pathologist.","Moderately-differentiated squamous cell carcinoma of the cervix with proportionate depth of invasion, tumor is circumferential. Parametrium shows one positive lymph node in anterior parametrium, no tumor invasive of soft tissue of the parametrium. Microscopic angiolymphatic invasion is present. All surgical margins are free of tumor, vaginal cuff resection margin free of tumor. Left ovary contains a serous cystadenoma. Multiple small leiomyomas are identified in the myometrium. Left external iliac lymph nodes show 4 out of 13 lymph nodes positive for metastatic tumor, while right external iliac, right obturator, right common para-aortic, left obturator, and left common iliac nodes are negative for tumor. Right parametrium shows fibroadipose tissue with no evidence of malignancy. Appendix is without diagnostic abnormality."
TCGA-DF-A2KR.7252DF0D-0D16-48DD-9484-9C4B83012927,"Sample Type TUMOUR. Sample Preparation. Fresh Frozen. Site of Primary (Event). Uterine. Site of Tissue. Year of Sample Collection. Age at Sample Collection (yrs). Sample Comments. Days to Procedure Date. 0. Days to Diagnosis. -58. Type of Procedure. Surgical resection. Site of Primary (Histology). Uterus. Bilateral Disease. Tumour Size (cm). 5.7999999999999998. Histology. Endometrioid adenocarcinoma, NOS. Grade/Differentiation. III. Pathological T. T2,NOS. Pathological N. N1. Number of Nodes Sampled. 1. Number of Nodes Positive. 7. Clinical M. M0. Histology Comments.","Endometrioid adenocarcinoma, NOS, grade III, with tumor cells exhibiting high-grade nuclear features and architectural patterns consistent with the diagnosis. Tumor infiltrates the myometrium, with lymphovascular space invasion not identified. No direct extension into adjacent structures is described, but the tumor is not confined to the uterus. Lymph nodes are positive for tumor, with metastatic carcinoma identified in the sampled nodes. No distant metastasis is identified clinically."
TCGA-57-1994.54c3dd01-b473-424f-987a-c5d6e972e9bb,"COMMENTS: Although the small deposit of neoplasm in the endometrium does not show distinct papillary growth features, cytologically it is essentially identical to the. neoplasm seen in the ovaries. Similarly, the neoplasm in the parametrial soft tissues does not show distinct papiliary growth pattern but is cylologically. similar to the ovarian neoplasm. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologia Findings: SPECIMENS: A. Left tube and ovary FS. B. Pelvic nodules. C. Uterus, right tube and ovary. D. Left pelvic nodes. E. Left para-aortic. F. Left pelvic. G. Right pelvic. H. Right para-aortic. I. Omentum. Umbilical hemia. SPECIMEN DATA. GROSS DESCRIPTION: A. Container A is labelec. 1 and consists of a 179 gram tan-gray hemormagic ovarian mass, 8.0 x 7.0 x 5.0 cm in greatest dimension. The. outer surface displays multiple nodules as well as an adhesed fallopian tube segment with delicate fimbria, 7.0 cm in length and 0.4 cm in diameter. Sectioning reveals serous fluid filled cystic cavity of the dimensions displaying gray-yellow papillary projections of the inner lining of the cyst wall in an. area 4.0 x 3.0 x 1.5 cm. Samples of this tissue are submitted for frozen section. Representative samples submitted in seven cassettes which are. designated as follows: frozen section tissue--1; falloplan tube--2; multiple samples cyst wall--3 to 7. A total of five blocks are submitted for genhomic. research from part A. B. Container B is labeled. and consists of a tan-yellow soft nodule, 1.0 x 1.0 x 0.5 cm. It is bisected and entirely submitted in one cassette. C. Container C is labeled. and consists of a 47 gram uterus, 6.0 x 3.5 x 2.5 cm in greatest dimension. The serosal surface is tan-orange. fibrous hemorrhagic displaying a few adhesions. The cervix is covered by a tan-gray glistening mucosa with a central patent os, 0.3 cm in diameter. The endocervical canal is tan-pink slightly roughened. The endometrial cavily is lined by tan-pink focally hemorrhagic mucosa, 0.2 cm in thickness. The. myometrium averages 1.6 cm is indurated displaying gray-white whorled nodules, 0.5 cm in diameter. Samples of the right and left parametrium are. submitted. The right parametrium is inked,. Attached is the right ovary and fallopian tube segment. The ovary is tan-yellow nodular hemorrhagic, 3.8 x 3.0 x 2.8 cm in greatest dimension. displaying. multiple adhesions. Sectioning reveals a tan-yellow lobular firm cut surface. Attached on the outer surface is a tan-gray fallopian tube segment with. delicate fimbria, 6.0 cm in length and 0.4 cm in diameter displaying multiple adhesion. Samples of the uterus have been submitted for genhomic studies in three orange cassettes. Representative samples submitted in twelve cassettes which are designated as follows: anterior cervix--1; posterior cervix--2; anterior myometrium-3. and 4; posterior myometrium--5 and 6; whorled nodules-7; right and left parametrium--8; ovary and fallopian tube-- 9 to 12. Following initial evaluation of the specimen microscopically, the remainder of the endometrium was blocked in C13-18. D. Container D is labeled. and consists of a tan-yellow lobular mass of adipose tissue, 1.0 x 0.8 x 0.5 cm in greatest dimension entirely. submitted in one cassette,. E. Container E is labelec. ad consists of a tan-yellow rubbery firm odule, 0.8 x 0.8 x 0.5 cm. The specimen is bisected and entirely. submitted in one cassette,. fr. F. Container F is labeled. nd consists of mulable tan-yellow lobular portions of adipose tissue, 4.0 x 3.0 x 3.0 cm in aggregate. Sectioning. reveals five tan-yellow firm rubbery nodules, the largest 1.4 cm in greatest dimension. Samples of these five nodules are submilled in two cassettes. G. Container G is labeled. .id consists of multiple tan-yellow lobular portions of adipose tissue, 6.0 x 4.0 x 3.0 cm in aggregate. Sectioning. reveals four tan-yellow firm fatty lymph nodes, the largest 2.8 cm in greatest dimension. Samples of these nodes are submitted in three cassettes. H. Container H is labeled. and consists of a tan-yellow lobular mass of adipose tissue, 2.4 x 1.0 x 1.0 cm in greatest dimension. Sectioning. reveals two tan-yellow firm the largest 0.8 cm. Samples are submitted in one cassette. I. Container I is labeled. A consists of a 288 gram mass of tan-yellow lobular omentum, 36.0 x 15.0 x 1.5 cm in greatest dimension. Sectioning reveals multiple yunow-while firm nodules, the largest 3.5 cm in greatest dimension. These nodules represent less than 10% of the. omentum. Representative samples submitted in four cassettes. J. Container J is. labeledund consistsofapurple-pink rubberymass ofmembranous tissue,3.8 x 1.8 x 1.0 cm in greatest dimension. Sectioning reveals a tan-yellow lobular firm cut surface. No lesions are grossly identified. Representative samples submitted in one cassette. IAGNOSIS: Ovary and fallopian tube, left, excision with frozen section: Papillary serous carcinoma of the ovary. Grade: 3/3. Degree of ovarian involvement: Ovary replaced. Size: 8.0 x 7.0 x 5.0 cm. Lymphovascular space invasion: Absent. Left fallopian tube: Uninvolved by neoplasm. i, Frozen section results confirmed. 3. Soft tissue, pelvis, excision: Nodular necrotic adipose tissue, consistent with torted appendix epiploica. : Uterus, cervix, excision: No pathologic alterations. Uterus, endometrium, excision: Adenocarcinoma, grade 3/3, 1.5 mm nodule confined to endometrium. Cystic atrophy, diffuse. Atrophic polyp. Uterus, myometrium, excision: Adenomyosis with atrophic changes. Leiomyomata. Uterus, serosa, excision: No pathologic alterations. Soft tissue, parametrial, excision: Adenocarcinoma, metastatic. Fallopian tube, right, excision: No pathologic alterations. Ovary, right, excision: Papillary serous carcinoma. 1. Grade: 3/3. 2. Degree of involvement: Replaces approximately 80% of ovary. 3. Size: 3.8 x 3.0 x 2,8 cm. 4. Lymphovascular space invasion: Absent. D. Soft tissue, left pelvic, biopsy: No pathologic alterations. No lymph nodes Identifled. E. Lymph nodes, left para-aortic, regional resection: No pathologic alterations, free of metastatic neoplasm, two lymph nodes examined. F. Lymph nodes, left pelvic, regional resection: No pathologic alterations, free of metastatic neoplasm, six lymph nodes examined. G. Lymph nodes, right pelvic, regional resection: No pathologic alterations, free of metastatic neoplasm, eight lymph nodes examined. H. Lymph nodes, right para-aortic, regional resection: No pathologic alterations, free of metastatic neoplasm, five lymph nodes examined. 1. Omentum, excision: Papiliary serous carcinoma, metastatic. Nodules grossly identified, up to 3.5 cm. J. Soft tissue, abdominal wall, excision:","Papillary serous carcinoma of the ovary, high-grade, with replacement of both ovaries. Lymphovascular space invasion is absent. The tumor shows papillary growth features and is cytologically similar to the neoplasm seen in the ovaries and parametrial soft tissues. The endometrium displays a small deposit of adenocarcinoma, grade 3/3, confined to the endometrium, with cystic atrophy and an atrophic polyp. The myometrium shows adenomyosis with atrophic changes and leiomyomata. Metastatic adenocarcinoma is present in the parametrial soft tissues and omentum, with nodules representing less than 10% of the omentum. No pathologic alterations are identified in the cervix, uterus serosa, right fallopian tube, and lymph nodes, which are free of metastatic neoplasm."
TCGA-DD-AAE9.64700E97-F031-49DE-83F0-8CCDBDEE23AF,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial hepatectomy. Organs: Liver (19.0 X 12.5 X 4.3 cm, 374.0 gm). Lesion: A well-defined round firm mass (5.0 x 4.8 x 4.0 cm). Cut surface: Yellowish tan and granular appearance. Gross type: HCC: Expanding nodular. Resection margin: Not involved grossly (safety margin: 1.0 cm). Others: Satellite nodule: No. Representitive sections were submitted. Gross photo: Present. Blocks. T1-4, - TB, tumor mass X 5. NB, L, liver parenchyma X 2. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation III. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: Complete capsule. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No, safety margin (1.0 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: Unknown. Multicentric occurrence: Unknown. NOT reported. Gross: liver, ,ectomy, ,hepatocellular carcinoma,Steatohepatitis,milds steatosis,periportal fibrosis. T56000, P10, M81703, Steatohepatitis, mild steatosis, periportal fibrosis. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma, moderately differentiated. Steatohepatitis with mild steatosis and periportal fibrosis (stage 2). Suggestion :","Hepatocellular carcinoma with trabecular histologic type and hepatic cell type. The tumor shows a complete fibrous capsule formation without capsular infiltration. No septum formation is identified. The tumor cells exhibit moderate differentiation with the worst differentiation being grade III. No fatty change is seen. Surgical resection margin invasion is not identified with no serosal invasion, portal vein invasion, or microvessel invasion. Steatohepatitis with mild steatosis and periportal fibrosis is present in the liver parenchyma. No satellite nodule is identified. The resection margin is free of tumor."
TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1,"copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Partial organ resection - right breast inner upper quad. Expected time of examination: 5 working days. Clinical diagnosis: Inner upper quadrant of the right breast. Macroscopic description: Fragment of the right breast sized 6.5 x 5 x 5.2 cm with a 3.5 x 1 cm skin flap, marked typically, no RTG. Tumour sized 2.1 x 1.5 x 2 cm in the cross section. Margins: 0.7 cm to the base; 2 cm to the skin surface; 0.2 cm to the sternum; 1.8 cm to the axilla; 2.7 cm to the shoulder; 1 cm. to the quadrant boundary. Postoperative result: Carcinoma ductale invasivum NHG3 (3 + 3 + 3/35 mitoses/10 HPF - visual area 0.55 mm), pT2. DCIS foci visible at the tumour edges (solid type with high nuclear atopia, comedo necrosis, 5% of tumour). (DCIS =. comedo type necrosis). Histopathological diagnosis: Carcinoma ductale invasivum (NHG3, pT2, pNo, SN). Invasive ductal carcinoma of the right breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive cancerous cells ( Score = 1+ ).","Invasive ductal carcinoma with high-grade nuclei, solid type ductal carcinoma in situ at the tumor edges with comedo necrosis. Tumor composed of cells with high nuclear atypia, mitoses, and comedo necrosis. No lymphovascular invasion identified. DCIS foci visible at the tumor edges. Tumor confined to the breast parenchyma with no extension into surrounding tissues. No tumor involvement at the inked surgical margin."
TCGA-FD-A62O.41E61CCB-5006-491B-94B7-BE81FB559D0E,"FINAL PATHOLOGIC DIAGNOSIS. A. Right pelvic lymph nodes; lymph node dissection: -Three of eleven lymph nodes positive for metastatic urothelial carcinoma. (3/11). B. Left pelvic lymph nodes; lymph node dissection: -Five of ten lymph nodes positive for metastatic urothelial carcinoma with. extranodal extension (5/10). C. Bladder, prostate; cystoprostatectomy: Bladder: High grade invasive urothelial carcinoma, see pathologic. parameter. - Diverticulum. Prostate: Prostatic urethral ulcer and squamous metaplasia. -High grade prostate intraepithelial neoplasia. -Prostatic abscess. -No involvement by urothelial carcinoma. D. Distal right ureter; excision: -Portion of ureter, no tumor. Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Invasive urothelial carcinoma. 2. Grade of tumor: High grade. 3. Depth of invasion: Extra vesicular soft tissue or adjacent organ (specify). 4. Tumor distribution: Solitary: 5 cm Size. Left lateral wall. Trigone. Posterior wall. 5. Ureteral margins: Negative. 6. Distal urethral margin: Negative. 7. Soft tissue margin or serosa: Negative. 8. Lymph nodes: Positive in 3 of 11 right and 5 of 10 left pelvic nodes (8/21). 9. pTNM: pT3a, N2, MX. Effective January 1, 2010 this Checklist utilizes the 7th edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). Interpretation performed by the Attending Pathologist and reviewed with the. Clinical History: The patient is a. year-old male with high grade urothelial carcinoma. undergoing cystoprostatectomy. Specimens Received: A: Right pelvic lymph nodes. B: Left pelvic lymph nodes. C: Bladder, prostate, vas deferens. D: Distal right ureter. Gross Description: The specimens are received in four containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. Right pelvic lymph. nodes"". Received fresh and placed in formalin is a 6 x 5.5 x 1.5 cm aggregate of. lobulated yellow fibrofatty tissue. The specimen is dissected for lymph nodes. to reveal 15 apparent lymph nodes ranging from 0.5-4.5 cm in greatest dimension. All apparent lymph nodes are submitted as follows: A1: 5 candidate lymph nodes. A2: 5 candidate lymph nodesA3: 3 candidate lymph nodes. A4-A5: One lymph node, serially sectioned. A6: One lymph node, serially sectioned. B. The second container is additionally identified as, ""2. Left pelvic lymph. nodes"". Received fresh and placed in formalin is a 7.5 x 5 x 2 cm aggregate of. lobulated yellow fibrofatty tissue. The specimen is dissected for lymph nodes. to reveal 14 apparent lymph nodes ranging from 0.5-5.5 cm in greatest dimension. All apparent lymph nodes are submitted as follows: B1: 6 candidate lymph nodes. B2: 3 candidate lymph nodes. B3: One candidate lymph node, bisected. B4: One candidate lymph node, bisected. B5: One candidate lymph node, bisected. B6: One candidate lymph node, bisected. B7-B9: One candidate lymph node, serially sectioned. C. The third container is additionally identified as, ""3. Bladder, prostate,. vas deferens"". Received fresh and placed in formalin is a 334.3 g, 15 x 10.5 x. 4.5 cm cystoprostatectomy specimen consisting of a 7.5 x 6.5 X 3.5 cm bladder. with attached mesenteric fat and a 5 X 4 x 3.2 cm prostate. Also received is a. 3.0 x 3.3 x 0.7 cm aggregate of yellow, lobulated adipose tissue and rubbery,. tan, tubelike structures. The right seminal vesicles measure 3.5 x 2.2 x 0.7 cm. and right vas deferens measures 8.5 X 0.6 cm. The left seminal vesicles. measures 3.5 x 1.3 x 0.8 cm and left vas deferens measures 8 x 0.6 cm. The. right ureteral stump measures 1.8 x 0.6 cm, the left measures 2 x 0.6 cm, and. each demonstrates an intact lumen which is probe patent to the trigone. The right half of the prostate is inked blue and the left half is inked black. The outside of the bladder is inked black. The bladder and prostate are opened. anteriorly along the urethra. The outer surface of the prostate is shaggy and. pink. Sectioning demonstrates rubbery, pink-tan, peri-urethral nodularity with a. 1 x 0.5 x 0.5 cm area of tan-brown nodularity at the urethra proximally, which. appears continuous with the bladder lesion. The opened bladder reveals a 5 x 3.5 cm tan, plaque-like indurated, lobulated,. ill-defined mass involving the posterior wall and entire trigone with extension. into the prostatic urethra. Also present is a 3 x 2.5 x 1 cm smooth-walled. cavity containing hemorrhagic fluid which is located subjacent to the right. posterior-lateral wall. On cut section, the mass extends through the muscularis. propria into the perivesical adipose tissue and is 0.1 cm from the deep margin. The mass also extends into the wall of the cystic lesion and the cystic lesion. extends to 0.2 cm from the deep margin. The surrounding bladder mucosa is. edematous and tan with a 1-2 cm wall thickness. Photographs are taken. Representative sections are submitted as follows: C1: Left ureter resection margin. C2: Right ureter resection margin. C3: Distal prostatic urethral margin. C4: Prostate apex. C5-C8: Representative right prostate from apex to base (nodular portion of. urethra C7-C8). C9-C12: Representative left prostate from apex to base (nodular portion of. urethra C11-C12). C13: Representative right vas deferens and seminal vesicle. C14: Representative left vas deferens and seminal vesicle. C15: Mass at deepest extent of invasion. C16: Mass extending into wall of cystic lesion with deepest extent of cystic. lesion. C17: Mass and cystic lesion. C18: Additional sections of mass and adjacent mucosa. C19: Grossly uninvolved posterior bladder. C20: Grossly uninvolved right wall. C21: Grossly uninvolved left wall. C22: Grossly uninvolved bladder dome. C23: Grossly uninvolved anterior bladder. D. The fourth container is additionally identified as, ""4. Distal right. ureter"". Received fresh and placed in formalin is a 4.5 x 1.5 x 0.7 cm. tan-yellow, rubbery, tubelike structure. The specimen is oriented with a suture. on the non-margin end. The margin end is shaved and submitted as D1. Criteria tw 4/5/13.","High grade invasive urothelial carcinoma with tumor cells exhibiting nuclear pleomorphism and hyperchromasia. The carcinoma invades through the muscularis propria into the perivesical adipose tissue. Lymphovascular space invasion is present. The tumor extends into the prostatic urethra and involves the posterior wall and entire trigone of the bladder. The surrounding bladder mucosa is edematous. Prostatic urethral ulcer and squamous metaplasia are noted, as well as high grade prostate intraepithelial neoplasia and prostatic abscess. No involvement by urothelial carcinoma is seen in the prostate. Ureteral margins are negative. Lymph nodes are positive for metastatic urothelial carcinoma, with extranodal extension noted in some nodes. The distal right ureter shows no tumor."
TCGA-CJ-4643.1a9fa2bc-9999-404d-87b0-667935744bce,"DIAGNOSIS. (A) RIGHT KIDNEY AND ADRENAL GLAND: RENAL CELL CARCINOMA, CONVENTIONAL (90% CLEAR CELLS AND 10% EOSINOPHILIC CELLS),. FURHMAN'S NUCLEAR GRADE 3. TUMOR CONFINED TO KIDNEY. TUMOR MEASURES 9.5 CM IN GREATEST DIMENSION. Vascular, ureteral and soft tissue margins of resection free of tumor. Adrenal gland with nodular cortical hyperplasia. GROSS DESCRIPTION. (A). RIGHT KIDNEY AND ADRENAL GLAND - A nephrectomy specimen (22.0 x 13.5 x 6,3 cm) including the right kidney (13.0x 5.5 x. 4.0 cm), a segment of the renal artery, the renal vein, two ureters (7.5 and 12.0 cm in length x approximately 0.4 cm in average. diameter), and the adrenal gland (0.6 x 3.7 x 1.8 cm). There is a 9.5 x 7.2 x 6.0 cm well-circumscribed tumor in the mid portion of the kidney. Centrally, the tumor has a myxoid appearance. with a focus of calcification; the periphery is orange-yellow and slightly friable. There are no definitive areas of hemorrhage or. recrosis. The tumor pushes onto the renal pelvis but does not invade it. There is no extention into the adipose tissue, renal sinus,. unal vein, or Gerota's fascia. The. adjacent kidney parenchyma is unremarkable. The pelvicalyceal system is smooth and devoid of any lesions. One possible hilar. lymph node measures 1.7 x 0.9 x 0.9 cm. Serial cross sections of the adrenal gland show an enlarged cortex measuring 0.5 cm. The remainder of the adrenal gland is. unremarkable. Portions of tumor have been submitted for possible electron microscopy and to the tumor bank. INK CODE: Black - Gerota's fascia and capsule nearest tumor. SECTION CODE: A1, both ureters, renal artery, and renal vein margins, en face; A2, enlarged portion of adrenal gland; A3, kidney,. representative sections; A4-A5, tumor within pelvis; A6-A8, tumor with inked capsule; A9-A10, tumor with adjacent kidney; A11, tumor;. A12, representative sections of Gerota's fascia overlying tumor; A13, one possible lymph node; A14, tumor with sinus;. A15,. tumor. with. pelvis; A16, adrenal gland, representative section. CLINICAL HISTORY. Right renal mass. 1.","Renal cell carcinoma, conventional type, with 90% clear cells and 10% eosinophilic cells, Fuhrman's nuclear grade 3. Tumor confined to kidney with a well-circumscribed growth pattern. Tumor composed of cells with clear cytoplasm and distinct cell borders. No vascular, ureteral, or soft tissue margin involvement by tumor. Adrenal gland shows nodular cortical hyperplasia. No tumor extension into adipose tissue, renal sinus, or Gerota's fascia. Adjacent kidney parenchyma is unremarkable. No definitive areas of hemorrhage or necrosis. Tumor pushes onto the renal pelvis but does not invade it. One possible hilar lymph node identified, but no definitive lymph node involvement by tumor."
TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740,"This report contains corrections, additions or deletions. Any previous versions are stored internally and are available if necessary,. Specimen: Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSTS. LEFT BREAST CANCER INVASIVE, BREAST ASYMMETRY. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE: LEFT SIMPLE MASTECTOMY, SENTINEL NODE BX, REDUCTION MAMMOPLASTY. PROCEDURE (CONT) : BREAST RECONSTRUCTIN WITH TISSUE EXPANDER. A. LEFT BREAST MASTECTOMY. B. LT BREAST 1ST SENTINEL NODE. C. LT BREAST 2ND SENTINEL NODE. D. LT BREAST 3RD SENTINEL NODE. E. LEFT BREAST TISSUE. F. RIGHT BREAST TISSUE. PART A RECEIVED FRESH LABELED. LEFT BREAST MASTECTOMY. STITCH AT SUPERIOR MEDIAL BORDER, IS A LEFT SIMPLE MASTECTOMY SPECIMEN AS. ORIENTED BY A SUTURE MEASURING 21 x 20 x 4.5 CM. A SKIN ELLIPSE MEASURES. 11.2 x 6.5 CM, WITH A GROSSLY UNREMARKABLE NIPPLE. THE SUPERFICIAL ASPECT. IS MARKED IN BLUE INK, THE DEEP ASPECT IN BLACK INK. IN THE MIDPORTION,. THERE IS A 0.9 X 0.1 X 0.9-CM LESION 2.5 CM FROM THE DEEP MARGIN. A. PORTION OF THIS IS SUBMITTED PER PROTOCOL, THE MIRROR IMAGE IS SUBMITTED. IN A1, AND THE CORRESPONDING DEEP MARGIN IN A2. A SECOND LARGER LESION IS. FOUND LATERAL TO THIS MEASURING 2.2 x 1.6 x 1.5 CM. THIS IS 2 CM FROM THE. DEEP MARGIN. THIS DEEP MARGIN IS SUBMITTED IN A3. THESE TWO AREAS ARE. 1.5 CM APART. MEDIAL TO ALL OF THESE IS A SMALL SUPERFICIAL LESION, 0.5. CM IN GREATEST DIMENSION, 2.5 CM FROM THE FIRST DESCRIBED LESION. THIS. LESION IS SUBMITTED IN A6. A5 REPRESENTS A SECOND SECTION OF THE LARGEST. MOST LATERAL LESION. THE SMALLEST LESION IS 4 CM FROM THE DEEP MARGIN,. WHICH IS SUBMITTED IN A7. THE REMAINING BREAST TISSUE CONSISTS OF BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. ADDITIONAL SECTIONS OF THE. BREAST TISSUE ARE SUBMITTED AS FOLLOWS: A8--PPER OUTER QUADRANT,. A9--UPPER INNER QUADRANT, A10--LOWER INNER QUADRANT, All--LOWER OUTER. QUADRANT, A12--NIPPLE. THE LARGEST LESION IS SUPERIOR TO THE NIPPLE, AND. Specimen: Spec Type: SURGICAL P. THESE LESIONS PROGRESS THEREFORE IN THE UPPER INNER QUADRANT OF THE. BREAST. PART B RECEIVED FRESH LABELED. LEFT BREAST FIRST. SENTINEL NODE HOT, IS A PORTION OF YELLOW FATTY TISSUE MEASURING 2.2 X 1.6. X 0.1 CM. SECTIONING REVEALS A 0.7-CM LYMPH NODE. ONE-HALF IS SUBMITTED. PER PROTOCOL; THE REMAINDER IS SUBMITTED LABELED B. PART C RECEIVED FRESH LABELED. LEFT BREAST SECOND. SENTINEL NODE HOT, IS YELLOW FATTY TISSUE MEASURING 3.8 X 1.1 X 0.8 CM. EXAMINATION REVEALS A 2.2 CM IN LENGTH GROSSLY UNREMARKABLE LYMPH NODE, A. PORTION OF WHICH IS SUBMITTED PER PROTOCOL, AND THE REMAINDER IS SUBMITTED. LABELED C. PART D RECEIVED FRESH LABELED. THIRD SENTINEL NODE, IS. AN OVOID PORTION OF YELLOW FATTY TISSUE MEASURING 2.5 x 1.2 X 1.0 CM. SECTIONING REVEALS FIRM TISSUE BUT NO GROSS NODAL TISSUE. A PORTION IS. SUBMITTED PER PROTOCOL, AND THE REMAINDER IS SUBMITTED LABELED D. PART E RECEIVED LABELED. SECOND BREAST TISSUE. SUPERFICIALLY OVER SUPERIOR MEDIAL ASPECT OVER HARD NODULE STITCH AT NEW. MARGIN, IS AN IRREGULAR PORTION OF YELLOW FATTY TISSUE MEASURING 2.9 x 2.0. x 0.5 CM. A SUTURE DENOTES A NEW MARGIN, AND THIS SIDE IS MARKED WITH. INK. THIS IS SECTIONED AND SUBMITTED LABELED E. PART F RECEIVED LABELED. RIGHT BREAST TISSUE, IS 256. GRAMS OF FIBROFATTY BREAST TISSUE AND SKIN. SECTIONING REVEALS BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THERE ARE NO AREAS OF BROAD. FIBROSIS OR MASSES IDENTIFIED. REPRESENTATIVE TISSUE IS SUBMITTED LABELED. F1 THROUGH 5. PROCEDURES. 88305, 88307/5, IMMUNOPEROXIDAS/3, A1 BLK, A10 BLK, All BLK, A12 BLK,. A2 BLK, A3 BLK, A4 BLK, A5 BLK, A6 BLK, A7 BLK, A8 BLK, A9 BLK, BBX X6,. CBX x6, DBX X6, El BLK, F1 BLK, F2 BLK, F3 BLK, F4 BLK, F5 BLK. NAI. PART A LEFT BREAST, SIMPLE MASTECTOMY: 1. MULTICENTRIC MODERATELY DIFFERENTIATED INTRADUCTAL AND INFILTRATING. DUCT CARCINOMAS (3), NUCLEAR GRADE 2 WITH MODERATE MITOTIC INDEX WITH AN. INSITU COMPONENT OF 5-10% OF SOLID AND CRIBRIFORM TYPE. Specimen : Spec Type: SURGICAL P. FIRAL. 2. THREE TUMORS MEASURING 2.2, 1.0 AND 1.0 CM ARE PRESENT WITH ONE TUMOR. INVOLVING THE SUPERFICIAL MARGIN. 3. DUCTAL CARCINOMA IN SITU IS PRESENT IN THE DEEP DUCTS OF THE NIPPLE. SKIN. THE NIPPLE SKIN AND DEEP MARGINS OF EXCISION ARE FREE OF NEOPLASM. 4. FOCI SUSPICIOUS FOR LYMPHATIC INVASION ARE PRESENT. PART B LEFT BREAST, FIRST SENTINEL NODE, BIOSPY: LYMPH NODE (1) WITH. AN. ISOLATED FOCUS OF TUMOR CELLS, MEASURING 0.01 MM, INDENTIFIED ON THE. CYTOKERATIN STAIN AND ONLY THE FIRST OF THREE STEP-SECTIONS OF THE H&E. STAINS. PART C LEFT BREAST, SECOND SENTINEL NODE, BIOPSY: LYMPH NODE (1). NEGATIVE FOR TUMOR BY ROUTINE AND CYTOKERATIN STAIN. PART D LEFT BREAST, THIRD SENTINEL NODE, BIOPSY: SMALL LYMPH NODES (5),. NEGATIVE FOR TUMOR BY ROUTINE AND CYTOKERATIN STAIN. PART E LEFT BREAST SUPERFICIAL TISSUE RE-EXCSION: FIBROADIPOSE TISSUE,. NEGATIVE FOR TUMOR WITH THE NEW INKED MARGIN FREE OF NEOPLASM. PART F RIGHT BREAST, REDUCTION MAMMOPLASTY: SKIN, ADIPOSE AND BREAST. TISSUE WITH FIBROCYSTIC CHANGE AND A FOCUS OF ATYPICAL LOBULAR. HYPERPLASIA. ONCOTYPE. RESULTS: = 14. CLINICAL EXPERIENCE: PATIENTS WITH A RECURRENCE SCORE OF 14 IN THE. CLINICAL VALIDATIONS STUDY HAD AN AVERAGE RATE OF DISTANT RECURRENCE AT 10. YEARS OF 9% (95% CI: 6%-12%) . (signature on file). 'il.","Multicentric moderately differentiated intraductal and infiltrating duct carcinomas with nuclear grade 2 and moderate mitotic index, and an in situ component of solid and cribriform type. Tumors involve the superficial margin. Ductal carcinoma in situ is present in the deep ducts of the nipple. Foci suspicious for lymphatic invasion are present. Lymph node with an isolated focus of tumor cells identified. Another lymph node is negative for tumor. Small lymph nodes are negative for tumor. Fibroadipose tissue is negative for tumor with the new inked margin free of neoplasm. Skin, adipose, and breast tissue show fibrocystic change and a focus of atypical lobular hyperplasia."
TCGA-02-2470.e21f66d9-e124-43d7-81fe-489d15d69cbf,"DIAGNOSIS. (A) BRAIN, PORTION OF ENHANCING NODULE, CRANIOTOMY: RECURRENT/RESIDUAL GLIOBLASTOMA (WHO GRADE IV) (SEE COMMENT). (B) BRAIN, RIGHT TEMPORAL LOBECTOMY, CRANIOTOMY: RECURRENT/RESIDUAL GLIOBLASTOMA (WHO GRADE IV) (SEE COMMENT). COMMENT. Tissue sections show a diffuse high grade astrocytoma with nuclear pleomorphism, increased mitoses, vascular proliferation,. fibrin thrombi and necrosis, which is more prominent on specimen B. In addition, focal perivascular lymphocytic infiltration and. macrophage infiltration is seen. Vessels with hyalinized walls are also present. GROSS DESCRIPTION. (A). PORTION OF ENHANCING NODULE, FROZEN AND PERMANENT - It consists of a rounded fragment of gray-tan soft. tissue. measuring 2.5 X 2.0 x 0.8 cm. The external surface is irregular and focally hemorrhagic. On cross sections the tissue. shows a gray-tan smooth cut surface. Grossly no areas of necrosis are identified. Smear preparations are performed. A. portion of the tissue is frozen for intraoperative consultation in cassette A1. The remaining tissue is submitted for microscopic. examination in three cassettes labeled A2-A4. SECTION CODE: A1, frozen section; A2-A4, permanent section. X: A1, RECURRENT/RESIDUAL MALIGNANT GLIOMA. (B) RIGHT TEMPORAL LOBECTOMY PERMANENT - It consists of an irregular portion of brain tissue measuring 5.0 X 4.0 X. 0.6. cm. The. resection. margin is irregular and hemorrhagic. The opposite surface shows mildly congested leptomeninges. On. cross sections a poorly circumscribed tumor is identified in the white matter. The tumor shows a variegated appearance with. cyst and areas of necrosis and hemorrhage. A portion of the specimen is submitted for Tissue Bank. The remaining specimen. is submitted for microscopic examination in seven cassettes labeled B1-B7. CLINICAL HISTORY. None given. SNOMED CODES. T-A2000, M-94403.","Recurrent/residual glioblastoma with diffuse high-grade astrocytoma characterized by nuclear pleomorphism, increased mitoses, vascular proliferation, fibrin thrombi, and necrosis. Focal perivascular lymphocytic infiltration and macrophage infiltration are also seen, along with vessels having hyalinized walls. The tumor shows a variegated appearance with cysts and areas of necrosis and hemorrhage. No lymph nodes are identified. Tumor cells are present with a poorly circumscribed margin, and the resection margin is irregular and hemorrhagic."
TCGA-BH-A0DX.EBAB36DE-A97F-4F8B-806C-EF182519933A,"P.20/33. FINAL DIAGNOSIS: PART 1: LEFT SENTINEL LYMPH NODE #1, BIOPSY -. ONE (1) LYMPH NODE. NEGATIVE FOR TUMOR (0/1). PART 2: LEFT SENTINEL LYMPH NODE #2, BIOPSY -. ELEVEN LYMPH NODES, NEGATIVE FOR TUMOR (0/11). PART 3: LEFT BREAST, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCT CARCINOMA, 0.8 X 0.7 X 0.6 CM. B. NOTTINGHAM SCORE: 7/9 (TUBULES - 2, NUCLEI - 2, MITOSES - 3). C. NO LYMPHOVASCULAR INVASION IDENTIFIED. D. DUCTAL CARCINOMA IN SITU, CRIBRIFORM TYPE. NUCLEAR GRADE 2, PRESENT IN THE SURROUNDING. BREAST TISSUE AND ASSOCIATED WITH MICROCALCIFICATIONS. E. SURGICAL MARGINS NEGATIVE FOR INFILTRATING DUCT CARCINOMA AND DUCTAL CARCINOMA IN. SITU. F. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE. G. TUMOR IS ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR FOCALLY AND WEAKLY. POSITIVE AND HER-2/neu IS NEGATIVE, SCORE: 0. H. FIBROCYSTIC CHANGES. I. THERMAL EFFECT. PART 4: LEFT BREAST, NEW POSTERIOR MARGIN, EXCISION -. A. NEGATIVE FOR TUMOR. B. FIBROCYSTIC CHANGES. BYNOPTIC -PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive componenti 0.8 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 2. Mitolic activity score: 3. Total Nottingham score: 7. Nottingham grade (1, 2. 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 11. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pMx. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HCR2/NEU: zero or 1+.","Infiltrating duct carcinoma with Nottingham score 7/9, characterized by tubule formation, nuclear features, and mitotic activity. Ductal carcinoma in situ, cribriform type, with nuclear grade 2, present in the surrounding breast tissue and associated with microcalcifications. No lymphovascular invasion identified. Tumor is estrogen receptor positive, progesterone receptor focally and weakly positive, and HER-2/neu negative. Surgical margins negative for infiltrating duct carcinoma and ductal carcinoma in situ. Changes consistent with previous core biopsy site, and fibrocystic changes are also noted. No tumor identified in the left sentinel lymph nodes or in the new posterior margin excision."
TCGA-K1-A6RV.0A448932-EEB0-4E9D-8B63-682E24BE2D0F,"FINAL DIAGNOSIS: PART 1: SOFT TISSUE, RIGHT THIGH, MASS, BIOPSY -. HIGH-GRADE LEIOMYOSARCOMA. PART 2: SKIN AND SOFT TISSUE, RIGHT THIGH, MASS, RESECTION -. A. HIGH-GRADE LEIOMYOSARCOMA, GRADE 3, 17.0 CM (see comment). B. MITOTIC FIGURES: 42/10 HIGH-POWER FIELDS, 80% NECROSIS. C. PROXIMAL MARGIN POSITIVE FOR MALIGNANCY, ALL OTHER MARGINS FREE OF TUMOR. D. ANGIOLYMPHATIC INVASION IDENTIFIED. E. PATHOLOGIC STAGE: pT2b Nx. F. PATHOLOGIC GRADE: GRADE 3. COMMENT: This malignant spindled ceil neoplasm consists of fascicles of pleomorphic spindled cells with eosinophilic cytoplasm,. blunt ended nuclei, coarse chromatin and some prominent nucleoli. Extensive necrosis (approximately 80%) and focal. myxoid areas are observed. Angiolymphatic invasion is present. Brisk mitotic figures are noted and many are atypical. (up to 42/10 high-powered fields). Immunohistochemical stains were performed and the cells of interest are positive for. desmin (focally, blocks 2A, B), calponin (blocks 2A, B), smooth muscle actin (blocks 2A, B), CD99 and pancytokeratin,. and negative for S-100, CD34 (highlights vascular structures) and C-kit. Ki-67 demonstrates up to 80% nuclear positivity. Osteocalcin and osteonectin show high background staining. The overall morphological and immunohistochemical. results support high grade leiomyosarcoma. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY SOFT TISSUE TUMORS. SPECIMEN TYPE: Marginal resection. TUMOR SITE: right thigh. TUMOR DEPTH: Deep: Subfascial. Deep: Intramuscular. TUMOR SIZE: Greatest dimension: 17 cm. PRERESECTION TREATMENT: Unknown. HISTOLOGIC TYPE (WHO classification of soft tissue tumors): leiomyosarcoma. RESULTS OF ANCILLARY STUDIES: see comment. MITOTIC RATE: 42/10 high-power fields. MACROSCOPIC NECROSIS: Present: Extent: 80%. MICROSCOPIC NECROSIS: Present: Extent: 80%. GRADE: System used: French Federation of Cancer Centers Sarcoma Group (FNCLCC). Grade: grade 3. PATHOLOGIC STAGING (pTNM): pT2b. pNX. Number regional lymph nodes examined: 0. Number regional lymph nodes involved: 0. pMX. MARGINS: Margins involved by sarcoma. Margin(s): proximal. MICROSCOPIC VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION: Present. PERINEURAL INVASION: Absent. SPECIAL PROCEDURES: Cytogenetics. Interpretation. Apparently normal male chromosome analysis. No clonal numerical or structural abnormalities were observed. The possibility that. the normal cells may represent normal stromal cells, and not the tumor cells, cannot be excluded. A few cells (see report below). with noncional chromosome abnormalities may be the result of a tissue culture artifact, but more likely represent the malignant. cells. G-Banding. No. of Cells Analyzed: 20. No. of Cells Karyotyped: 6. No. of Chromosomes: <46. 46. No. of Cells: 2. 18. Twenty trypsin-Giemsa banded metaphase cells were analyzed from 4, 5, 6, and 7-day harvests of monolayer cell cultures from. tissue labeled ""right thigh mass."" Fifteen cells had an apparently normal male chromosome complement. One cell had a. hypodiploid karyotype, likely as a result of random chromosomal loss. One cell each had the following chromosome complement: 45,XY,t(3;12)(q21:q24.1),-19 and 46,XY,t(8;12)(q11.1;p11.1). Two cells from the same slide and the same microscopic field of. vision both had a 16,XY,t(12;13)(q13;q14) chromosome complement. Average band level/haploid set: 400.","High-grade leiomyosarcoma, grade 3, with fascicles of pleomorphic spindled cells having eosinophilic cytoplasm, blunt-ended nuclei, coarse chromatin, and some prominent nucleoli. Extensive necrosis and focal myxoid areas are observed. Angiolymphatic invasion is present. Brisk mitotic figures are noted, and many are atypical. The tumor exhibits a high-grade morphology with significant nuclear pleomorphism and atypia. The proximal margin is positive for malignancy, while all other margins are free of tumor. Angiolymphatic invasion is identified, and there is no perineural invasion. The tumor cells show a high mitotic rate and significant necrosis, indicating an aggressive neoplasm."
TCGA-AX-A06F.4904C404-B17E-4471-AA2F-6DC705E4FBF2,"NCBH# : EXAM DATE. Room# : Sex: F. THIS IS A CONFIDENTIAL REPORT PRINTED FROM. IND MAY BE UNAUTHENTICATED. Do not release without patient, legal representative or proper authorization. Please place in patient record or discard by shredding or tearing to protect. patient confidentiality. REFERENCE: FINAL PATHOLOGIC DIAGNOSIS. MICROSCOPIC EXAMINATION AND DIAGNOSIS. A. UTERUS, AND RIGHT AND LEFT ADNEXA, HYSTERECTOMY BILATERAL. SALPINGO-OOPHORECTOMY: UTERUS: Endometrioid endometrial adenocarcinoma with. squamous differentiation extending into the cervix with invasion. of the cervical stroma and full thickness invasion of. the myometrium (see comment and cancer protocol. below). Right uterine adnexa obiiterated by tumor. B. BLADDER WALL, PARTIAL EXCISION: Endometrial. adenocarcinoma invading the muscularis propria from outside in. Secondary inflammation and marked submucosal edema. C. LYMPH NODES, RIGHT PELVIC, LYMPHADENECTONY: Metastatic. endometrial carcinoma in one of eleven lymph nodes. D. PERITONEUM, BIOPSY: Metastatic endometrial. adenocarcinoma. E. LEFT PELVIC LYMPH NODES, LYMPHADENECTOMY. Metastatic endometrial carcinoma in one of five lymph. nodes. F. ILEUM, SEGMENTAL RESECTION: Metastatic endometrial. carcinoma extending from outside in all the way into the mucosa. with perforation evident. in alide F3. Margins free of tumor. Metastatic endometrial carcinoma in one of five lymph nodes. G. OMENTUM, OMENTECTOMY. Benign adipose tissue. NCBH# : EXAM DATE: Room#. Sex. F. THIS IS A CONFIDENTIAL REPORT PRINTED FROM. AND MAY BE UNAUTHENTICATED. Do not release without patient, legal representative or proper authorization. Please place in patient record or discard by shredding or tearing to protect. patient confidentiality. REFERENCE: H. VERMIFORM APPENDIX, APPENDECTOMY: Benign appendix with. fibrous luminal obliceration. I. LYMPH NODE, PERIAORTIC, BIOPSY: One lymph node, benign. COMMENT: The tumor is a poorly differentiated endometrioid endometrial. adenocarcinoma with squamous differentiation and focal. neuroendocrine differentiation. Histologically, the tumors in. the ileum and urinary bladder present an appearance suggestive of. neuroendocrine differentiation with the tumor in the ileum. particularly suggestive of neuroendocrine differenciation and. that in the bladder more suggestive of more poorly differentiated. neuroendocrine tumor. However, immunohistochemical stains to. cytokeratins 7 and 20, synaptophysin and chromogranin applied to. blocks A7 (uterus) B2 (urinary bladder) and F2 (ileum) show the. tumor in all three sites to be strongly reactive for cytokeratin. 7 with only tocal strong dot cytoplasmic reactivity for. cytokeratin 20 in the ileum and focal reactivity to chromogranin. in the endometrium and the ileum. There is no reactivity to. synaptophysin in any of the three sites. The block from the. ilcum was also scained for CD56 and shows weak diffuse. reactivity. The positive and negative controls worked. appropriately. The above findings are most consistenc with a. primary poorly differentiated endometrioid endometrial. adenocarcinoma with aquamous differenciation and focal. neuroendocrine differentiation. I do not see evidence of serous. endometrial carcinoma, however, disregarding its classification. the present tumor has already expressed its poor biological. nature. ""These tests were developed and their performance. characteristics determined by. They have not been cleared or. approved by the U.S. Food and Drug Administration. The FDA has. determined that such clearance or approval ia not necessary. These tests are used for clinical purposes They should not be. regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. laboratory cesting."". GYN: ENDOMETRIAL HYSTERECTOMY CANCER PROTOCOL. NCBH# : EXAM DATE: Room# : Sex: F. THIS IS A CONFIDENTIAL REPORT PRINTED FROM AND MAY BE UNAUTHENTICATED. Do not release without patient. legal representative or proper authorization. Please place in patient record or discard by shredding or tearing to protect. patient confidentiality. REFERENCE: SPECIMEN TYPE: Hysterectomy. TUMOR SIZE: Greatest dimension: 11. Additional dimensions: 10 x 9.5 cm. OTHER ORCANS PRESENT: Left ovary. Left fallopian tube. HISTOLOGIC TYPE: Endometrioid adenocarcinoma, not otherwise. characterized. HISTOLOGIC GRADE: FIGO Architectural Grade: Grade 3. FIGO Nuclear Grade: Grade 2. FICO Final Grade: Grade 3. DEPTH OF MYOMETRIAL INVASION: ( 100 7). ENDOCERVICAL INVOLVEMENT. Cervical stromal invasion. INVOLVEMENT OF OTHER STRUCTURPS: Right tube and ovary. MARGINS. Cannot be assessed. LYMPHOVASCULAR INVASION: Fresent. AJCC (FICO) STAGE. PRIMARY TUMOR. pT4 (IVA). REGIONAL LYMPH NODES: pN1. Number involved: 2. Number examined: 17. DISTANT METASTASIS: pM1 (IVB). Site(B). Intraabdominal lymph node (1/5, specimen F). I have personally reviewed the alides and/or other related. materials referenced, and have edited the report as part of my. pathologic assessment and final interpretation. Ph.D. ... Specimen(a) Received. A: Uterus and bilateral tubes and ovaries. B: Bladder wall with tumor. C: Right pelvic lymph nodes. D: Peritoneal biopsy. E. Left pelvic lymph nodes. F: Portion of ileum. G- Omentum. H: Appendix. NCBH# : EXAM DATE : Room# : Sex: F. THIS IS A CONFIDENTIAL REPORT PRINTED FROM LASTWORD AND MAY BE UNAUTHENTICATED. Do not release without patient, legal representative or proper authorization. Please place in patient record or discard by shredding or tearing to protect. patient confidentiality. REFERENCE: I: Periaortic lymph node. Clinical History. Endometrial carcinoma. Cross Description. A. A 470 g uterus with adnexal structures attached is received. The uterus is 13 x 12 x 8 cm. The left ovary is 6.4 g and 1.5. x. 1.0 x 0.4 cm The left tube is 6.5 cm in length x 0.5 cm in. diameter The left ovary and left tube are separated from the. uterus and wrapped. On the right side of the uterus there is a. large fungating mass through the serosa which has replaced the. right ovary The ectocervical mucosa is 2.2 x 2.0 cm and has a. 1.1 x 1.0 cm patent as. The os has red-tan friable tissue. extending through it. The resection margin is inked black and the. uterus is opened to reveal a fungating masa that has multiple. areas of myometrial invasion. The dominant mass is 11 x 10 x 9.5. cm and has eroded through the right wall of the uterus. In this. area the tumor appears to have encased and replaced the right. tube and ovary. The tumor comes within 2 cm from the os. sectioning through the left ovary and tube reveals. normal-appearing - white-tan lobulated ovarian tissue and the tube. with a normal-appearing patent lumen. Tissue is submitted as. follows. BLOCK SUMMARY. A1-A2. anterior cervix, tandem section with blue ink. opposing surfaces (A2 concaining tumor with closest approach to. cervix) ;. A3-A4. representative gection of posterior cervix, blue ink. tandem section opposing surfaces;. AS-A6. anterior uterine wall full thickness section, tandem. surfaces inked blue;. A7-A8. posterior uterine wall full thickness section, blue ink. tandem, opposing surfaces;. A9-A10. representative sections of locally invasive tumor into. right adnexal structures;. All. representative sectic if left tube and ovary. An 8 x 7 x 3 cm fragment of tissue is received On one aspect. there is roughened white-tan .parent tumor. On the opposite. aspect there is an apparent 3.6 x 2 0 cm area of apparent mucosa. NCBH#. EXAM DATE: Room# : Sex: F. THIS IS A CONFIDENTIAL REPORT PRINTED FROM. AND MAY BE UNAUTHENTICATED. Do noc release without patient, legal representative or proper authorization. please place in patient record or discard by shredding or tearing to protect. patient confidentiality. of. REFERENCE. Representative sections are submitted in cassette 31-83. C. Multiple yellow-tan fragments of adipose tissue aggregate to. 8 x 6 x 2.0 cm. Lymph node search ig performed revealing multiple. lymph nodes ranging in size from 0.5 cm up to 2.0 cm in greatest. dimension are identified Tissue is submitted as follows: BLOCK SUMMARY: C1. three apparent nodes;. C2. two apparent nodes: single node bisected. C4. single node bisected;. C5. single node bisected;. C6. single node bisected;. C7-CB. single node bisected;. C9-C10. single node bisected. D. Multiple yellow-tan soft tissue fragments aggregate to 4 x. 3.5 x 1.0 cm are received. on one aspect there is a roughened. white-tan apparent tumor implant present. Representative sections. are submitted in cassettes D1-D2. E. Five apparent lymph nodes are found ranging in size from 1 cm. up to 3.4 cm in max1mum dimension. Tissue is submitted as. follows. BLOCK SUMMARY: E1. single apparent node;. E2. single apparent node bisected;. E3. single apparent node bisected;. E4. representative sections of large node;. ES. representative sections of largest node. F. A 32 cm in length x 2.5 cm in diameter segment of small. intestine is received unoriented. Staple lines are inked black. and shaved On the serosal surface there are two surface tumor. nodules One is 6.5 cm x 3.0 cm and comes within 1 cm of one of. the staple lines The gecond -1 or nodule 19 4.5 x 3.0 cm and. comes within 11 cm of the opposite staple line margin. The. specimen is opened to reveal normal tan-brown mucosa with. appropriate folds. However there is an apparent perforation at. the smaller of the two surface tumor nodules Thie perforation. measures 15 cm from one staple line and 17 cm from the opposite. staple line Tiesue is submitted as follows. NCBH# : EXAM DATE: Accounti. Room#. Sex: F. THIS IS A CONFIDENTIAL REPORT PRINTED FROM. AND MAY BE UNAUTHENTICATED. DO not release without patient, legal representative or proper authorization. Please place in patient record or discard by shredding or tearing to protect. patient confidentiality. REFERENCE: BLOCK SUMMARY: F1. section from staple line with close approach with tumor;. F2. representative section of larger tumor implant;. F3. representative section of smaller tumor implant. with. perforation;. F4. representative section. o : normal-appearing intestine;. F5. representative section from opposite staple line. Sectioning through the meser.. :ry of the small bowel reveals a. single apparent cumor implant which measures up to 1.9 cm in. greatest dimension. Representative section of this is submitted. in cassette F6 and four apparent lymph nodes ranging in size from. 0.6 up to 1.2 cm in greatest dimension are identified These are. submitted as follows: single apparent node bisected;. F8. two apparent nodes: F9. single apparent node bisected. G. A 14 cm x 9 cm x up to 2.0 cm segment of yellow-tan adipose. tissue consistent with omentum is received. Sectioning reveals. normal-appearing yellow-tan adipose tiesue. Representative. gections are submitted in cassettes G1-G2. H. A 3.5 cm in length x up to 0.5 cm in diameter apparent. appendix is received with yellow-tan adipose tisgue extending off. of one aspect up to 2.2 cm. Sectioning through the appendix. reveals normal-appearing appendix with tan-pink serosa, wall. thickness averaging 0.2 cm with a pink patent lumen and. normal-appearing mucosa. Tissue is submitted as follows: BLOCK SUMMARY: H1. representative cross section from proximal tip and middle. end of appendix (proximal tip with blue ink) and longitudinal. section through diste! tip. I. A 4.0 x 1.8 x 1.0 cm red-brown fragment of soft tissue is. received Sectioning reveals a gingle apparent lymph node. measuring up to 3.6 cm in greatest dimension. Representative. sections of this node are submitted in cassettes 11-12. Please. note approximately 50% of the lymph node is submitted for. histologic evaluation. NCBH#. EXAM DATE: Room# : Sex: F. THIS IS A CONFIDENTIAL REPORT PRINTED FROM LASTWORD AND MAY BE UNAUTHENTICATED. Do not release without patient, legal representative or proper authorization. Please place in patient record or discard by shredding or tearing to protect. patient confidentiality. REFERENCE. Uterus and bilateral tubes and ovaries. LABEL: RESULTS. COPY. PRINTED.","Endometrioid endometrial adenocarcinoma with squamous differentiation extending into the cervix with invasion of the cervical stroma and full thickness invasion of the myometrium. Right uterine adnexa obliterated by tumor. Tumor composed of cells with poorly differentiated morphology and focal neuroendocrine differentiation. Lymphovascular invasion present. Metastatic endometrial carcinoma identified in lymph nodes, peritoneum, and ileum, with tumor extending into the mucosa and causing perforation. Bladder wall invasion by tumor, with secondary inflammation and marked submucosal edema. Omentum shows benign adipose tissue. Appendiceal tissue is benign. Periaortic lymph node is benign. Tumor margins cannot be assessed. Metastatic tumor in the ileum and urinary bladder presents with neuroendocrine differentiation. No evidence of serous endometrial carcinoma. Tumor has expressed its poor biological nature."
TCGA-12-1097.6b38cc54-221e-45c5-b287-f4c7b2f8755d,"AP Surgical Pathology: Additional Info. CLINICAL HISTORY: presented the weekend of. with severe headache. He went. to the urgent care on. and followed up with his primary care. physician on. He was treated conservatively. On the morning on. while at work he had difficulty reading what was on a piece of. paper. Over the next two to three days he experienced worsening confusion. and went back to his primary care physician on. who ordered a CT. scan for. revealing evidence of a large right occipital. abnormality. He had a follow-up MRI with contrast revealing an enhancing. lesion consistent with high-grade primary glioma. He was taken to the. operating room on. with. for a biopsy confirming the. diagnosis. GROSS EXAMINATION: A. ""Brain tissue (AF1)' "", received for frozen section is a 72.1 gram roughly 6. x 6 x 5 cm piece of brain. Sectioning reveals a focal 2 x 1 x 1 cm. subcortical hemorrhage. There is also a diffuse area of necrosis. approximately 3 x 2 x 3 cm. Representative sections are submitted, including. the aforementioned area of hemorrhage and necrosis, in blocks A1-5. B. ""Brain tissue (BF1)"", received for frozen section is a less than 1 mm. fragment of brain tissue which is completely submitted in block B1. C. ""Brain tissue (CF1) "", received for frozen section is a less than 0.1 mm. fragment of brain tissue. The frozen section remnant is submitted in block. C1. D. ""Brain tissue"", received fresh and placed in formalin is a 3.5 X 3 x 1 cm. aggregate of brain tissue. Representative sections are submitted in D1-2. INTRA OPERATIVE CONSULTATION: A. ""Brain tissue"";AF1-high grade glioma. Glioblastoma. B. ""Brain tissue"":BF1-high grade glioma. C. ""Brain tissue"":CF1-high grade glioma. MICROSCOPIC EXAMINATION: The tissue is brain that is infiltrated by neoplastic proliferation of. malignant astrocytes characterized by intermediate fibrillar astrocytes. The. tumor exhibits vascular proliferation and pseudopalisading necrosis. DIAGNOSIS: A. ""BRAIN TISSUE"" (CRANIOTOMY) : GLIOBLASTOMA (WHO GRADE IV) . B. ""BRAIN TISSUE"" (CRANIOTOMY) : HIGH GRADE ASTROCYTOMA. C. ""BRAIN TISSUE"" (CRANIOTOMY) : HIGH GRADE ASTROCYTOMA. 1 of 3. D. ""BRAIN TISSUE"" (CRANIOTOMY) : GLIOBLASTOMA (WHO GRADE IV) . I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 1: Please see Image Cytometry Report. for results of supplementary. tests. FISH INTERPRETATION SUMMARY: CHROMOSOME 7 CENTROMERE - POLYSOMY (44% OF TUMOR CELLS EXHIBIT POLYSOMY). EGFR - AMPLIFICATION (90% OF TUMOR CELLS EXHIBIT AMPLIFICATION). CHROMOSOME 10 CENTROMERE - CENTROMERE LOSS (65% OF TUMOR CELLS EXHIBIT LOSS). PTEN - ALLELIC LOSS (72% OF TUMOR CELLS EXHIBIT LOSS). 9p21 - LOSS (68% OF TUMOR CELLS EXHIBIT LOSS). CHROMOSOME 9 CENTROMERE - CENTROMERE LOSS (44% OF TUMOR CELLS EXHIBIT LOSS). 4 OF 4 ABNORMAL MARKERS. COMMENT: A MULTIVARIATE SURVIVAL ANALYSIS OF. PATIENTS WITH GLIOBLASTOMAS. REVEALS THAT THE HAZARD OF SHORT SURVIVAL AMONG PATIENTS WITH 0-2 ABNORMAL. MARKERS (OUT OF 4) WAS SIGNIFICANTLY LOWER THAN THAT FOUND WITH PATIENTS WITH. 4 ABNORMAL MARKERS EVEN AFTER ADJUSTMENT FOR AGE EFFECT. FISH DATA INDICATE THAT PTEN GENE IS LOST WHILE IMMUNOHISTOCHEMISTRY INDICATES. THAT PTEN PROTEIN EXPRESSION IS INTACT. THE SIGNIFICANCE OF THIS DISCREPANCY. IS UNKNOWN, BUT IT MAY REPRESENT A FALSE POSITIVE BY IMMUNOHISTOCHEMISTRY. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 2: IMMUNOHISTOCHEMICAL, LABELING INDEX OF TUMOR CELLS: TISSUE TYPE: BRAIN TISSUE CONTAINING GLIOBLASTOMA (WHO GRADE IV;. BLOCK A3) . PROLIFERATION INDEX INTERPRETATION: MODERATE PROLIFERATION INDEX (5% OF TUMOR. CELLS EXHIBIT STAINING). MGMT - NEGATIVE (20% OF TUMOR CELLS). EGFR wt - POSITIVE (3+ IN 90% OF TUMOR CELLS). EGFR VIII - POSITIVE (2+ IN 30% OF TUMOR CELLS). PTEN - INTACT (3+ IN 90% OF TUMOR CELLS). 2 of 3. pS6 - POSITIVE (2+ IN 40% OF TUMOR CELLS). pAKT - POSITIVE (2+ IN 80% OF TUMOR CELLS). pMAPK - POSITIVE (3+ IN 30% OF TUMOR CELLS). Please see Image Cytometry Report. bor results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . 3 of 3.",Glioblastoma characterized by neoplastic proliferation of malignant astrocytes with intermediate fibrillar astrocytes. The tumor exhibits vascular proliferation and pseudopalisading necrosis. High-grade astrocytoma with brain tissue infiltrated by malignant cells. Vascular proliferation and necrosis are present. The tumor cells are malignant astrocytes with pseudopalisading necrosis. No lymphovascular invasion or perineural invasion identified. Brain tissue shows infiltration by neoplastic cells with high-grade features. No margin involvement by tumor cells is described. Non-neoplastic brain tissue is not described in detail.
TCGA-QA-A7B7.20257CE0-FCFF-41B4-B9A3-47397B147ED8,"Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histology. (Verified). Acc #: (Age: M. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LIVER AND DIAPHRAGM, RIGHT LOBE, PARTIAL HEPATECTOMY: - HEPATOCELLULAR CARCINOMA, MODERATE TO POORLY DIFFERENTIATED (6.8 X 5.0 CM). - CARCINOMA INVADES INTO THE PERIDIAPHRAGMATIC SOFT TISSUE AND IS 2 MILLIMETERS AWAY FROM. THE DIAPHRAGMATIC MARGIN. CARCINOMA IS 8 MILLIMETERS FROM PARENCHYMAL RESECTION. MARGIN. -VASCULAR INVASION IS PRESENT. UNINVOLVED LIVER SHOWS FOCAL MINIMAL PORTAL INFLAMMATION BUT NO OTHER SPECIFIC PATTERNS. OF INJURY. NO EVIDENCE OF CIRROSIS. - GALLBLADDER WITH CHOLESTROLOSIS. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use. disclosure. or reproduction of this information is strictly prohibited. Anat Path Reports. Synoptic Worksheet. A. Right liver lobe with diaphragm: Clinical History: Hepatitis B infection. Specimen: Liver. Gallbladder. Procedure: Partial hepatectomy. Tumor Size: Greatest dimension: 6.8 cm. Additional dimension: 5.0 cm. Tumor Focality: Solitary, location: segment 7. Histologic Type: Hepatocellular carcinoma. Histologic Grade: Other: Moderate to poorly differentiated. Tumor Extension: Tumor directly invades other adjacent gans:Diaphragm. Margins: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 2 mm. Margin: Diaphragmatic margin. Other margin: Parenchymal margin (8 mm), uninvolved by invasive carcinoma. Lymph-Vascular Invasion: Macroscopic Venous (Large Vessel) Invasion (V) not identified. Microscopic (Small Vessel) Invasion (L) present. Perineural Invasion: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5. cm. Regional Lymph Nodes (pN): pNX: Regional lymph nodes cannot be assessed. Number of nodes examined: 0. Number of nodes involved: 0. Distant Metastasis (pM): Distant Metastasis (pM), not applicable. Additional Pathologic Findings: Chronic hepatitis, etiology: Focal mild non-specific chronic portal inflammation. Clinical History. Right hepatectomy. Specimen(s) Received. A: Right liver lobe with diaphragm. Gross Description. The specimen is received fresh, labeled with the patient's name, medical record number and designated ""right liver lobe with. diaphragm."" It consists of a partial hepatectomy with attached gallbladder and a loosely attached fragment of diaphragm. The. specimen weighs 362.0 grams and measures as follows: liver 19.0 x 10.0 x 3.5 cm, gallbladder 8.5 x 4.7 x 1.8 cm and diaphragm. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. 8.0 x 3.0 x 0.3 cm. There is a 6.8 x 5.0 x 4.5 cm well circumscribed yellow mass identified 0.7 cm from the closest resection. margin and 4.9 cm from the gallbladder. The mass grossly invades the liver capsule and possibly so involvement of the. diaphragm. The liver mass beneath the diaphragm is fragmented and disrupted. No other lesions are identified. The gallbladder. is remarkable for cholesterolosis but is otherwise unremarkable. The gallbladder wall measures up to 0.4 cm in thickness. The. specimen is inked as follows: cauterized resection margin black, diaphragm blue. A representative section of the mass as well. with uninvolved liver is submitted to Tissue Procurement Services. Representative sections are submitted as stated below. (Dictated by. CASSETTE SUMMARY: A1: Mass closest to resection margin. A2: Mass in relationship to capsule. A3: Mass in relationship to normal liver. A4,5: Mass in relationship to diaphragm. A6: Additional representative diaphragm. A7: Uninvolved liver. A8: Representative gallbladder.","Hepatocellular carcinoma, moderate to poorly differentiated, with vascular invasion present. Carcinoma invades into the peridiaphragmatic soft tissue. Uninvolved liver shows focal minimal portal inflammation but no other specific patterns of injury, and no evidence of cirrhosis. Gallbladder with cholesterosis. Tumor directly invades the diaphragm. Parenchymal margin is uninvolved by invasive carcinoma. Microscopic lymph-vascular invasion is present. No perineural invasion identified. Chronic hepatitis with focal mild non-specific chronic portal inflammation."
TCGA-3P-A9WA.4B2E4D3D-128A-49DD-AE0B-ACFC78615B16,"PATHOLOGY EXAMINATION. CLIENT: ADDITIONAL: NO ADDITIONAL PHYSICIANS. Page Tor4. SPECIMEN(S) RECEIVED: A: Left tube and ovary. B: Uterus + cervix. C: Omentum. D: Sigmoid biopsy. E: Left pelvic side wall. F: Right tube and ovary. G: Left pelvic lymph node. H: Left common illac lymph node. I: Right pelvic lymph node. J: Aortic lymph node. K: Right side wall biopsy. CLINICAL DATA/HISTORY: Not provided. FINAL PATHOLOGIC DIAGNOSIS: A, B, C, D, E, F, G, H, I, J, K. LEFT TUBE AND OVARY, UTERUS AND CERVIX, OMENTUM, SIGMOID BIOPSY,. LEFT PELVIC SIDE WALL, RIGHT TUBE AND OVARY, LEFT PELVIC LYMPH NODE, LEFT COMMON. ILIAC LYMPH NODE, RIGHT PELVIC LYMPH NODE, AORTIC LYMPH NODE, AND RIGHT SIDE WALL. BIOPSY: LEFT OVARY WITH HIGH GRADE PAPILLARY SEROUS CARCINOMA. TUMOR SIZE: 7.5X5X5CM. SPECIMEN RECEIVED DISRUPTED. LEFT PELVIC SIDE WALL BIOPSY POSITIVE FOR SEROUS CARCINOMA. REMAINING SPECIMENS NEGATIVE FOR ATYPICAL CHANGE OR MALIGNANCY. REGIONAL LYMPH NODES INCLUDING LEFT PELVIC NODE, LEFT COMMON ILIAC NODE, RIGHT. PELVIC NODE, AND AORTIC LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA. SEE. SYNOPTIC REPORTS BELOW. SYNOPTIC REPORTS: SPECIMEN: RIGHT AND LEFT OVARIES, RIGHT AND LEFT FALLOPIAN TUBES, UTERUS, CERVIX,. OMENTUM, LEFT PELVIC SIDE WALL AND RIGHT PELVIC SIDE WALL. PROCEDURE: HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMIESI WITH. OMENTECTOMIES, LEFT AND RIGHT SIDE WALL AND SIGMOID BIOPSIES. LYMPH NODE SAMPLING: PERFORMED WITH LEFT PELVIC NODE, LEFT COMMON ILIAC NODE,. RIGHT PELVIC NODE AND AORTIC NODE. SPECIMEN INTEGRITY: LEFT OVARY RECEIVED DISRUPTED. PRIMARY TUMOR SITE: LEFT OVARY. OVARIAN SURFACE INVOLVEMENT: ABSENT. TUMOR SIZE: 7.5 x 5 x 5 CM (GROSS MEASUREMENT). HISTOLOGIC TYPE: SEROUS CARCINOMA. HISTOLOGIC GRADE: POORLY DIFFERENTIATED/HIGH GRADE. EXTENT OF INVOLVEMENT OF OTHER ORGANS AND TISSUES: RIGHT OVARY NOT INVOLVED. RIGHT AND LEFT FALLOPIAN TUBES NOT INVOLVED. OMENTUM NOT INVOLVED. UTERUS NOT INVOLVED. Page 2 01 4. o. PERITONEUM INCLUDING LEFT PELVIC SIDE WALL AND RIGHT PELVIC SIDE WALL AND. SIGMOID NOT INVOLVED. PRIOR ENDOMETRIAL POLYP SPECIMEN. INTRAEPITHELIAL SEROUS CARCINOMA. LYMPHOVASCULAR INVASION: NOT IDENTIFIED. PATHOLOGIC STAGE: pT2b pNO (FIGO STAGE 28). REGIONAL LYMPH NODES (SUMMARY OF G, H, I, J): 3 OF 3 LEFT PELVIC LYMPH NODES (SPECIMEN G). NO LEFT COMMON ILIAC LYMPH NODE PRESENT (SPECIMEN H). 1 OF 1 RIGHT PELVIC LYMPH NODES (SPECIMENT I). 1 OF 1 AORTIC LYMPH NODES (SPECIMEN J): o ALL NEGATIVE FOR METASTATIC CARCINOMA. ADDITIONAL PATHOLOGIC FINDINGS: EXTENSIVELY SAMPLED ENDOMETRIUM NEGATIVE FOR RESIDUAL INTRAEPITHELIAL SEROUS. CARCINOMA. ADENOMATOID TUMOR AND MULTIPLE LEIOMYOMAS. CHRONIC CERVICITIS WITH SQUAMOUS METAPLASIA. NEGATIVE FOR ATYPICAL CHANGE OR MALIGNANCY. BENIGN SEROSA AND FALLOPIAN TUBES. UNREMARKABLE OMENTUM. RIGHT SIDEWALL BIOPSY: CAUTERIZED FIBROADIPOSE TISSUE NEGATIVE FOR ATYPICAL. CHANGE. SIGMOID BIOPSY WITH GRANULATION TISSUE, MONONUCLEAR INFLAMMATION AND FIBROSIS. NEGATIVE FOR ATYPICAL CHANGE OR MALIGNANCY. SEE COMMENT. COMMENT: See alsd. land. No residual intraepithelial serous carcinoma is present within the. extensively sampled endometrium. The ovary was received disrupted. Results discussed with. These would appear to represent synchronous serous carcinomas of the ovary and endometrium. """"ELECTRONICALLY SIGNED OUT. FROZEN SECTION DIAGNOSIS: A. LEFT TUBE AND OVARY: SEROUS CARCINOMA. Reported to. B. UTERUS AND CERVIX: NO TUMOR SEEN, LEIOMYOMA, ADENOMYOSIS AND POSSIBLE POLYP. Reported to. GROSS DESCRIPTION: A. Left tube and ovary. Received fresh labeled. eft tube and ovary"" and consists of a 53 gram. ovaran mass measuring 7.5 x 5 x 5 cm. The accompanying fimbriated fallopian tube measures 5 x 1 cm. Adjacent. to the fallopian tube is a surface disruption measuring 1.5 cm. through which friable debris extends. The adjacent. serosa is marked with black ink. The remaining ovarian surface is smooth and glistening to faintly bosselated. The. wary is serially sectioned revealing abundant friable tan cut surfaces. A representative portion of the specimen is. frozen in A-FS1 cryoblock frozen section remnant as A1 with touch preparations x1 obtained. Three representative. sections of the mass are utilized for tissue banking. Additional sections of the specimen are submitted for permanent. section. A2) mass, two fragments adjacent to portion utilized for tissue banking. A3-A5) mass, two fragments per. cassette. A6) fallopian tube. B. Uterus + cervix: Received fresh for frozen section evaluation labeled. uterus and cervix"" and. consists of a 99 gram uterus and cervix without adnexal complexes, measuring 10 x cm. The asymmetric. uterus has a faintly bosselated surface. The cervical epithelium is white, smooth and glistening with a slit-like. cervical os measuring 0.9 cm in greatest dimension. The specimen is inked as follows: right parametrium green; left. parametrium yellow; anterior uterus and cervix blue; posterior uterus and cervix black. The endocervical canal is. patent and elliptical. The endometrium is tan with an average thickness of 0.2 cm. Sectioning of the myometrium. reveals up to 3 well circumscribed, tan, whorled nodule with the largest measuring 2 cm in greatest dimension. The. remaining myometrium is unremarkable and has an average thickness of 2.2 cm. Representative sections of the. endometrium, myometrium and serosa along with a separate section of the largest tan nodule are frozen in B FS1. cryoblock with the FS remnant as B1 with touch preparations x 1 obtained. The gross dissection is directed by. No portion of the specimen is utilized for tissue banking due to the lack of grossly appreciated abnormality. Representative sections of the specimen are submitted for permanent section: B2) Right parametrium en face. B3) Left parametrium en face. B4) Anterior cervix. B5) Anterior lower uterine segment longitudinal (B4-B5. sections are contiguous, yellow ink designates adjacent tissue, not margin). 86) Posterior cervix. B7) Posterior. lower uterine segment longitudinal (B6-B7 sections are contiguous, yellow ink designates adjacent tissue, not margin). B8) Anterior endometrium, myometrium, and serosa B9-B10) Anterior Endometrium B11) Posterior Endometrium,. Myometrium, and Serosa, B12) Posterior Endometrium, B13-B14-B15) Whorled nodules. C. Omentum: Received in formalin labeled. Omentum"", is a 24.8 x 7.7 x 2.0 cm portion of yellow,. lobulated omentum. The specimen is serially sectioned to reveal yellow, lobulated, fatty cut surfaces. No. discrete. mass lesions or areas of nodularity are identified within the omentum. Representative sections are submitted in C1-C5. D. Sigmoid biopsy: Received in formalin labeled. Sigmoid biopsy"", is a 1.3 x 1.0 x 0.3 cm. irregular, pink-tan soft tissue which is placed into a filter bag and submitted in toto in D1. E. Left pelvic side wall: Received in formalin labeled. Left pelvic side wall"", is a 1.3 x 0.8 x 0.4. cm aggregate of three pink-tan soft tissues which are placed into a filter bag and submitted in toto in E1. F. Right tube and ovary: Received in formalin labeled. Right tube and ovary"", is a 14 gram. adnexal complex which includes a 4.0 x 2.0 x 2.0 cm ovary with an attached 3.0 x 0.6 cm fimbriated fallopian tube. The outer surface of the ovary is pink-tan, smooth, displays a mild cerebriform architecture, and displays numerous. simple cysts averaging 0.2-0.3 cm. Sectioning of the ovary reveais a pink-tan, smooth stroma. No ovarian mass. lesions are identified. Sectioning of the fimbriated fallopian tube reveals a pinpoint and stellate lumen. Representative sections are submitted as follows: F1 ovary. fallopian tube to include fimbriae. G. Left pelvic lymph node: Received in formalin labeled. Left pelvic lymph node"", Is a 3.5: 2.0 x. 0.6 cm irregular, yellow, lobulated portion of adipose tissue which contains three elongated, pink-yellow, fatty,. ill-defined candidate lymph nodes ranging from 1.0 x 0.5 x 0.3 cm to 1.8 x 0.5 x 0.4 cm. The specimen is submitted. in toto in G1. H. Left common iliac lymph node: Received in formalin labeled. Left common illac lymph node"",. is a 1.8 x 1.0 x 0.4 cm irregular, yellow, lobulated portion of adipose tissue with no easily palpable candidate lymph. nodes. The specimen is submitted in toto in H1. 1. Right pelvic lymph node: Received in formalin labeled. Right pelvic lymph node"", is a 1.8 x 0.6. x 0.5 cm elongated, fatty, tan-gray candidate lymph node which is bisected to reveal a fatty cut surface. The. specimen is submitted In its entirety in I1. J. Aortic lymph node: Received in formalin labeled. Aortic lymph node"", is a 2.5: x 1.5: x 0.4 cm. irregular, yellow, lobulated portion of adipose tissue which may contain a 0.5 x 0.3 x 0.3 cm somewhat palpable. candidate lymph node. The specimen is submitted in toto in J1. K. Right side wall biopsy: Received in formalin labeled. Right side wall bioosy"", is a 1.6x 1.0: x. 0.5 cm irregular, purple-gray fibromembranous soft tissue which is submitted in toto in K1. MICROSCOPIC DESCRIPTION: A. Sections display papiliary serous carcinoma. Permanent sections confirm the frozen section. interpretation. No definitive surface involvement is present. Sections through the fimbriated end of the fallopian. tube are negative. B. Sections through the parametrium do not display any lymph nodes or atypical change. Sections through. the cervix display a mononuclear inflammatory cell infiltrate with neutrophilic inflammation, squamous metaplasia and. reactive epithelial changes. No dysplasia, HPV change or malignancy is present. Sections through the. endometrium display basalis and proliferative phase endometrium. Sections through the myometrium display an. adenomatoid tumor and multiple nodules of bland appearing spindle shaped smooth muscle cells. Areas of. superficial adenomyosis are present. No residual intraepithelial serous carcinoma is present. No tumor is present. within vascular spaces. The serosa does not display any endometriosis or atypical change. Sections through some. of the leiomyomas display hyalinization and calcification. C. Sections display omentum. No definitive metastatic carcinoma or endometriosis is present. D. Sections display fibrous connective tissue with inflammation and reactive stromal changes. No definitive. atypical change or malignancy is present. The specimen is entirely submitted for histologic evaluation. E. Sections display serous carcinoma. F. Sections display ovary with surface adhesions. No definitive atypical change or malignancy is present. Sections through the fallopian tube do not display any surface of fimbriated end involvement by serous carcinoma. No. endometriosis is present. G. Sections display three completely submitted lymph nodes. No metastatic carcinoma is present. H. The specimen is entirely submitted for histologic evaluation. No definitive nodal tissue or malignancy is. present. I. Sections display completely submitted lymph node. No definitive metastatic carcinoma is present. J. Sections display lymph node. No metastatic carcinoma is present. K. Sections display fibroadipose connective tissue. No atypical change or malignancy is present.","Papillary serous carcinoma of the left ovary, high grade, with no surface involvement. The tumor is composed of papillary structures with cellular atypia and mitotic figures. No lymphovascular invasion is identified. The right ovary, fallopian tubes, uterus, and cervix are not involved by tumor. The omentum does not display metastatic carcinoma or endometriosis. The left pelvic side wall biopsy is positive for serous carcinoma. Regional lymph nodes, including left pelvic, left common iliac, right pelvic, and aortic lymph nodes, are negative for metastatic carcinoma. The endometrium displays basalis and proliferative phase endometrium with no residual intraepithelial serous carcinoma. Adenomatoid tumor and multiple leiomyomas are present in the myometrium. Chronic cervicitis with squamous metaplasia is noted. The sigmoid biopsy displays fibrous connective tissue with inflammation and reactive stromal changes, but no atypical change or malignancy. The right side wall biopsy shows fibroadipose connective tissue with no atypical change or malignancy. No tumor is present within vascular spaces, and the serosa does not display any endometriosis or atypical change."
TCGA-AA-3812.4393113d-6c83-4763-a258-96ab9b8f604d,"Diagnosis. This concerns a resected sigma sample with a moderately differentiated adenocarcinoma. with histopathological differentiation grade G2, with ulceration of the inner surface of the. tumor, with necrosis, with peritumoral, chronic recurrent secondary inflammation with an. acute inflammation flare, with carcinomatous lymphangitis, with tumor infiltration of the. sigma wall layers to the subserous fatty connective tissue, with moderate chronic. lymphadenitis of the tumor-free lymph nodes (0/13), with tumor-free overview slices from. the resection margins and from the anastomosis ring, as well as with a sigma diverticulosis. According to the preparation sections at hand, the spreading of the tumor of the sigma. carcinoma corresponds to a tumor stage of pT3, pNO, MX, L1, R0.","Moderately differentiated adenocarcinoma with histopathological differentiation grade G2, presenting with ulceration of the inner surface of the tumor, necrosis, and peritumoral chronic recurrent secondary inflammation with an acute inflammation flare. Carcinomatous lymphangitis is identified, along with tumor infiltration of the sigma wall layers to the subserous fatty connective tissue. There is moderate chronic lymphadenitis of the tumor-free lymph nodes. The resection margins and anastomosis ring are free of tumor. Sigma diverticulosis is also noted. Tumor infiltration extends to the subserous fatty connective tissue, with no lymph node involvement."
TCGA-VN-A943.089DAFFA-4FD5-4219-9C79-17F6E5405784,"Admit Date: Gender: Male. Birth Date: Attending: DIAGNOSIS: 1. Prostate, radical prostatectomy: Adenocarcinoma, Gleason score 8 (4 + 4), involving 40% of the. left lobe and 25% of the right lobe. Perineural invasion present. No seminal vesicle or extracapsular invasion seen. Margins of resection are free of tumor. See Note. 2. Seminal vesicle, left, portion of, radical prostatectomy: Seminal. vesicle, no tumor seen. 3. Lymph node, obturator, right, radical prostatectomy: Three lymph. nodes, no tumor seen (0/3). 4. Lymph node, obturator, left, packet, radical prostatectomy: Seven. lymph nodes, no tumor seen (0/7). 5. Lymph node and fat, over anterior prostate, radical prostatectomy: Fibroadipose tissue, no tumor seen. NOTE: CAP Cancer Protocol: Procedure: Radical prostatectomy. Prostate Size. Weight: 49.5 g. Size: 5.1 x 3.5 X 4.5 cm. Lymph Node Sampling: Pelvic lymph node dissection. Histologic Type: Adenocarcinoma (acinar, not otherwise specified). Histologic Grade. Gleason Pattern. Primary Pattern: Grade 4. Secondary Pattern: Grade 4. Total Gleason Score: 8. Tumor Quantitation. Proportion (percentage) of prostate involved by tumor: 40% of left. lobe, 25% of right lobe. Extraprostatic Extension: Not identified. Seminal Vesicle Invasion: Not identified. Margins : Margins uninvolved by invasive carcinoma. Treatment Effect on Carcinoma: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Pathologic Staging (pTNM). Primary Tumor (pT). pT2c: Bilateral disease. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Number of Lymph Nodes Examined. Specify: 10. Number of Lymph Nodes Involved. Specify: 0. Do not file in Medical Record. Gender: Male. Birth Date: Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None identified. Ancillary Studies: Not performed. Immunoperoxidase and in-situ hybridization tests performed here and. used for diagnosis were developed and their performance characteristics. determined by the. They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA. has also determined that such clearance or approval is not necessary. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity. clinical laboratory testing. CLINICAL INFORMATION: Brief Clinical History: prostate cancer Specimen. Taken For Protocol: Yes Allocate Order to Protocol: PROCEDURE: Operative Findings: prostate and lymph nodes. Post-Operative Diagnosis: prostate cancer Pre-Operative Diagnosis: prostate cancer. SPECIMENS SUBMITTED: 1. PROSTATE. 2. SEMINAL VESICLE, LEFT. 3. OBTURATOR LYMPH NODE(S), Right. 4. OBTURATOR LYMPH NODE(S), Left. 5. LYMPH NODES, Fat over anterior prostate. GROSS DESCRIPTION: Received are 5 freshly submitted specimens each. labeled "". and further specified as. follows: 1. ""Prostate"" consists of a prostatectomy specimen weighing 49.5 grams. with the following measurements: Left to right: 5.1 cm,. Anterior-posterior: 3.5 cm,. Apex-base: 4.5 cm,. Left seminal vesicles: 3.1 x 1.2x 0.8 cm,. Left vas deferens: 3.8 cm in length x 0.4 cm in diameter,. Right seminal vesicles: 4.2 x 1.6 x 0.7 cm,. Right vas deferens: 4.0 cm in length X 0.6 cm in diameter. The prostate is follows: Urethra in yellow, anterior 1/3 in black,. right posterior 2/3 in blue, and left posterior 2/3 in red. Gross. photographs are taken. One cut is made revealing a tan nodular cut surface and yellow hard. area measuring approximately 1.5x cm. Approximately 1 x 0.8 x 0.2. cm of tumor left the apex and approximately 1 x 0.8 x 0.2 cm of. normal-appearing prostatic tissue from the right apex are procured for. the. and documented by. on. at. Received in Surgical Pathology is a specimen matching the above. description. The prostate is serially sectioned from apex to base. Do not file in Medical Record. Gender: Male. Birth Date: using a custom-fabricated mold. Summary of sections is as follows: 1A-H: Serially sectioned prostate from apex to base, entirely submitted. 1I-L: Left seminal vesicles and vas deferens, entirely submitted. 1K-O: Right seminal vesicles and vas deferens, entirely submitted. 2. ""Portion of left seminal vesicles"" is a single unoriented tan soft. tissue fragment with two surgical clips in place at either end, overall. measuring 0.9 x 0.5 x 0.2 cm. The clips are removed and the tissues. are entirely submitted in white cassette. 3. ""Right obturator lymph node"" is a single yellow lobulated adipose. tissue fragment, 5.5 x 2.5 x 0.7 cm, incorporating a single elongated. tan rubbery candidate lymph node, 3.6 x 1 x 0.6 cm. The candidate. lymph node is bisected revealing a partially fat replaced cut surface. The specimen is submitted as follows: /3A 1 candidate lymph node, sectioned. #3B remainder of the specimen comprised largely of adipose. tissue. 4. ""Left obturator lymph node packet"" are 2 yellow lobulated fatty. tissue fragments, in the aggregate 5.5 x 2.5 x 0.7 cm incorporating 3. tan rubbery candidate lymph nodes ranging from 1 to 1.9 cm. The. cimen is entirely submitted as follows: #4A 1 bisected candidate lymph node. #4B 2 smaller intact candidate lymph nodes. #4C remainder of the specimen largely comprised of adipose. tissues. 5. ""Fat and lymph nodes over anterior prostate"" are 6 yellow lobulated. adipose tissue fragments ranging from 0.9 to 2.4 cm in greatest. dimensions and in the aggregate 2.4 x 2.4 x 0.8 cm. The tissues are. palpated and obvious macroscopic candidate lymph nodes are not. identified All of the fragments are submitted in white cassettes. Gross Description dictated by. No consultants. Accessioned: Final Report Signed Out: <Resident Signatura>. Date Report Signed: Confidential Patient Information. Unauthorized disclosure is prohibited by the Fede.","Adenocarcinoma of the prostate with a Gleason score of 8, involving both lobes. Perineural invasion is present. No seminal vesicle or extracapsular invasion is seen. Tumor is composed of acinar cells with grade 4 patterns. Margins of resection are free of tumor. Seminal vesicle, left, shows no tumor. Lymph nodes, including obturator lymph nodes, right and left, and lymph nodes over anterior prostate, show no tumor. Prostate tissue displays a tan nodular cut surface with yellow hard areas. Tumor is present at the apex and normal-appearing prostatic tissue is seen at the right apex. No lymph-vascular invasion is identified."
TCGA-OR-A5JA.6A505565-429B-4D8A-A591-AAB54CF43B66,"Requesting Doctor's information: HISTOPATHOLOGY FOR REVIEW. T. H. o. Slides were reviewed as part of a study comparing CGH performed on fresh frozen. tissue in benign and malignant adrenal cortical tumours. L. o. I agree with. diagnosis of adrenal cortical carcinoma. G. Tumour Weight 865 g. Y. Weiss criteria: All 9 from 9. Less than 25% clear cells. Necrosis. Diffuse Architecture. Venous invasion. Sinusoidal invasion. Capsular invasion. High nuclear grade. High mitotic rate. Atypical mitosis. A. N. FINAL DIAGNOSIS: Adrenal: Adrenal cortical carcinoma. A. T. O. M. REPORTING PATHOLOGIST: (Electronic Signature). I. C. A. L. P. A. H. o. O. D.O. Specimen : Specs. Multiple Type. Exams : Z 2 C5 FS1 IP4. CLINICAL HISTORY. Nodule from anterior duodenum ? met from adrenal tumour. 1. Torted appendix epiploicae transverse colon. 2. Rt adrenocortical tumour. 3. IVC invasive mass. Addition tumour from crus of Rt diaphragm. MACROSCOPIC. 1. LABELLED 'NODULE ON FRONT OF DUODENUM'. A single 3mm biopsy. All. embedded in one block. Examined by frozen section and reported by Dr. as ""No. evidence of malignancy. 2. LABELLED 'RIGHT ADRENO CORTICAL CANCER'. A large tumour weighing. 865g and measuring 150 x 100 x 100mm. The tumour is incompletely. surrounded by fibrous capsules, has been previously opened and has. a. ragged haemorrhagic, variegated yellow grey nodular cut surface. Blocks: A-C tumour with capsule; D-K representative sections tumour. 3. LABELLED `IVC INVASIVE MASS'. Two pieces of ragged tissue with an. aggregate weight of 21g. They measure 55 x 35 x 25mm and 50 x 20 x. 20mm. They have a ragged yellow grey cut surface. Representative. sections in four blocks. 4. LABELLED 'ADDITIONAL TUMOUR FROM CRUS OF DIAPHRAGM'. A. haemorrhagic tissue fragment measuring 23 x 15 x 10mm. All embedded. in one block. 5. LABELLED 'TORTED APPENDIX EPIPLOICAE OF TRANSVERSE COLON'. A. pedunculated grey mass with shiny grey serosal surface measuring 22 x. 7. x 5mm. All embedded in one block. continued. 1. MICROSCOPIC. 1. Sections show fibrous tissue in which there is no significant. abnormality. 2. Sections show an encapsulated adrenal tumour comprising cells with. large amount of ecsinophilic cytoplasm and pleamorphic nuclei forming. trabeculae and clustes. There is marked tumour necrosis. Mitoses. focally measure up to 18/10 HPF. Immunoperoxidase studies show staining of the tumour cells for HMB45,. inhibin and synaptophysin. There is no staining for cytokeratin and. chromogranin A. The appearances are consistent with an adrenocortical carcinoma. 3. Sections show trabeculae of abnormal cells with focal overlying. endothelial cells and organising thrambi. The appearances are. consistent with adrenocortical carcinoma. 4. Sections show trabeculae of abnonmal cells invading the fibrous. tissue. The appearances are consistent with metastasis from the adrenocortical. carcinoma. 5. Sections show nodular fibrous tissue with overlying mesothelium. The appearances are consistent with organised torted appendix. epiploicae. CONCLUSTION. 1. Front of duodenum - Fibrous nodule. 2. Right adrenal - Adrenocortical carcinama. 3. IVC - Adrenocortical carcinoma. 4. Crus of diaphragm - Adrenocortical carcinoma. 5. Transverse colon - Torted appendix epiploicae. Reported on.","Adrenal cortical carcinoma with encapsulated tumour comprising cells having a large amount of eosinophilic cytoplasm and pleomorphic nuclei forming trabeculae and clusters. Marked tumour necrosis is present. Mitoses are focally prominent. The tumour exhibits diffuse architecture, venous invasion, sinusoidal invasion, capsular invasion, and high nuclear grade with atypical mitosis. The tumour cells are arranged in a trabecular pattern with focal areas of necrosis. High mitotic rate and atypical mitoses are noted. The tumour invades the fibrous tissue, consistent with metastasis from the adrenocortical carcinoma. No lymph nodes are identified. Non-neoplastic findings include nodular fibrous tissue with overlying mesothelium, consistent with organised torted appendix epiploicae, and fibrous tissue with no significant abnormality in the duodenum."
TCGA-24-2036.3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e,"OVARY, RICHT, ADNEXECTMY - POORLY DIFF'ERENTIATED OVARIAN. ADENOCARCINOMA (SEE COMMENT ). FALLOPIAN TUBE, RIGHT, ADNEXECTOMY - BENIGN PARATUBAL CYSTS. OMENTUM, OMENTECTOMY - OMENTUM AND FAT WITH NO HISTOPATHOLOCIC. ABNORMALITY. - FIBROUS TISSUE WITH ACUTE INFLAMMATION. SOFT TISSUE, ""CUL-DE-SAC NODULE, "" BIOPSY. - METASTATIC ADENOCARCINOMA. UTERUS, CERVIX, HYSTERECTOMY - ACUTE AND CHRONIC INPLAMMATION. - SQUAMOUS METAPLASIA. UTERUS, ENDOMETRIUM, HYSTERECTOMY - INACTIVE ENDOMETRTUM WITH. NO HISTOPATHOLOCIC ABNORMALITY. UTERUS, MYOMETRIUM, HYSTERECTOMY -ADENOMYOSIS. OVARY, LEFT, SALPINCO-OOPHORECTOMY - NO HISTOPATHOLOCIC ABNORMALITY. FALLOPIAN TUBE, LEFT, SALPINCO-OOPHORECTOMY - BENICN PARATUBAL. CYSTS. LYMPH NODIS, LEFT EXTERNAL ILIAC, DISSECTION. - .NO EVIDENCE OF MALICNANCY IN FOUR LYMPH. NODES (0/4). LYMPH, NODES, LEFT OBTURATOR, DISSECTION. - NO EVIDENCE OF MALICNANCY IN FOURTEEN. LYMPH NODES (0/14). LYMPH NODES, LEFT PARA-AORTIC, DISSECTION. - NO EVIDENCE OF MALICNANCY IN FIVE. LYMPH NODES (0/5). Surg. Path. LYMPH NODES, RIGHT EXTERNAL ILIAC, DISSECTION. - NO EVIDENCE OF MALICNANCY IN FIVE. LYMPH NODES (0/5). - TWO SOFT TISSUE ADENOCARCINOMA. METASTASES. LYMPH NODES, RIGHT OETURATOR, DISSECTION. - NO EVIDENCE OF MALICNANCY IN NINE. LYMPH NODES (0/9). LYMPH NODES, RIGHT PARA-AORTIC, DISSECTION. - NO EVIDENCE OF MALICNANCY IN FIVE. LYMPH NODES (0/5). SOFT TISSUE, LEFT CUTTER, BIOPSY - FIBROFATTY TISSUE WITH ACUTE. AND CHRONIC INFIAMMATION AND. HEMORRHACE. SOFT TISSUE, SICMOID NODULE, BIOPSY - METASTATIC ADEMOCARCINOMA. - NECROSIS. - ACUTE AND CHRONIC. INFLAMMATION. - CRANTULATION TISSUE. DIAPHRAGM, BIOPSY - METASTATIC ADENOCARCINOMA. SOFT TISSUE, RICHT CUTTER, BIOPSY - FIBROFATTY TISSUE WITH ACUTE. INFLAMMATIOM AND NUMEROUS. REACTIVE MESOTHELIAL CELLS. SOFT TISSUE, RICHT SIDEWALL, BIOPSY -- NECROSIS. - ACUTE AND CHRONIC. : I.NFLAMMATION. SOFT TIS(SU,E, EEFT SIDEWLE I BIOPSY of NECROSIS. ACUTE INFLAMMATION. --2--. SPECIMEN (s) SUBMITTED. Part 1: FS1-RICHT ADNEXA. Part 2: X-RICHT ADEXA. Part 3: OMENTUM. Part 4: CUL-DE-SAC. Part 5: UTERUS, CERVIN, LEFT ADNEXA. Part 5: LEFT EXTERNAL ILIAC LYMPH NODE. Part 7: LEFT OBTURATOR LYMPH NODE. Part 8: LEFT PERI-AORTIC LYMPH NODE. Part 9: RIGHT EXTERNAL ILIAC LYMPH NODE. Part 10: RICHT OBTURATOR LYMPH NODE. Part ""11: RICHT PERI-AORTIC LYMPH NODE. Part 12: LEFT CUTTER. Part 13: SIGMOID NODULE. Part 14: DIAPHRACM. Part 15: RICHT CUTTER. Part 16: RICHT SIDEWALL. Part 17: LEFT SIDEWALL. HISTORY. Th patient ic a. with a history of breact. cancer. negativo; treated with chemotherapy and. radiation therapy) The patient now presents with a $ight adnexal. mass and ploural effucion. Operative procedure: Not stated, but. appears to be right adnoxectomy followed by hycterectmy and left. aalpingo-oophorectomy as well as staging with multiplo lymph node. dissections and intra-abdominal biopsies. Clinical diagnosis: Right adnoxal macs and pleural effucion with a remote history of. breact cancer. FROZEN. Right adnexa - ""Mullerian ncoplacm of at least low molignant. potentil, "". 3. CROSS. The specimens are received in 17 containers of formalin, each. labolled with the patient's G name. The first in labelled ""FS"" and. containo one framment of whitc-tan tissue, measuring 1.8 x 1.1 x. 0.2 cm. The second container is labelled ""X, #2, right adnexo. "" It. contains four fragments of tissue, one of which is an 11.5 x 11.0. x 9.0 cm., tan, partly papillary, but mostly necrotic mass. The. other three fragmento appear to have come from the mass and in. aggregate measure 4. 5 x 4.8 x 1.5 cm. No cystic areas ane scen-in. any of the fragments). All four fragmento in aggregate woigh 441.2. grams. Crossly no normal ovary is seen olthough one of the. fragments separate from the tumor macs is a potenti candidato;. this fragment of brown-tan tissue measures 2.7 x 1.2 x 2.1 cm. A. 2.0 c'm. long, tube-chaped qtructure with a greatest cylindrical. diameter of 0.9 cm. is scen. This grossly ic suggestive of a. fallopian tubc. CPT. Labelled XA-XF with XA-XD being apparent. tumor, XE being possiblo normal ovary, and XF being three sections. of possible fallopian tube. The third container 1c labolled ""#1, omontum"" and contains two. separate fragments of fatty tissue, one of which looks more like. classical omentum with the other (the smaller) appearing more like. pericolonic fat. The larger fragment, which looks more like. omentum, measures 30.0 x 15.0 x 2.1 cm. The separate smaller. fragment, which appears more like pericolonic fat, measures 10.5 x. 5.5 x 1.8 cm. Labelled A1-A5, sections of what grossly oppears to. omentum; AS, dection of separate fragment fat that grossly. appears more consistent ""with pericolonic fat : The fourth container is labelled ""#3, cul-de-sac nodule. It. contains eleven fragmento of ticsue, some of which oppear to be. clot, the remainder is firm, white-ton-brown tissue. In aggregato. the specimen measures 5.0 x 5.2 DE 1.5 cm. The fifth container is labolled ""#4, uterus, cervix, LSO. "". contains a hysterectomy specimen consisting of corpus and cervix. with attached left ovary and left follopian tubc. The 94.4 gram. uterus measures 8.2 dm. superoinferiorly by 4.5 cm. medial-laterally - by 4.0 cm. anteroposteriorly The ectocervix. --4--. CROSS (continued). measures 3.3 cm. medial-laterally - by 3.5 cm. The endocervical canal is 5.0 cm. long. The endometrial cavity. measures 2.0 cm. medial - -laterally by 2.3 cm. superoinforiorly. A. 1.5 cm. cubseroal discrete, firm, white, whorled lesin without. necrosic ic seen in the posterior corpus. No other abnormalities. of the uterus are seen. The grossly normal left ovary measures. 1.8 x 0.8 x 0.8 cm. The 3.5 cm. long fallopian tube has a. greatest cylindrical diameter of 0.8 cm. Four apparent benign. paratubal cysto are scen, each with greatest dimencion varying. from 0.1 to 0.6 cm. Labelled C1, anterior cervix; C2 posterior. corvix; E1, anterior endomyomtrium; E2, posterior endomyometrium;. M, putative leiomyoma; LO, left ovary; LT, two transverse sections. of left fallopian tube along with the largest apparent bonign. paratubal cyst. The sixth container is labelled ""#5, left oxternal iliac lymph. node.' It contains one fragment of partly soft, yellow, fatty. ticsue but also partly firm, brown tissue. The fragment measures. 3.8 x 2.2 x 1.5 cm. The seventh container is labelled ""#G, left obturator lymph node. "". It contains one fragment of partly soft, yellow, fatty. tissue in. which ic intermixed firm, brown tissue. The fragment measures. 4.5 x 3.2 X 1.5 cm. The cighth container is labelled ""#7, left para-aortic lymph. node."" It contains three fragments of mostly soft, yellow, fatty. ticcue in which is intermixed firm, brown tisses mh fragmento. in aggregate meacure 2.0 x 1.8 x 0.8 cm. The ninth container is labolled ""#8, right oxternal lymph. node.' It containo fivo fragmento of soft. yellow, fatty tissue. with which ic intermixed firm, tan and white tissue. In aggregate. the specimen measures 4.0 x 3.0 x 2.0 cm. The tonth container is labolled ""#9, right obturator lymph node. "". It contains seven fragments of partly soft, yellow, falt ly ticsue. with which ic intermixed firm, brown-tan tissuc. In alagregato the. fragmento measure 5.0 x 3.5 x 2.5 cm. The cleventh container is labolled ""#10, right para-acrtic lymph. --5--. CROSS (continued). node. "" It contains. one fragment of mostly soft, vellow fotty. ticsue measuring 3. x 1.5 x 1.1 2 cm. The twolfth container its labelled ""#11, left gutter biopsy. "". containg one frigment. of soft tan tissue measuring 1.3 x 0. x. 0. cm. The thirteenth container is labelled ""#12, sigmoid nodule. "" It. contains two frigmento of white and brown tissue. in aggregato. measuring 1.4 x 1.4 x 0. cm. The fourtcenth ontaliner is labelled ""#13, diaphragm biopsy "". contains one fragment of white tissue, measuring 0.7 x 0. 4 x 0.2. cm. Marked with hematoxylin and wrapped. The fiftcenth container is labelled ""#14, right gutter biopsy. "". It contains one fragment of firm, yellow and brown tissue,. mcasuring 0.7 x 0.5 R 0. cm. The sixtcenth C? ntainer is labolled ""#15, right sidewall biopsy. "". It contains one fragment of L-chaped, brown tissuo, measuring 1. 2. x 0.8 x 0.3 cm. The ceventeenth conthiner is labelled ""#16, left sidcwall biopsy. "". It contains one fragment of brown and ton ticsuo, measuring 0.7 x. 0.5 x 0.3 cm. COMMENT. The poorly ovarion adenocarcinoma is predominantly. of in papillary ceroup pattern; howover, portions of the. adenocarcinoma have an endometrioid pattorn. The metastases seen. chow an adenocarcinomo with histology identical to the primary. of the right ovary. SYNOPTIC DEPORTING FORM l'OR MALICNANT OVARIAN NEOPLASMS. 1. A ncoplasm is PRESENT. 2. The HISTOLOCIC DIACNOSIS ic: Adenocarcnoma, see comment. --6--. of COMMENT (continued). 3. The LOCATION(S) OF THE PRIMARY TUMOR (S) is/arc: Right ovary only. 4. The FICO CRADE of/the tumor ic: III (Tumor composed of greater than 50% solid cellular. nests). 5. The NUCLEAR (ERODERS') GRADE of the tumor is: C3 Poorly-differentiated). Tumor IS identified on the ovarian surface(s). The presence of tumor invasion of the mesovarium CANNOT. DE EVALUATED. Invasion of adjacent fallopian tube CANNOT EE EVALUATED. Tumor invasion off the polvic soft ticsue CANNOT BE. EVALUATED. Tumor involvement of the pelvic peritonoum de PRESENT. Mtactatic involvement of the EXTRAPELVIC poritoneum is. PRESENT. 12. Metactatic involvement of the omentum is ABSENT. 13. Metastatic involvement of the uterine seroca is ABSENT. 14. Metactatic involvement of the endometrium is. ABSENT. 15. Regional lymph node metastases are ARSENT, although two. soft ticsue metastases are present in the right external. iliac lymph node dissection. 16. The total number of regional lymph nodes examined is 42. 17. The total number of metastatically-involved regional Jymph. nodes 10 0. Extranodal extencion by. tumor ic NOT APPLICABLE; no. --7--. Surg. Path. COMMENT (continued). nodal metastaces are present. 18. DETAILED STAGING INFORMATION. Based on the above information, the PRIMARY TUMOR ic. C tascified as: TNM SCHEME. FICO SCHEME. DEFINITION. IIIA. Microscopic peritoncal. metastasis beyond truc pelvis. THE RECIONAL LYMPH NODES are clascified as: NO (Nodes are free of mctastases). THE STATUS OF DISTANT TUMOR SITES 15 classified as: MO. (Distant metactases are reportedly absent). 19. The FINAL AJCC/FIGO STACE IS: AJCC SCHEME. FICO SCHEMF. (T32) NO/ MO). IIIA. (End of Report ). -8--.","Poorly differentiated ovarian adenocarcinoma with a predominantly papillary serous pattern, however, portions of the adenocarcinoma have an endometrioid pattern. The metastases show an adenocarcinoma with histology identical to the primary of the right ovary. Tumor invasion of the pelvic soft tissue is present. Tumor involvement of the pelvic peritoneum is present. Metastatic involvement of the extrapelvic peritoneum is present. Metastatic involvement of the omentum is absent. Metastatic involvement of the uterine serosa is absent. Metastatic involvement of the endometrium is absent. Regional lymph node metastases are absent, although two soft tissue metastases are present in the right external iliac lymph node dissection. Necrosis is present in the metastatic adenocarcinoma. Acute and chronic inflammation is present in the soft tissue. Reactive mesothelial cells are present in the right gutter biopsy. Benign paratubal cysts are present in the left fallopian tube. Adenomyosis is present in the myometrium. Inactive endometrium is present with no histopathologic abnormality. Acute and chronic inflammation is present in the uterus, cervix. Squamous metaplasia is present in the cervix."
TCGA-HC-7741.7fbf6ee1-60f4-4bb6-abf2-fc97791128b5,"DIAGNOSIS. DIAGNOSIS: A. Right pelvic lymph node: Benign, hyperplasia. B. Left pelvic lymph node: Benign, hyperplasia. C. Radical prostatectomy: Carcinoma. Tumor Characteristics: 1. Histologic type: Adenocarcinoma, conventional type. 2. Gleason Grade: a. Primary pattern: 3/5. b. Secondary pattern: 4/5. c. Score: 7/10. 3. Tumor involves: Both lobes. 4. Tumor quantitation: Tumor involves approximately 25% of the specimen. 5. Seminal vesicle involvement: Yes, left seminal vesicle. 6. Extra-capsular tumor extension: No. 7. Lympho-vascular space invasion: Yes. 8. Perineural space invasion: Yes. 9. High grade PIN: Present. Surgical Margin Status: 1. Bladder Neck: Negative. 2. Apical (inferior): Negative. 3. Inked prostatic margin: Negative. Lymph Node Status: 1. Total number of lymph nodes examined: 2. 2. Number of lymph nodes containing metastatic carcinoma: None. Other significant findings: 1, Frozen section correlation statement: All three frozen section diagnoses are confirmed. 2. Other findings: Status post treatment changes are noted. 3. pTNM stage: pT3b, NO, MX. D. Bladder neck: Benign, no pathological diagnosis. PATIENT INFOF TON. WFORMATION. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right pelvic lymph node with frozen section. B. Left pelvic lymph node with frozen section. C. Prostate. D. Bladder neck with frozen section. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received in four containers labeled with the patient's name. A. Container A is additionally labeled #1 and contains a 3.5 x 2.0 x 0.7 cm aggregate of yellow-tan fibroadipose tissue which is sectioned to reveal two. pink-tan, firm, fatty nodules consistent with possible lymph node. They are 0.9 and 1.3 cm in greatest dimension. Portions of these nodules are. submitted for frozen section with the residual entireiv & for permanent section in cassette A1 labeled. All remaining possible. lymphoid tissue is submitted in cassette A2 labeled. B. Container B is additionally labeled left pelvic lymph node and contains a 50 x 3.0 x 1.0 cm aggregate of yellow-tan fibrofatty soft tissue containing. multiple possible firm, fatty lymph node ranging from 0.1 up to 1.0 cm in greatest dimension. A representative section is submitted for frozen section. with the residual entirelv recuhmitted for permanent section in cassette B1 labele. Additional possible whole lymph nodes are submitted. in cassette B2 labeled. c. Container C is additionally labeled prostate and contains a 34.1 gm, 4.5 x 3.5 x 3.0 cm prostate with attached bilateral adnexa, 2.5 x 2.0 x 1.0 cm in. overall dimension. The specimen has been previously inked as follows: right side red and left side blue. The right side is now over-inked with black. The base and the apical margins are coned and serially sectioned. The remainder of the specimen is serially sectioned to reveal a pink-tan, focally. cystic cut with diffuse periurethral nodularity. No discrete lesions are identified. Representative sections are submitted in cassettes C1-18. labeled. Jesignated as follows: C1 right prostate/seminal vesicle junction; C2 left prostate/seminal vesicle junction; C3-4 apical margin,. perpendicular;. C5-6 base margin, perpendicular; C7-9 right anterior, apex to base; C10-12 right posterior, apex to base; C13-15 left anterior anex.to. base; C16-18 left posterior, apex to base. Additionally, a yellow and green cassette are submitted for genomic research labelec. D. Container D is additionally labeled bladder neck and contains a portion of rubbery tan-white tissue, 0.6 cm in diameter with stitch on one aspect. which is inked red, bisected, and entirely submitted for frozen section with the residual entirely resubmitted for permanent section in cassette D labeled. INTRA-OPERATIVE CONSULTATION: Frozen section part A: No metastatic carcinoma identified. Frozen section part B: No metastatic carcinoma identified. Frozen se 20 part D: Line of resection free of tumor. MICROSCOPIC EXAMINATION: All three frozen section diagnoses are confirmed.","Adenocarcinoma, conventional type, with tumor involving both lobes. Gleason Grade: primary pattern 3, secondary pattern 4, score 7. Tumor quantitation: tumor involves a significant portion of the specimen. Seminal vesicle involvement: yes, left seminal vesicle. Extra-capsular tumor extension: no. Lympho-vascular space invasion: yes. Perineural space invasion: yes. High grade PIN: present. Surgical Margin Status: negative at bladder neck, apical, and inked prostatic margin. Lymph Node Status: no metastatic carcinoma in lymph nodes examined. Other significant findings: status post treatment changes noted. Tumor cells have a conventional adenocarcinoma appearance with a mixture of glandular and acinar formations. Nuclear features include moderate pleomorphism and prominent nucleoli. No necrosis identified."
TCGA-50-5941.d49e610e-998f-4c6e-bb3d-b9c3a4221544,"PATIENT HISTORY: PRE OP DIAGNOSIS: Right lung mass, left thyroid nodule. POST OP DIAGNOSIS: Same. PROCEDURE: Bronch, right lung resection, right VATS, left thyroidectomy. FINAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT LEVEL 10, EXCISION -. ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 2: LYMPH NODE, RIGHT LEVEL 11, EXCISION -. METASTATIC CARCINOMA IN ONE OF ONE LYMPH NODE (1/1). PART 3: LUNG, RIGHT UPPER LOBE, RESECTION -. A. MODERATELY TO POORLY DIFFERENTIATED ADENOCARCINOMA WITH SQUAMOUS DIFFERENTIATION, 2.2. CM (see comment). B. CARCINOMA INVADES THE VISCERAL PLEURA (see comment). C. ANGIOLYMPHATIC INVASION PRESENT. D. CENTRILOBULAR EMPHYSEMA. E. METASTATIC CARCINOMA IN ONE OF TWO PERIBRONCHIAL LYMPH NODES (1/2) WITH EXTRACAPSULAR. EXTENSION INTO THE PERIBRONCHIAL CONNECTIVE TISSUE. F. NEGATIVE RESECTION MARGINS. PART 4: LUNG, RIGHT UPPER LOBE ORIFICE, BIOPSY -. BENIGN BRONCHIAL MUCOSA. PART 5; LYMPH NODE, RIGHT LEVEL 4, EXCISION -. LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 6: LYMPH NODE, RIGHT LEVEL 11, EXCISION -. METASTATIC CARCINOMA IN ONE OF ONE LYMPH NODE (1/1). PART 7: RIB, RIGHT FIFTH, RESECTION -. UNREMARKABLE SEGMENT OF RIB. PART 8: LUNG, RIGHT UPPER LOBE MARGIN, EXCISION -. METASTATIC CARCINOMA IN PERIBRONCHIAL LYMPH NODE (1/1) WITH EXTRACAPSULAR EXTENSION INTO THE. PERIBRONCHIAL CONNECTIVE TISSUE (see comment). PART 9: LYMPH NODE, RIGHT LEVEL 7, EXCISION -. SIX LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/6). PART 10; LYMPH NODE, RIGHT LEVEL 4 PACKET, EXCISION -. METASTATIC CARCINOMA IN THREE OF THREE LYMPH NODES (3/3) WITH EXTRACAPSULAR EXTENSIN. PART 11: THYROID, LEFT, PARTIAL THYROIDECTOMY -. NODULAR THYROID HYPERPLASIA WITH ADENOMATOID AND HURTHLE CELL NODULES. COMMENT: Part 3: Elastic stain hightights the presence of visceral pleura invasion (PL1). The neoplastic cells are positive for TTF-1,. and PASD, focally and weakly for p63 and are negative for CK5/6 stains. All controls show appropriate reactivity. The metastatic carcinoma in peribronchial lymph node shows extracapsular extension into the peribronchial connective. tisaue. Part 8: The malignant cells are highlighted by pancytokeratin stain while LCA stain highlights the lymphocytes. The. carcinoma cells extend into the perinodal connective tissue. TNM STAGE (AJCC, 7th Edition): p T2a N2 cMO. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Upper Lobe. PROCEDURE: Lobectomy. TUMOR SIZE: Maximum dimension: 2.2 cm. Minor dimension: 2.0 cm. TUMOR TYPE: Invasive adenocarcinoma,. Dominant Pattern: Solid. HISTOLOGIC GRADE: G3, Poorly differentiated. MICROSCOPIC ""SATELLITES""/METASTASES: Number of microscopic lesions: o. EXTRAPULMONARY EXTENSION/INVASION OF TUMOR: Visceral pleura (PL1). ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. SURGICAL MARGIN SITE: Distance of invasive turnor to closest margin. 11 mm, Bronchial margin. INFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 3. Number of N1 lymph nodes examined: 5. EXTRACAPSULAR SPREAD OF N1 METASTASES: N1 LYMPH NODES INVOLVED: Level 11. N2 LYMPH NODES: Number of N2 lymph nodes positive: 3. Number of N2 lymph nodes examined: 10. EXTRACAPSULAR SPREAD OF N2 METASTASES: N2 LYMPH NODE GROUPS INVOLVED: Level 4. UNDERLYING DISEASE(S): T STAGE, PATHOLOGIC: p12a. N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: Not applicable.","Moderately to poorly differentiated adenocarcinoma with squamous differentiation, invading the visceral pleura. Angiolymphatic invasion present. Carcinoma in peribronchial lymph nodes with extracapsular extension into the peribronchial connective tissue. Negative resection margins. Metastatic carcinoma in lymph nodes, including those at levels 4 and 11, with extracapsular extension. Centrilobular emphysema noted. Nodular thyroid hyperplasia with adenomatoid and Hurthle cell nodules in the left thyroid. No tumor necrosis exceeding 50%. Mild inflammatory or desmoplastic reaction. Lymph nodes show metastatic carcinoma with extracapsular spread."
TCGA-IB-AAUW.64606B7A-008D-459F-8E32-296016364BB1,"CONFIDENTIAL. Nam. Demographics (for. verification purposes). Sex: F. ADDENDUM REPORT. Addendum Report. Collected Date/Time. Received Date/Time. Addendum Reason. Grade listed in the diagnostic line was incorrectly listed as moderately instead of. poorly in the original report. Addendum Diagnosis. PLEASE NOTE: This Addendum Report introduces a potentially significant. change in the diagnosis or a change in patient information. Please clearly. mark the Original Report as having been changed, with a clear reference to. this Addendum Report (e.g. ""Please see additional report""). Diagnosis. A. Lymph Node, Group B, Resection: - Two lymph nodes, negative for malignancy (0/2). B. Gallbladder, Cholecystectomy. - Acute cholecystitis. - Cholelithiasis. c. Lymph Node, Peripancreatic, Resection: - Fibrofatty tissue, negative for malignancy. - Lymphoid tissue not identified. D. Pancreatico-duodenectomy, Whipple Resection: - Invasive pancreatic ductal adenocarcinoma, poorly differentiated,. size, 3.5 x 2.1 cm (see synoptic report). - Adenocarcinoma within 0.2 cm from the vascular bed and 0.1 cm from. the uncinate resection margin. Bile duct resection margin and pancreatic body resection margin,. negative for malignancy. Six lymph nodes, negative for malignancy (0/6). E. Lymph Node, Portal, Resection: - One lymph node, positive for metastatic carcinoma (1/1). - Size of metastatic deposit, 0.5 cm. - Extracapsular invasion identified. Verified: Responsible Resident: Addendum Discussion. The grade was correctly listed as poorly differentiated in the synoptic line but. incorrectly listed as moderately differentiated in the diagnosis line in the original. Collected Date/Time. Received Date/Time. Specimen Description. A. Lymph node group 8 at. B. Gallbladder at. c. Prepancreatic lymph node at. D. Whipple specimen at. E. Protal lymph node at. Clinical Information. Mass in head of pancreas. Diagnosis. A. Lymph Node, Group B, Resection: Two lymph nodes, negative for malignancy (0/2). B. Gallbladder, Cholecystectomy: Acute cholecystitis. - Cholelithiasis. c. Lymph Node, Peripancreatic, Resection: - Fibrofatty tissue, negative for malignancy. - Lymphoid tissue not identified. D. ancreatico-duodenectomy Whipple Resection: - Invasive pancreatic ductal adenocarcinoma, moderately differentiated,. size, 3.5 x 2.1 cm (see synoptic report). Adenocarcinoma within 0.2 cm from the vascular bed and 0.1 cm from. the uncinate resection margin. - Bile duct resection margin and pancreatic body resection margin,. negative for malignancy. - Six lymph nodes, negative for malignancy (0/6). E. Lymph Node, Portal, Resection: - One lymph node, positive for metastatic carcinoma (1/1). - Size of metastatic deposit, 0.5 cm. - Extracapsular invasion identified. Verified: Responsible Resident: Synoptic Report. SPECIMEN: Head of pancreas. Body of pancreas. Duodenum. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection) . partial pancreatectomy. TUMOR SITE: Pancreatic head. Pancreatic body. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 2.1 x 1.8. cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades duodenal wall. Tumor invades retroperitoneal soft tissue. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.0. mm. Specified margin: uncinate. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 9. Number involved: 1. DISTANT METASTASIS (pM) : Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN III. CLINICAL HISTORY: Not specified. Gross Description. Received are specimen containers A to E. Al1 requisitions and specimen containers are. labelled with the patient'e name,. The cassettes and. identifiers are. labelled with the Surgical Number. A. The specimen is received fresh and is subsequently placed into formalin, designated. as ""A - lymph node group 8 at. The specimen consists of an irregular portion of. fibrofatty tissue measuring 2.0 x 1.4 x 0.5 cm. Two possible lymph nodes are identified. ranging in size from 1.2 x 0.8 x 0.3 cm to 1.4 x 0.7 x 0.3 cm. Sections are submitted as. follows: A1. two possible lymph nodes. A2. remainder of tissue submitted in toto. B. The specimen is received fresh and is subsequently placed into formalin, designated. as ""B - gallbladder at. The specimen consists of a brown tan non-intact. gallbladder measuring 11.5 x 4.8 x 2.3 cm. The serosal surface is tan to dark brown,. smooth and congested. A surgical defect is identified at the fundus measuring 2.4 cm in. length. Cystic duct is patent. Cystic duct lymph node is not identified. The lumen. does not contain bile or calculi, however, two calculi are received with the specimen. Both are black and ovoid. The smaller calculus measures 1.0 x 0.7 x 0.5 cm. The larger. calculus measures 4.0 x 2.8 x 2.4 cm. There are tan and hemorrhagic exudate adherent to. the mucosa. The mucosa is brown and fibrotic. The wall is thickened and averages 0.6 cm. in thickness. Sections are submitted as follows: B1. cystic duct margin and representative sections from neck and body. B2. representative sections from fundus including surgical defect. C. The specimen is received fresh and is subsequently placed into formalin, designated. as ""C - prepanreatic lymph node at "" The specimen consists of a rubbery irregular. portion of fibrofatty tissue measuring 2.5 x 1.0 x 0.3 cm. Specimen is submitted in toto. in one cassette. D. The specimen is received fresh and is subsequently placed into formalin, designated. as ""D - Whipple specimen at The specimen consists of a whipple's resection. including a portion of pancreas (7.0 x 4.0 x 1.5 cm), duodenum (25.0 cm in length and. averaging 6.0 cm in circumference) and attached peripancreatic soft tissue extending to. a maximum depth of 2.5 cm, as well as a small portion of attached mesentery extending to. a maximum depth of 2.0 cm. Proximal and distal margins are stapled. Specimen is inked. as follows: Body margin orange, vessel bed margin green, uncinate margin blue. The. common bile duct measures 4.0 cm in length and averages 0.7 cm in circumference. The. body margin of the pancreas measures 2.5 x 1.0 cm. The uncinate margin measures 6.0 x. 2.5 cm. The pancreas is serially sectioned. A firm ill-defined yellow to light tan. variegated lesion is identified surrounding the common bile duct measuring 3.5 x 2.1 x1.8. cm. It is 0.5 cm from the common bile duct margin, 1.0 cm to the body margin, 0.1 cm to. the vessel bed, 1.2 cm to the uncinate margin, 0.3 cm to the posterior surface, 2.5 cm to. the anterior surface, 1.5 cm to the proximal margin, and 18.5 cm to the distal margin. The serosal surface of the duodenum is tan and smooth and appears grossly unremarkable. The mucosa is tan to brown and appears grossly unremarkable. Sections are submitted as. follows: D1. common bile duct margin en face. D2-4. distal margin trisected. D5. proximal margin bisected. D6. shaved section body margin including pancreatic duct margin. D7-8. contiguous section bisected, demonstrating lesion in closest relation to the. vessel bed. margin also including uncinate margin. D9-10. contiguous section bisected, lesion in closest relation to uncinate margin. and posterior. surface which is inked purple. D11-12. contiguous section bisected, lesion underlying duodenal mucosa and including. vessel. bed margin. D13. lesion in relation to anterior surface. D14. lesion in relation to posterior surface. D15. grossly uninvolved pancreas including vessel bed margin. D16. transition from common bile duct through ampulla of Vater. D17. four possible peripancreatic lymph nodes ranging in size from 0.5 x 0.4 x. 0.3 cm to 1.3 x. 0.8 x 0.3 cm. E. The specimen is received fresh and is subsequently placed into formalin, designated. as ""E - portal lymph node"". The specimen consists of an irregular portion of fibrofatty. tissue measuring 2.8 x 1.8 x 0.8 cm. A possible lymph node is identified measuring 2.3 x. 1.4 x 0.8 cm. Possible lymph node is bisected and submitted in toto in cassettes E1 and. E2. Sample and Test Request Deficiency. Minor sample and/or test request deficiency. Location of physician not provided. Pathologist Comment. representative tumour block=D10. Normal block=D15. Encounter Number. Patient Location.","Invasive pancreatic ductal adenocarcinoma, poorly differentiated. Tumor invades duodenal wall and retroperitoneal soft tissue. Lymphovascular invasion and perineural invasion are present. Adenocarcinoma is within the vascular bed and near the uncinate resection margin. Bile duct resection margin and pancreatic body resection margin are negative for malignancy. Six lymph nodes are negative for malignancy, while one portal lymph node is positive for metastatic carcinoma with extracapsular invasion. Acute cholecystitis and cholelithiasis are also identified. Pancreatic intraepithelial neoplasia is present. Tumor margins are uninvolved by invasive carcinoma."
TCGA-LK-A4NW.9FA130FA-B7F3-44C9-824D-4B332B72CB3E,"FINAL DIAGNOSIS: PARTS 1 AND 2: SKIN AND CHEST WALL, ""CHEST WALL MASS"" AND ""CHEST WALL MASS DEEP ASPECT"",. EXCISION -. FISTULA TRACT ASSOCIATED WITH FOREIGN-BODY GIANT CELL REACTION, GRANULATION TISSUE, FAJ. NECROSIS, AND SCAR, ASSOCIATED WITH MALIGNANT MESOTHELIOMA WITHIN THE PERI-FISTULA TRACT. CONNECTIVE TISSUE AND ADIPOSE TISSUE. PART 3: BONE, 7TH RIB, RESECTION -. PORTIONS OF BONE AND BONE MARROW WITH NO SIGNIFICANT ABNORMALITY. PART 4: PLEURA, ""PLEURAL MASS"", BIOPSY -. DIFFUSE MALIGNANT MESOTHELIOMA, TUBULOPAPILLARY TYPE (see comment). PART. 5: BRONCHUS, LEFT SECONDARY CARINA, BIOPSY -. FRAGMENTS OF BRONCHIAL MUCOSA WITH CHRONIC INFLAMMATION. GROCOTT AND TRICHROME. STAINS. ARE NEGATIVE. CORRELATION WITH CULTURE RESULTS SUGGESTED. NO EVIDENCE OF MALIGNANCY. PART 6: DIAPHRAGM, ""DIAPHRAGMATIC NODULE"", BIOPSY -. DIFFUSE MALIGNANT MESOTHELIOMA, TUBULOPAPILLARY TYPE. PART. 7: LYMPH NODE, ""LEVEL 7 LYMPH NODE"", BIOPSY -. A. ONE (1) OF THREE (3) LYMPH NODES WITH MICROSCOPIC SUBCAPSULAR AGGREGATES OF CELLS. CONSISTENT WITH METASTATIC MALIGNANT MESOTHELIOMA. B. PERI-NODAL SOFT TISSUE IMPLANTS OF MALIGNANT MESOTHELIOMA. PART 8: PLEURA, ""ANTERIOR THYMIC PLEURA"", BIOPSY -. DIFFUSE MALIGNANT MESOTHELIOMA ASSOCIATED WITH ACUTE AND ORGANIZING PLEURITIS. PART. 9: LYMPH NODES, ""LEVEL 5 LYMPH NODES"", BIOPSY -. A. TWO (2) OF FOUR (4) LYMPH NODES WITH SUBCAPSULAR MICROSCOPIC FOCI OF METASTATIC. MALIGNANT MESOTHELIOMA. B. PERI-NODAL SOFT TISSUE IMPLANTS OF MALIGNANT MESOTHELIOMA. PARTS 10, 11, 12, 13, 14, 15. 16, 17, 18, 19 AND 20: PLEURA, ""PARAPHRENIC MASS"", ""DIAPHRAGMATIC TUMOR"",. ""HILAR TISSUE"", ""TUMOR"". ""PERICARDIAL FAT PAD"", ""THYMUS PARAMAMMARY"", ""THYMUS"", ""PLEURAL. MASS"", ""POSTERIR DIAPHRAGMATIC SULCUS TUMOR"", PERICARDIUM"", AND ""PHRENIC AREA"",. BIOPSIES -. DIFFUSE MALIGNANT MESOTHELIOMA ASSOCIATED WITH ACUTE FIBRINOUS AND ORGANIZING PLEURITIS. COMMENT: The diffuse malignant mesothelioma shows characteristic tubulopapillary growth pattern, associated with extensive. pleural and angiolymphatic infiltration. Immunostains show a typical pattern of staining for malignant mesothelioma. within neoplastic cells expressing nuclear calretiniri, cytokeratin 5/6, thrombomodulin, D2-40, and WT-1, and failing to. express TTF-1, CEA, B72.3, Leu-M1, PSA, thyroglobulin, and CDX-2. Focal expression of BerEP4 is prsent. Histochemical stains show glycogen expression with PAS stains, but no intracytoplasmic neutral mucin production with. diastase pre-digestive PAS stains. Overall, this histomorphology and immunophenotype is characteristic of a diffuse. malignant mesothelloma. Samples of the level-7 and level-5 lymph nodes show occasional cells within the subcapsular sinus of the nodes,. documented by cytokeratin stains. For this reason, we would stage this pleural mesothelioma as a T4N1 malignant. mesothelioma. Addendum. This case has been reviewed at the. where the diagnosis. of malignant mesothelioma was confirmed. Addendum. Probe: LSI 9p21/CEP9 Dual Color Probe. Cytogenetic Location: 9p21; Centromere 9. Probe Description: LSI 9p21 dual color DNA probe hybridizes to the band. 9p21 and the centromere of chromosome 9, This probe may be useful for the detection of the p16 region associated with. 9p21. The SpectrumOrange LSI p16 probe spans approximately 190 kb and contains a number of genetic loci including. D9S1749, D9S1747, p16(INK4A), p14(ARF), D9S1748, p15(INK4B) and D9S1752,. # Cells Analyzed: 75. Ratio p16/CEP9: 0.0. % Cells deleted: 100%. Hemizygous loss: 0%. Homozygous loss: 100%. Complex loss: 0%. % Hyperdiploid: 0%. These results are much more common in malignant mesothelioma than any other primary pleuropulmonary neoplasm.","Diffuse malignant mesothelioma with characteristic tubulopapillary growth pattern, associated with extensive pleural and angiolymphatic infiltration. The tumor shows necrosis and is associated with acute and organizing pleuritis. Lymphovascular invasion is present. Metastatic malignant mesothelioma is identified in lymph nodes, with subcapsular microscopic aggregates of cells and peri-nodal soft tissue implants. The tumor infiltrates surrounding tissues, including the diaphragm and pleura. No evidence of malignancy is found in the bronchus. Chronic inflammation is present in the bronchial mucosa. The malignant mesothelioma is associated with a foreign-body giant cell reaction, granulation tissue, and scar formation."
TCGA-52-7810.2da4232b-8a69-480f-a5f1-671cc7ed5213,"Pathologic Interpretation: A. Right lower paratracheal lymph node #4R,. - No tumor seen in one lymph node (0/1). B. Subcarinal lymph node #7,FS: - No tumor seen in one lymph node (0/1). C. Lateral bronchial angle lymph node 10,. - No tumor seen in one lymph node (0/1). D. Peribronchial lymph node, right upper lobe #11R: - One lymph node, no malignancy seen. E. Inferior pulmonary ligament lymph node #9: - One lymph node, no malignancy seen. F. Right lung for bronchial margin,. - Infiltrating poorly differentiated focally keratinizing squamous cell carcinoma, 9.3 cm in greatest dimension invading. through pleura into ribs. - No tumor seen in nine (9) lymph nodes (0/9). - Pulmonary artery and vein, no tumor seen. - The tumor is in the bone marrow of the ribs including the superior posterior rib margin. Tumor Summary: Specimen Type. - Pneumonectomy. Laterality. - Right. Tumor Site. - Upper lobe. - Middle lobe. - Lower lobe. Tumor Size. - Greatest dimension: 9.3 cm. Additional dimensions: 8.5 x 8.0 cm. Histologic Type. - Squamous cell carcinoma. Histologic Grade. - G3: Poorly differentiated. Pathologic Staging (pTNM). Primary Tumor (pT). - pT3: Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors),. diaphragm, mediastinal pleura, parietal pericardium; or. Tumor of any size in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or. Tumor of any size associated atelectasis or obstructive pneumonitis of the entire lung. Regional Lymph Nodes (pN). - pNO: No regional lymph node metastasis. - Specify: Number examined: 12. Number involved: 0. Distant Metastasis (pM). - pMX: Cannot be assessed. Margins. - Margin(s) involved by invasive carcinoma: Ribs (posterior-superior). Direct Extension of Tumor. - Chest wall (including superior sulcus tumors). - Visceral pleura. Venous (Large Vessel) Invasion (V). - Absent. Arterial (Large Vessel) Invasion. - Absent. Lymphatic (Small Vessel) Invasion (L). Present. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Intraoperative Consultation. A. Right lower paratracheal lymph node #4R,. No tumor seen in one lymph node (0/1). B. Subcarinal lymph node #7. No tumor seen in one lymph node (0/1). C. Lateral bronchial angle lymph node 10,. No tumor seen in one lymph node (0/1). F. Right Lung,. No carcinoma seen in bronchial margin. Clinical History: None given. Operation Performed. Mediastinoscopy, right thoracotomy, right pneumonectomy. Pre Operative Diagnosis: Lung cancer. Specimen(s) Received: A: Right lower paratracheal lymph node #4R,. B: Subcarinal lymph node #7. C: Lateral bronchial angle lymph node 10,. D: Peribronchial lymph node, right upper lobe #11R. E: Inferior pulmonary ligament lymph node #9. F: Right lung for bronchial margin,. Gross Description: A. Received fresh is a single ovoid soft tissue fragment consistent with a lymph node, 1 X 0.9 x 0.5 cm. The specimen is. submitted in toto in one block for frozen section. B. Received fresh is an irregularly shaped soft tissue fragment, 1 x 0.6 x 0.4 cm. The specimen is bisected and submitted in. toto in one block for frozen section. C. Received fresh are multiple irregularly shaped soft tissue fragments, 2.5 X 2 X 0.5 cm in aggregate. The specimen is. submitted in toto in one block for frozen section. D. Received in formalin is a single ovoid soft tissue fragment, 0.5 x 0.5 x 0.3 cm in greatest dimension. The specimen is. bisected and submitted in toto in one block. E. Received in formalin is an ovoid soft tissue fragment, 1.5 X 0.5 x 0.5 cm in greatest dimension. The specimen is bisected. and submitted in toto in one block. F. Received fresh is a lung resection specimen, which is anatomically distorted, with multiple staple lines. The pleural. surface is intact, pale purple-blue without any areas of obvious puckering. There is a main stem bronchus extending from. the specimen for a distance of 4 cm. Surrounding this bronchus are multiple subcarinal lymph nodes. Attached to the. anterior lateral surface of the specimen are three ribs. The lung measures 21 x 14 x 8 cm in greatest dimension. The. attached rib measures 12.5 cm in length and 7.5 cm in aggregate diameter. Upon opening the specimen along the. bronchial tree, there is a cystic mass replacing the majority of the lung parenchyma. It measures 9.3 x 8.5 x 8 cm in. greatest dimension. The cystic mass is unilocular. The wall of the mass is at most 2.5 cm in thickness. Centrally located. within the cyst is hemorrhagic and necrotic fluid. Upon removing the fluid, a large papillary necrotic mass is identified. measuring at most 5 cm in greatest dimension. This lesion grossly appears to approach the pleura at the right superior. lateral aspect close to the ribs and is grossly at a distance of 0.1 cm from the inked pleural surface. Grossly, this lesion. appears to focally involve the surrounding portion of rib in the central portion of the length of the rib and is at least 2.5 cm. from the anterior bone resection margin and at least 2 cm from the lateral posterior bone resection margin. The. pulmonary parenchyma surrounding the cavitary lesion is hemorrhagic and consolidated. No other lesions are grossly. identified. Sections are submitted as follows: 1. Bronchial resection margin for frozen section. 2&3. Sections of cavitary lesion in relation to closest inked parietal pleura. 4&5. Composite section through greatest thickness of cavitary wall. 6. Section of lesion in relation to large vessels. 7&8. Additional sections of lesion. 9. Section of lesion in relation to surrounding congested and consolidated pulmonary parenchyma. 10-13. One possible lymph node per block. 14. Two possible lymph nodes. 15-18. One possible lymph node in toto. 19. Pulmonary artery and vein. 20-23. Section of lesion in relation to bone (for decalcification). 24. Rib margin, anterior superior. 25. Rib margin, anterior middle. 26. Rib margin, anterior inferior. 27. Rib margin, posterior superior. 28. Rib margin, posterior middle. 29. Rib margin, posterior inferior.","Infiltrating poorly differentiated focally keratinizing squamous cell carcinoma invading through pleura into ribs. No tumor seen in multiple lymph nodes. Pulmonary artery and vein, no tumor seen. The tumor is in the bone marrow of the ribs including the superior posterior rib margin. Squamous cell carcinoma, poorly differentiated, with lymphatic invasion present. Tumor invades chest wall and visceral pleura. Margin involved by invasive carcinoma: ribs. No venous or arterial invasion. No tumor seen in bronchial margin. Multiple lymph nodes show no malignancy."
TCGA-C5-A7X8.06979EDA-C06B-46E7-A4B0-C20D1E340F4B,"SURGICAL PATHOLOGY REPORT - CONSULT. F. F. MRN : (Age: M.D. DIAGNOSIS. UTERUS, CERVIX, SUPERIOR, BIOPSY. - INVASIVE MUCINOUS ADENOCARCINOMA, ENDOCERVICAL TYPE, EXTENSIVELY INVOLVING. CAUTERIZED MARGINS (SEE COMMENT). SQUAMOUS EPITHELIUM WITH ACUTE AND CHRONIC INFLAMMATION. UTERUS, CERVIX, INFERIOR, BIOPSY (i. - INVASIVE MUCINOUS ADENOCARCINOMA, ENDOCERVICAL TYPE, EXTENSIVELY INVOLVING. CAUTERIZED MARGINS. UTERUS, ENDOCERVIX, ""ENDOCERVICAL CANAL,"" BIOPSY. - ABUNDANT DETACHED FRAGMENTS OF MUCINOUS ADENOCARCINOMA. By this signature. 1 attest that the above diagnosis is based upon my personal. examination of the sides(and/or other material indicated in the diagnosis). M.D. "". M.D. Microscopic Description and Comment. Histologic sections from both superior and inferior cervical biopsies show invasive adenocarcinoma, moderately. differentiated. The morphologic features are distorted in much of these specimens by extensive cautery effect. Where. relatively well preserved, the tumor invades as large nests of moderately pleomorphic cells with abundant mucinous. cytoplasm and a high mitotic rate. This tumor is best classified as mucinous adenocarcinoma of endocervical type,. although many of the cells have signet ring features and there are small foci of endometrioid differentiation as well. Tumor is present on virtually every section from these large biopsies and is present at multiple inked and cauterized. margins. Detached fragments of adenocarcinoma are present in the endocervical canal biopsy. Ph.D. History. The patient is a !year old woman with cervical cancer. SURGICAL PAIMOLOGY KEPORI. Material(s) Received. Received are 15 slides labeled. Three are not further sublabeled, three are sublabled A2, three. are sublabeled B1, three are sublabeled B2 and three are sublabled C1. These are derived from a superior cervix. biopsy (A), inferior cervix biopsy (B), and endocervical canal biopsy (C). h the. accompanying corresponding pathology report. The material originates from. END OF REPURT.","Invasive mucinous adenocarcinoma of endocervical type, extensively involving the cervix, with moderately differentiated morphology and abundant mucinous cytoplasm. The tumor invades as large nests of moderately pleomorphic cells with a high mitotic rate, and many cells have signet ring features, along with small foci of endometrioid differentiation. Tumor is present at multiple inked and cauterized margins, and detached fragments of adenocarcinoma are present in the endocervical canal biopsy. Squamous epithelium with acute and chronic inflammation is also noted."
TCGA-IN-AB1V.388833EE-F0C7-4B1C-8E98-31F4AAF90AE7,"Anonymous number: Accession Date: FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEVEL 9, BIOPSY -. THREE LYMPH NODE FRAGMENTS, NEGATIVE FOR CARCINOMA (0/3). PART 2: PARAESOPHAGEAL HERNIA NEAR LEFT MAINSTEM BRONCHUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 3: LYMPH NODE, PARAESOPHAGEAL NEAR RIGHT MAINSTEM BRONCHUS, BIOPSYONE. LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 4: LYMPH NODE, PARAESOPHAGEAL NEAR AZYGOUS, BIOPSY -. THREE LYMPH NODE FRAGMENTS, NEGATIVE FOR CARCINOMA (0/3). PART 5: LYMPH NODE, NEAR RIGHT VAGUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 6: ESOPHAGUS AND PROXIMAL STOMACH, ESOPHAGOGASTRECTOMY -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION, 2.2 CM,. INVADING INTO THE SUBMUCOSA AND ASSOCIATED WITH BARRETT'S MUCOSA. B. NEGATIVE FOR ANGIOLYMPHATIC INVASION. C. ALL SURGICAL MARGINS UNINVOLVED (PROXIMAL, DISTAL AND CIRCUMFERENTIAL ADVENTITIA). D. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). E. PATHOLOGIC STAGE: pT1b NO. PART 7: LYMPH NODE, PERIGASTRIC, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 8: LYMPH NODE, SUBCARINAL NEAR TRACHEA, BIOPSY. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 9: LYMPH NODE, SUBCARINAL ON ESOPHAGUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 10: LYMPH NODE, FAT PAD, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 11: GASTROESOPHAGEAL FAT, EXCISION -. TWENTY-FOUR LYMPH NODES, NEGATIVE FOR CARCINOMA (0/24). PART 12: LYMPH NODE, SUBCARINAL, AZYGOUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEVEL 9, BIOPSY -. THREE LYMPH NODE FRAGMENTS, NEGATIVE FOR CARCINOMA (0/3). PART 2: PARAESOPHAGEAL HERNIA NEAR LEFT MAINSTEM BRONCHUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 3: LYMPH NODE, PARAESOPHAGEAL NEAR RIGHT MAINSTEM BRONCHUS, BIOPSY-. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 4: LYMPH NODE, PARAESOPHAGEAL NEAR AZYGOUS, BIOPSY -. THREE LYMPH NODE FRAGMENTS, NEGATIVE FOR CARCINOMA (0/3). PART 5: LYMPH NODE, NEAR RIGHT VAGUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 6: ESOPHAGUS AND PROXIMAL STOMACH, ESOPHAGOGASTRECTOMY -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION, 2.2 CM,. INVADING INTO THE SUBMUCOSA AND ASSOCIATED WITH BARRETT'S MUCOSA. B. NEGATIVE FOR ANGIOLYMPHATIC INVASION. C. ALL SURGICAL MARGINS UNINVOLVED (PROXIMAL, DISTAL AND CIRCUMFERENTIAL ADVENTITIA). D. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). E. PATHOLOGIC STAGE: pT1b NO. PART 7: LYMPH NODE, PERIGASTRIC, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 8: LYMPH NODE, SUBCARINAL NEAR TRACHEA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 9: LYMPH NODE, SUBCARINAL ON ESOPHAGUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 10: LYMPH NODE, FAT PAD, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 11: GASTROESOPHAGEAL FAT, EXCISION -. TWENTY-FOUR LYMPH NODES, NEGATIVE FOR CARCINOMA (0/24). PART 12: LYMPH NODE, SUBCARINAL, AZYGOUS, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). PART 13: STOMACH, GASTRECTOMY -. SEGMENT OF STOMACH WITHOUT SIGNIFICANT ABNORMALITY. PART 14: ANASTOMOTIC RINGS, RESECTION -. SEGMENTS OF STOMACH AND ESOPHAGUS WITHOUT SIGNIFICANT ABNORMALITY. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectomy. TUMOR SITE: Tumor midpoint centered on esophagogastric junction Resigned 11/20/14. TUMOR SIZE: Greatest dimension: 2.2 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (PTNM). pT1b. pNO. Number of lymph nodes examined: 39. Number of lymph nodes involved: 0. 17 or more regional lymph nodes were identified. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 13 mm. Specify margin: Circumferentitial adventitial margin. ANGIOLYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Intestinal metaplasia (Barrett's esophagus).","Moderately differentiated adenocarcinoma of the esophagogastric junction, invading into the submucosa and associated with Barrett's mucosa. Negative for angiolymphatic invasion. All surgical margins uninvolved. No carcinoma identified in multiple lymph nodes examined. Adenocarcinoma composed of cells with glandular formation and moderate nuclear pleomorphism. Intestinal metaplasia, consistent with Barrett's esophagus, present. No necrosis identified. Tumor confined to the esophagogastric junction with no extension into adjacent structures. No tumor involvement at the surgical margins. Non-neoplastic stomach and esophagus show no significant abnormality. Multiple lymph nodes, including those from perigastric, subcarinal, and fat pad locations, are negative for carcinoma."
TCGA-CN-A6V1.D671DB14-574E-468B-8296-3B5CA4B33B01,"Report Type. Date of Event. Authored by. Hosp/Group. Record Status. FINAL DIAGNOSIS: PART 1: LEFT TONSIL, TONSILLECTOMY. A. INVASIVE SQUAMOUS CELL CARCINOMA, 2.1 CM, NON-KERATINIZING. B. PERINEURAL INVASION IS ABSENT. C. CARCINOMA EXTENDS TO THE SUPERIOR TISSUE EDGE AND IS < 0.1 CM. FROM THE. DEEP TISSUE EDGE. D. IMMUNOHISTOCHEMICAL STAIN FOR P16 IS POSITIVE (AS A SURROGATE. MARKER. FOR HUMAN PAPILLOMAVIRUS) . E. pT2. PART 2: LEFT POSTERIOR PHARYNGEAL WALL, BIOPSY. NO TUMOR SEEN. PART 3: LEFT DEEP CONSTRICTOR, BIOPSY. NO TUMOR SEEN. PART 4: SOFT PALATE, BIOPSY. NO TUMOR SEEN. PART 5: RIGHT TONSIL, TONSILLECTOMY. A. INVASIVE SQUAMOUS CELL CARCINOMA, ABOUT 0.8 CM, NON-. KERATINIZING. B. MARGINS ARE FREE OF CARCINOMA. By Pathologist: My signature is attestation that I have personally reviewed the. submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received unfixed in five parts. Part 1 is labeled with the patient's name, initials XX and ""left tonsil,. short. stitch superior, long stitch posterior"". The specimen consists of a. 3.0 X 2.2. X 1.5 cm tonsillectomy. There is a long suture designating the. posterior and. a short suture designating superior. There is a tan-gray, soft and firm lesion present measuring 2.1 X 1.2. x. 1.0. cm. The lesion comes to within 0.2 cm of the posterior margin. The. lesion is. 0.3 cm from superior, 0.4 cm from anterior, 0.2 cm from the deep and. 0.2 cm. from anterior. Remainder of the specimen consists of tan-gray, soft focally. hemorrhagic. amount of mucosa and tan-brown, focally hemorrhagic muscle. Following. frozen. section consult digital images are taken. Banked for. Ink code: Blue- superior. Green- posterior. Black- deep. Orange - inferior. Red- anterior and Area banked. Section code: 1AFS - remainder of the tissue is frozen is submitted. 1B - shave of the superior margin. 1C - shave of the inferior margin. 1D-1G - remainder of specimen entirely submitted. Formalin exposure time: 30 hours. Part 2 is labeled with the patient's name, initials XX and ""left. posterior. pharyngeal wall"". It the specimen consists of a 1.2 X 0.5 X 0.3 cm. tan-gray,. soft to firm strip of mucosa and roughened tissue. The specimen is. entirely. submitted in cassette labeled 2A. Formalin exposure time: 28 hours. Part 3 is labeled with the patient's name, initials XX and ""left deep. constrictor"" The specimen consists of a tan-brown, soft to firm,. roughened. and cauterized un-oriented fragment of tissue measuring 2.0 x 0.6 X 0.3. cm. The specimen is entirely submitted in cassette labeled 3A. Formalin exposure time: 28 hours. Part 4 is labeled with the patient's name, initials XX and ""soft. palate"" The. specimen consists of a tan-pink, soft to firm and cauterized portion of. tissue. measuring 0.6 x 0.3 X 0.2 cm. The specimen is entirely submitted. cassette. labeled 4A. Formalin exposure time: 28 hours. Part 5 is labeled with the patient's name, initials XX and ""right. tonsil"". The specimen consists of a 3.0 X 2.0 x 1.0 cm tan-pink, soft, focally. hemorrhagic, cauterized and un-oriented portion of tissue grossly. resembling a. tonsil. The area of cautery is inked and the specimen is serially. cross. sectioned. Upon cross section reveals multiple crypts with yellow. mucoid. material present. The specimen is entirely submitted on cut surface in. cassettes labeled 5A through 5C. Formalin exposure time: 28 hours. INTRAOPERATIVE CONSULTATION: 1 AFS: TONSIL, LEFT, ANTERIOR, POSTERIOR, DEEP MARGINS, RADIAL,. TONSILLECTOMY. (frozen section) -. A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. NON-KERATINIZING SQUAMOUS CELL CARCINOMA. D. MARGINS WERE SUBMITTED SEPARATELY. E. DISCUSSED WITH. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. Part 5: Immunohistochemical stain for p16 (positive) was repeated on. Part 5. (in addition to Part 1) to better appreciate the extent of second focus. of. squamous cell carcinoma (contralateral focus). The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics. determined by. the. as required by. the CLIA. '88 regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue. fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity. clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this. laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY. GLAND. TUMORS. SPECIMEN TYPE: Resection: tonsillectomy. TUMOR SITE: Pharynx, oropharynx. TUMOR SIZE: Greatest dimension: 2.1 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: Not applicable. PRIMARY TUMOR (pT) : pT2. REGIONAL LYMPH NODES (pN) : pNX. DISTANT METASTASIS (pM) : pMX. MARGINS : Cannot be assessed. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L) : Indeterminate. PERINEURAL INVASION: Absent. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Tonsil cancer. PROCEDURE: Tonsillectomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMOTHERAPY: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION Not answered. OTHER DISEASES Not answered. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Tonsil, Left. Stain/. Block. H&E X 1. B. H&E X 1. C. ANEG Mouse X. 1. D. H&E X 1. D. P16 x 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. AFS. IMSU x 1. (none). Part 2: Left Pharyngeal Wall. Stain/. Block. H&E x 1. A. Part 3: Left Deep Constricture. Stain/. Block. H&E X 1. A. Part 4: Soft Palate Biopsy. Stain/. Block. HHE X 1. A. H&E x 1. A. Part 5: Tonsil, Right. Stain/cr. Block. ANEG Mouse X. 1. A. H&E x 1. A. P16 X 1. A. H&E x 1. B. H&E x 1. C. CONSULTING PATHOLOGIST (S) : TC1.","Invasive squamous cell carcinoma, non-keratinizing, with carcinoma extending to the superior tissue edge. Perineural invasion is absent. Carcinoma is present at the tissue edge. Non-keratinizing squamous cell carcinoma is also identified in the right tonsil. Margins are free of carcinoma in the right tonsil. No tumor is seen in the left posterior pharyngeal wall, left deep constrictor, or soft palate biopsies. Lymphovascular invasion is not identified. Tumor cells exhibit squamous cell carcinoma morphology with no keratinization. No necrosis is identified."
